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Thesis Abstract 
According to WHO report issued on 5th June, 2010, cancer claims 
-7.6 milhon people annually around the world. Its prevention, control 
and management are important fields of research since long. Many 
strategies have been employed for effective treatment of this disease 
but none of them are able to contain it effectively. Chemotherapy and 
radiotherapy are two main modes of treatment offered to the cancer 
patients and combination of the both shows better effect rather than 
alone. 
Cisplatin is the most widely used anticancer drugs under 
chemotherapy alone as well as in combination with other drugs 
together with or without radiotherapy. Its prolonged clinical usage 
exerts many side effects such as nephrotoxicity, hepatotoxicity, 
neurotoxicity and ototoxicity etc. The severity of these side effects 
hampers chemotherapy and worsens the sufferings of the patients. It 
is documented that their occurrence is probably due to the cisplatin 
induced oxidative and nitrosative stresses in vivo. Hence, their 
regulation is very important for better management of the disease, 
better quality of life and also for increasing life span of the patients. 
For the last three decades, many ameliorative agents have been tested 
and implemented for these stresses during chemotherapy. They 
include supplementation of antioxidants, vitamin-A, C and E, 
glutathione, melatonin, flavinoids, medicinal herbs as well as 
techniques like diuresis and intravenous hydration are also employed. 
Riboflavin is an essential hydrosoluble vitamin occurring in all 
forms of aerobic life. It has excellent photosensitizing property that 
has been used in photodynamic therapy and ribophototherapy for the 
treatment of various diseases. The photodynamic action of this 
vitamin involves generation of reactive oxygen species (ROS) that have 
been documented to exert damaging effects to diverse types of 
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biomolecules. Hence, important class of biologically active 
commercially available compounds can potentially interact with 
riboflavin yielding undesirable or desirable effects in vivo. Many drugs 
have been reported to be effected by riboflavin via their mutual 
interaction leading to their deterioration, denaturation or 
detoxification upon administration in living systems that may 
consequently hamper or improve the effects of the drugs or decrease 
the toxic side effects of the same. Chemopreventive drugs for various 
diseases including cancer are essential group of compounds whose 
investigation in this milieu is of paramount significance in the field of 
medicinal research. Like other photosensitizers, riboflavin being an 
efficient and endogenous photosensitizer, can absorb energy of visible 
as well as UV-A light and hence can interact with the administered 
drugs negatively or positively resulting into unsought or coveted 
effects in vivo. 
The present work in this thesis entitled "In vivo studies on 
riboflavin-cisplatin interaction^' deals with interaction between the two 
compounds predominantly investigating any negative or positive 
impact of this interaction in presence or absence of light. Moreover, if 
any such effect exists, can they be replicated in vivo? The study has 
been designed to address all the consequences of riboflavin and 
cisplatin induced toxicities individually as well as in combinations in 
mice as animal model system. The investigation is based on the 
clinical relevance of interaction mediated consequences of drug and 
sensitizer which is very similar to the patients undergoing 
radiotherapy, chemotherapy or the both. 
In the present analysis, the impacts of riboflavin have been 
elucidated on cisplatin under photoilluminated condition. This is 
probably the first study of its kind in such context in vivo. The 
conscious investigations under the study can help us in 
comprehension of these interactions, the mechanisms involved and 
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their possible utilization in the photodynamic therapy and medicinal 
research for better treatment of the diseases including cancer. The in 
vivo work presented here can be broadly divided into three parts: Dose 
and light dependent study, gender dependent study and age 
dependent study. 
In the first part of the work, cisplatin as well as riboflavin 
treated groups showed that both the compounds elicited toxic effects 
as the activity of antioxidant enzymes (CAT, SOD, GR), cellular 
reductants (-SH and GSH) and detoxifying enzymes (GST, TR) were 
highly compromised concomitant with abnormally elevated levels of 
renal function markers (Urea, creatinine, BUN), liver function markers 
(SGOT, SGPT), MDA level, NO* level and carbonyl contents as 
compared to the control. The effect was found stronger in cisplatin 
treated group followed by riboflavin treated group in presence and 
absence of light exposure. The groups treated with combination of 
cisplatin and riboflavin demonstrated normalization of all the 
parameters under this study in a dose dependent manner. 
Furthermore, histopathology of kidney and liver also confirmed the 
ameliorative effect of riboflavin on cisplatin induced tissue-damage. 
As the groups under photoillumination displayed better recovery in all 
the parameters compared to the one without light exposure, hence all 
the experiments were done under photoilluminated condition. 
In the second part of the presented work, male and female 
groups of mice were used and similar parameters were studied as in 
the first part of the study. Between both the sexes, females exhibited 
the better resistance to the cisplatin and riboflavin elicited toxicities 
as well as demonstrated better response to the combinations as 
compared to the males in all the parameters tested. To confirm it 
further, alkaline single cell gel electrophoresis was conducted which 
substantiated that liver and kidney cells of male mice were found 
more vulnerable to the cisplatin and riboflavin elicited toxicities and 
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also responded to the combinations less strongly than the female 
mice. 
The third part was aimed to probe the effect of age on the 
outcome of the similar treatment as in chapter I using three distinct 
age-groups of male mice divided into young (2-3months old), adult (5-
8 months old) and old (12-14 months old). It was observed that young 
aged mice showed moderate tolerance to the toxic insults exerted by 
cisplatin and riboflavin which increased with age till their adulthood 
which declined in the old mice. Similarly, the combinations of 
cisplatin and riboflavin displayed best response in the adult mice-
group followed by young and old groups of mice respectively. The 
comet assay of cisplatin and riboflavin treated kidney and liver cells of 
adult mice depicted better DNA integrity with respect to the young and 
old groups of mice in the sequence. Comet assay of liver and kidney 
cells of treated groups with the combinations demonstrated greater 
recovery in the adult group followed by the young and old groups. 
Finally the in vitro part of the work involving FTIR of riboflavin, 
cisplatin and their combination with and without photoillumination 
was conducted to get insight of mechanism of interaction involved 
between the compounds. The study revealed that active hyroxylated 
form of cisplatin interacts with N-atoms present in the alloxazine ring of 
riboflavin leading to formation of four types of complexes. The N-atom 
occurring in the central ring of the alloxazine ring of riboflavin possibly 
participates in the formation of those complexes which could inhibit the 
free radical generating potential of cisplatin as well as riboflavin. The 
complex formation can occur even in absence of light but their formation 
gets stronger under photoillumination as light causes excitation of 
electrons that promotes various types of interactions. This is the most 
plausible explanation for riboflavin showing better ameliorating effects 
towards cisplatin induced toxicities in vivo which also agrees well with 
the photosensitizing property of riboflavin. Continuous bombardment 
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by free radicals in the target organs can damage them which may 
induce nitric oxide generation. That is why its level was elevated in 
vivo in cisplatin and riboflavin treated mice. Hence, the toxicities 
exerted by cisplatin and riboflavin involve oxidative and nitrosative 
stress in vivo. Hitherto, when the combinations of cisplatin and 
riboflavin were given to the mice, these stresses seemed to decline 
remarkably and consequently the toxicities of both cisplatin and 
riboflavin were shown to decrease. These results were harmonious 
with the results of comet assay and histopathological observation too. 
From these studies, it can be concluded that riboflavin and 
cisplatin individually induce toxicity via oxidative and nitrosative 
stresses in living system and the effects are pronounced further when 
coupled with photoillumination. Hitherto, when the combination of 
cisplatin with riboflavin is given to the living system, their individual 
Itoxic potentials are markedly decreased. It seems that the 
combination of the compounds work on the basis 'toxin cuts toxin' 
theory. This occurs most probably because of their mutual molecular 
interaction in which the hydroxyl groups of active form of cisplatin 
make complex with the N-atoms of alloxazine ring of riboflavin. This 
can lead to lowering of free radicals generating potential as compared 
to their individual potentials. Although it can occur without 
photoillumination but the complex formation is accelerated under 
light. Moreover, female mice can withstand oxidative and nitrosative 
stress and corresponds better to the combinations than the male 
rrfice. Literatures suggest that estrogen in the female mice may also 
help them to withstand the enhanced stress level as well as provide 
increased immunity to fight infections more effectively as compared to 
the males. 
Based on this investigation, we suggest that it is beneficial to give 
riboflavin in moderation to the cancer patients undergoing cisplatin 
based chemoradiotherapy which can help them to decrease the drug 
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associated side effects. It may consequently decrease the suffering of 
the patients along with increase in the quality and span of life. The 
research also opens new vista to design novel drug combination for 
more effective and efficient treatment of cancer. 
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Free radical biology: 
Free radicals are the chemical species having unpaired electrons that 
are generated in vitro as well as in vivo. They are highly reactive 
entities and remain so until and unless their valence shells electrons 
get paired and attain stability. They are formed from parent molecules 
via the breakage of a chemical bond keeping one electron by each of 
its fragment or by cleavage of a radical to generate another radical. 
Besides, they are also produced in redox reactions (Pialliwell and 
Gutteridge, 2007). Except the anaerobic organisms, every living 
system exists as a result of its interplay with the elixir of life, oxygen 
that is essentially required to fuel their whole metabolic system and 
thus their survival. However, such an extremely essential process like 
this comes with a potentially suicidal effect; that is generation of 
promiscuously reactive molecules called as free radicals. In living 
beings, they can be formed by two ways. The first way of generation is 
comprised of enzymatic reactions that includes various steps in 
different oxidation-reduction reactions of metabolic pathways; for 
instance, xenobiotic detoxification mechanism involving cytochrome P-
450 system or peroxisomal P- oxidation, prostaglandins synthesis, 
immune response to viral or microbial invasion in our body (Beckman 
and Ames, 1998; Griot et a l , 1989, Weiss and LoBuglio, 1982). The 
alternate way of production of biological free radicals is from non-
en2ymatic reactions that include substrate level oxidative 
phosphorhylation in mitochondria. Besides, strenuous exercising, 
exposure to ultra violet and ionizing radiation, redox chemicals, 
cigarette smoking, environmental pollution and aging are the few of 
environmental and conditional factors that can also elicit free radicals. 
All these pathways or reactions produce reactive oxygen species (ROS), 
reactive nitrogen species (RNS) and combination of both as nitrogen 
oxygen active species (NOAS). 
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Figure 1: Sources of formation of free radicals 
These radicals are produced by either endogenous sources or by 
exogenous sources. Endogenously, these radicals are generated from 
physiological or bodily actions such as immune response, 
inflammation, toxicity, infection, excessive exercise, ischemia, cancer 
and aging etc. Exogenous sources include pollution (air and water), 
heavy metals (lead, mercury, cadmium etc.), certain drugs 
(gentamycin, cyclosporine), smoking and radiations etc. These agents 
after getting into the body via different routes are decomposed or 
metabolized and trigger generation of various free radicals (Pham-Huy 
e t a l , 2008). 
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Reactive Oxygen Species 
Superoxide anion 
Hydroperoxyl radical 
Peroxyl radical 
Alkoxyl radical 
Hydroxyl radical 
Hydrogen peroxide 
Hypochlorite 
Hypochlorous acid 
Ozone 
Singlet oxygen 
Reactive Nitrogen Species 
Nitric oxide (nitrogen monoxide) 
Nitrogen dioxide 
Peroxynitrite 
Peroxynitrous acid 
Dinitrogen trioxide 
Nitryl chloride 
Nitronium ion 
Alkylperoxynitrite 
Nitrosothiols 
Formula 
•02~ 
HO* 
R0« 
R0» 
•OH 
H2O2 
HOCl" 
HOCl 
O3 
lAg02 
Formula 
NO' 
N02« 
ONOO" 
ONOOH 
N2O3 
NO2CI 
NO^ 
ROONO 
RSNO 
[Adapted from Stocker R, Keany JF. Role of oxidative modifications in 
atherosclerosis. Physiol. Rev. 84; 1381-1478: 2003] 
Table 1: Major reactive oxygen and nitrogen species in biological systems 
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These pathways and sources eject various types of free radicals 
in two forms: ionic (free radical) forms and non-ionic (non-free radical) 
forms. For illustration, oxygen radicals occur in ionic forms of 
superoxide and hydroxyl ions while hydrogen peroxide and singlet 
oxygen are non-ionic forms of oxygen radicals. Besides, nitrogen 
radicals are also elicited in two forms as peroxynitrite (ionic form) and 
nitrogen oxide (non-ionic form) in the pathways (Beckman and Ames, 
1998). Although they are useful but majority of them exert derogatory 
effects on our cellular structure and functions. Hence, living systems 
have been equipped with antioxidant defense system comprising of 
antioxidant enzymes [such as superoxide dismutase (SOD), catalase 
(CAT), glutathione reductase (GR), glutathione peroxidase (GPx)] and 
endogenous antioxidant molecules or cellular reductants [glutathione 
(GSH), sulfhydryl groups (-SH), thioredoxin]. This system traps and 
nullifies the endogenously generated radicals in various metabolic 
reactions in virtually all the aerobic living systems. The livings stay 
healthy as far as the delicate balance between free radical generation 
and their neutralization by the antioxidant defense system is 
maintained. If anyhow, this balance gets disturbed by excessive 
radical generation, insufficient action of antioxidant defense system or 
avitaminosis of A, C and E, the living systems face free radicals 
mediated stress in the body. If the stress is because of oxygen free 
radicals, it is called as oxidative stress or if nitrogen free radicals 
cause such stress then it is referred as nitrosative stress. 
Hence, all kinds of free radicals in the living system generated 
due to endogenous or exogenous factor(s) are continuously produced 
and subsequently countered by the antioxidant systems inside the 
body. A great deal of literature indicates that free radicals especially 
active oxygen-centered ones are highly heterogeneous and highly 
reactive that can invade on the important biomolecules like 
proteins, lipids and DNA. This consequently can lead to enzyme 
inactivation, protein modification (deactivation or hyperactivation). 
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lipid peroxidation, membrane degradation, DNA- strand breakage and 
base modification and so on. Hence, biological free radicals are 
potentially reactive enough to damage the neighboring biomolecules 
and can be causative agents for various diseases, aging and cancer. 
Free radicals in health and disease 
The reactive oxygen species (ROS), reactive nitrogen species (RNS) and 
nitrogen oxygen active species (NOAS) generated in living systems 
collectively induce oxidative and nitrosative stress respectively. All of 
them have dual roles in biological systems that mean they are useful 
generally if released in small amount but elicit harmful effects if 
generated beyond the threshold capacity of antioxidant defense 
system (Valko et al., 2004; Back et al., 2003; Lieberthal et al., 1996). 
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Figure 2: Effect of free radicals on a normal cell 
The beneficial effects of reactive oxygen species (ROS) during the 
immune responses is respiratory burst that destroy pathogens (e.g. 
superoxide radical, peroxynitrite anion), help in killing of microbes 
during inflammation, detoxify xenobiotics or induce mitogenic 
response (Valko et al., 2006). In addition, reactive nitrogen species 
(RNS) also mediate a number of important biological functions. For 
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example, nitric oxide (NO*) is a prominent signal molecule for many 
physiological processes like blood pressure regulation, homeostatic 
regulation, glomerular and tubular function, cell proliferation, 
transcription, neurotransmission, smooth muscle relaxation, energy 
metabolism and immune response (Alderton et al., 2001; Bergendi et 
al., 1999; Chiueh, 1999; Koshland, 1992). Contrary to all these, they 
can exert damaging effects to cellular membranes, proteins, lipids and 
DNA up to various extents depending upon the amount and the 
reactivity of the radicals involved. For example, hydroxyl radicals are 
highly reactive while superoxide anion radicals are less damaging by 
self but can initiate chain of reactions leading to the generation of 
other strong ROS (Valko et a l , 2004; Wickens, 2001; Halliwell and 
Gutteridge, 1999). Hence, their check by endogenous and exogenous 
antioxidants under normal levels is obligatory for healthy life in a,ll 
aerobes. Excessive oxidant exposure, increased endogenous oxidative 
metabolism, redox active xenobiotic system or compromised 
antioxidant capacity; any of these conditions can elevate the free 
radicals to pathological levels in vivo (Halliwell and Gutteridge, 2007; 
Marcillat et al., 1989; Sies, 1985; Davies et a l , 1982). Regardless to 
their source of generation, they can alter the behavior of several cell 
types manifested by various diseases and pathological conditions. 
Oxidative and nitrosative stresses have been manifested in 
general decline in the functions of various organs leading to diseases 
including atherosclerosis, diabetes mellitus, inflammation, AIDS, 
cardiovascular diseases, Alzheimer's disease, Parkinson's disease, 
neurodegenerative diseases, various cancers and aging (Hogg and 
Kalyanaraman, 1998; Beckman and Ames, 1998; Meyer et a l , 1998; 
Pace and Leaf, 1995; Verma et al., 1995; Sies, 1991). Parallel to these 
literature also suggests that many drugs generate free radicals 
mediated side effects or toxicities in situ as well as in vivo (Chirino and 
Pedraza-Chaverri, 2009; Pham-Huy et a l , 2008). 
Review of Literature 7 
Studies claim that ROS and RNS have many common 
characteristics of potential carcinogens. Mutagenesis caused by them 
can assist in initiation of cancer besides performing important roles in 
promotion and progression phases of the disease. They can bring 
structural alteration in DNA that can mutate protooncogenes or tumor 
suppressor genes increasing the vulnerability of the organism to 
cancer. They can even affect cytoplasmic and nuclear transduction 
pathways that can further hamper many cellular functions. These 
radicals modulate activity of many proteins as well as expression of 
various genes which are directly or indirectly related to cell 
proliferation, cell cycle control, differentiation and apoptosis (Wiseman 
and Halliwell, 1996). Analogous to these, a great deal of literature 
entails a strong relationship between the radicals and occurrence of 
chronic inflammation and cancer. One of the emblem activities of 
tumor promoters in animals is their ability to assign/recruit 
inflammatory cells to the effected site and stimulate a respiratory 
burst in these cells to release ROS/RNS and lipid oxidation products 
(Gordon and Weilzman, 1988). Furthermore, blocking the respiratory 
burst in animal models with agents like retinoids, steroids or 
antioxidants leads to the inhibition of tumor promotion (Frenkel, 
1992). 
Many studies indicate a prominent link between the capacity of 
tumor promoters to trigger inflammatory cells to release ROS and RNS 
and their ability to promote tumors. A heightened level of oxidative 
and nitrosative stress is cytotoxic to the cells that can halt 
proliferation by induction of apoptosis or necrosis whereas a moderate 
or low level of such stresses can stimulate cell division and assist in 
immunity. Hence, monitoring and regulation of such radical induced 
stresses is very critical for control and management of cancer as 
evidenced by altered antioxidant network with excessive free radicals 
generation in the tumor cells when co-cultured with active immune 
cells (Valko et al., 2006; Ramacle et a l , 1992). 
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Cancer 
Cataractogenesis 
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Asthma 
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Figure 3: Effect of free radicals on various organs of the body. 
Cancer development is a cumulative process of multi-stage 
events like initiation, promotion and progression. ROS and RNS actively 
participate in all these events. It is also assumed that the radicals 
generated from cancerous cells can generate secondary malignancies 
in the cancer patients. Hence, exploration of their physiological and 
pathological roles in vivo has become a hot field of research for last 
four decades (Minghetti and Levi, 1998). The robust control over the 
free radical generation in the body can open new vista to restrict the 
progression of various diseases like cancer (Wiseman and Halliwell, 
1996). 
Many contemporary studies are directed to manipulate the level 
of various free radicals at different stages of cancer for its effective 
treatment. For example, if the cancerous tissues are in dividing phase 
and they are thrusted with flush of free radicals by any means or 
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agent, they can be forced to undergo apoptosis or necrosis. Although 
necrosis is wrong choice for killing cancerous cells, hence current 
research is aimed at controlling the level of free radicals in such 
circumstance so that apoptosis is operated as predominant mode of 
destroying those cells. 
SaqiMiie* LMKing to Nuip lu t * 
VIruMS 
••< "- Chsmteafe 
Procardnogw^ 
Iniiiation \ - / 
DlriKt CBfChwflpvrw' 
iRtimatd caKinogens 
(a»U 
II 
# 
changd 
F^oniotlon 
Preoeoplaalic 
iaskan 
CkirvtrMSion 
OSel»ctiv» donal 
(ieneiic 
I 
lumor 
• 
II 
Progression 
Ciinlcaj ' 
cancer) H 
ui. 
^ 
I I 
intMnwntton and Sttrafeiiflto* 
} Avoid 
'i»qpos<jr« 
Block 
lnl«rac6ons 
V r . 
lormaKori o< '^ • 
canotnogtris 
1 1 
Primary 
,-i_.J Chemo 
•"-"•] protectiotn 
^Suppress ^^^-i_ 
grtwrth "-J 
Earty 
diagnosis 
Swgsfy 
JUaerspy. 
dwnoUhsfBpy 
Pnaveflft r«te|3fta 
and sftbondafy 
Secondary I 
pfevenlloo ; 
Therapy 
t^  
Tdrliary 
prevenllon ^ 
©ELSEVIER. INC. - ELSEVIERIMAGES.COM 
Figure 4: Stage-wise strategy to counter cancer (Source: Elsevier.com) 
Thus, free radical biology can pioneer the panorama of 
prospective treatment for several diseases including cancer. 
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Riboflavin 
Riboflavin or vitamin B2 is an essential water soluble vitamin which is 
chemically called as 6, 7-dimethyl-9-D-l-ribityl-isoalloxazine. The 
term 'flavin' refers to the yellow chromophoric redox active prosthetic 
groups of a class of respiratory proteins collectively called 
'flavoproteins' ubiquitously present in almost all forms of life. The 
fascinating roles of this vitamin in biological world are quite broad. 
Figure 5: Structure of riboflavin (6, 7-dimethyl-9-D-l-ribityl-
isoalloxazine) 
For examples: photochemical oxidation of dairy products, 
photodegradation of environmental pollutants and bioluminescence in 
bacteria. All these have made flavin based photochemistry an active 
and interesting field of research since 1960s (Gao et a l , 2009; 
Hussain and Alkhateeb, 2007; Sikorska et a l , 2005; Kim et al., 2003). 
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It occurs in almost all aerobes in free or in conjugated forms in 
body fluids and tissues (Heelis, 1982). It is essential for normal 
cellular functions, growth and development. It is utilized in various 
metabolic redox reactions in two prominent forms of cofactors in 
biological systems: Flavin mononucleotide (FMN) and Flavin 
dinudeotide (FAD). These are used by many important enzymes like 
glutathione reductase, succinate dehydrogenase, a-ketoglutarate 
dehydrogenase, pyruvate dehydrogenase complex and NADPH 
reductase. Its daily recommended dose for adults is 2-3 mg (Heelis, 
1982). Riboflavin deficiency is classically associated with the oral-
ocular-genital syndrome. Its deficiency causes many pathological 
conditions like angular cheilitis, photophobia, scrotal dermatitis, 
anemia, growth retardation, acidosis, indigestion, swollen gums, skin 
lesions and poor eye sight etc. Previous studies suggest that riboflavin 
deficient cells are arrested in Gl phase of cell cycle. Furthermore, 
contemporary studies reveal that riboflavin deficiency increases DNA 
strand breakage and enhances the expression of cluster of genes like 
pleimorphic adenoma gene like-1 and perforin-1 in HepG2 cells that are 
involved in cell stress and apoptosis (Manthey et al., 2006). Earlier, 
Friedrich (1988) has reported that riboflavin deflciency impairs proper 
protein folding and genomic stability leading to anemia in humans. 
Riboflavin deficiency has also been linked to increased susceptibility 
to cancers and neurodegenerative diseases (Bareford et al., 2008; 
Webster et al., 1996). Protein carbonylation, DNA breakage and cell 
cycle progression have also shown a strong correlation with its 
deficiency. 
A great deal of literature mentions that light exposure of certain 
chemicals can generate ROS strong enough to introduce mutations in 
vitro as well as in vivo (Vuillaume, 1987). Riboflavin photochemistry 
has also been developed along with light sensitive chemicals as it is an 
excellent photosensitizer. Ribophotochemistry has a greater relevance 
with biology because such photoreactions can occur in different 
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systems under visible light exposure in vitro as well as in vivo. For 
example, staling of food and milk in transparent packages, skin aging, 
sunburn, cataract and skin cancer (Cardoso et al., 2007; Ahmed and 
Mukhtar, 2004; Edward and Silva, 2001; Silva et al., 1999). 
Riboflavin is ubiquitously present in most of the animal and 
plant tissues. When it is exposed to sunlight or radiation, it elicits 
toxic insults or injuries leading to photodamage and cell death as 
evidenced by sunburn, skin lesions and cataract etc. Similar 
speculation has been assigned to a hard jogger for sunburns who jogs 
under sunlight for long duration (Minami et al., 1999). In view of the 
relevance of riboflavin in physiological processes and its excellent 
photosensitizing properties, we have made riboflavin a molecule of 
choice to study its biological photochemistry (Husain et al., 2006). 
Figure 6: Depiction of photodynamic therapy based cancer treatment 
In spite of convincing toxicological literature postulating 
derogatory effects of this vitamin, its application in the field of 
photobiology and phototherapy has been developed into an effective 
mode of treating various diseases like neonatal hyperbilirubinemia, 
pigmented skin lesions and blue nevi (Sato et al., 2000; Behrman et 
al., 1974). Further, its application in inactivation of neurotoxin A, 
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neutralization of carcinogens, killing of tumors, sterilization of 
platelets concentrates and packaged food increased its horizons of 
usage under p?Lotodynamic therapy (PDT) (Cui et al., 2008; Rivlin, 
2007; Eubanks et al., 2005; Edwards et al., 1994; Rivlin, 1973). 
Photochemistry of riboflavin 
The ROS generated by riboflavin can introduce photomodification in 
the compounds which either do not absorb light directly or are not 
modified by visible light themselves (Grossweiner, 1969). It can occur 
either by direct interaction with a substrate to generate radical 
intermediates [type I mechanisms or radical mediated), or by energy 
transfer to oxygen generating singlet oxygen [type II mechanism or 
singlet oxygen mediated). The type I mechanism includes the 
formation of free radicals or radical ions through the transfer of 
hydrogen atoms or electrons by directly interacting with the triplet 
excited state of the sensitizer with target molecules while the type 11 
mechanism involves the generation of singlet oxygen (lAg02) by energy 
transfer from the excited triplet sensitizer to a ground state oxygen 
molecule. It is documented that riboflavin gets excited under 
visible/UV light and forms singlet state that further can attain triplet 
state by absorbing more energy. While coming back to the ground 
state, it emits energy strong enough to give rise singlet oxygen 
molecules via energy transfer in aqueous medium (Chacon et al., 
1988). The actual mechanism of it is very complicated because of 
concurrent involvement of various oxygen radicals including singlet 
molecule and superoxide anion radical which sire generated with 
quantum yields of 0.49 and 0.009 respectively (Krishna et a l , 1991). 
Abstraction of an electron from a substrate AH by excited riboflavin 
can form cation radical, AH+ and riboflavin semiquinone anion radical 
(Heelis, 1982). Then, this riboflavin anion radical can donate electron 
to AH+ and undergo dismutation to form AH and reduced riboflavin or, 
can donate to the dissolved oxygen molecule to produce superoxide 
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radicals that can further generate hydroxyl radicals in presence of 
divalent metals (Ahmad et al., 2010; Nazarul et al., 2006; Kumari et 
a l , 1996; Silva and Godoy, 1994; Grossweiner, 1969). It is also 
reported that photo-excited riboflavin having reduction potential of 
1.89 V can oxidize a large variety of compounds and in absence of 
other oxidizable substrate, it can even oxidize other riboflavin 
molecules into lumichrome, lumiflavin and 7, 8-dimethyl-lO-
formylmethyl isoalloxazine by photoaddition and photoreduction 
reactions (De Souza Queiroz et al., 2007; Ahmad et a l , 2006). These 
photoproducts of riboflavin are stable enough to sustain their effect on 
the other molecules in the medium for appreciably long time. 
Many in vitro studies have shown that riboflavin generated 
reactive substances can photodamage biomolecules like proteins, 
lipids and DNA (Fontana et a l , 2011; Nazarul et al., 2006; Jazzer and 
Naseem, 1994; Naseem et a l , 1993; Kasai et a l , 1992). Apart from 
these, photoproducts of riboflavin can influence or modify some 
vitamins, herbicides, polymers and drugs under UV-visible radiations 
that can change/enhance/diminish their native properties (Amine-
Khodja et al., 2004; Kochansky and Nasi, 2004; Konstantinou et al., 
2001). Riboflavin is degraded through a variety of reactions in vitro 
including photolysis (intramolecular photoreduction) and 
photoaddition (intramolecular photoaddtion) as major types. 
Additionally, near UV light and daylight fluorescent light irradiated 
riboflavin produces derogatory effects on mammalian cells in culture 
which has been attributed to products of the riboflavin-sensitized 
photooxidation of tryptophan and/or tyrosine such as a 
complex mixture of indolic, flavinic and indolic-flavin type 
aggregates/photoadducts (Edward and Silva, 2001; Edward et al., 
1994). The biological effects following these reactions are, however, 
much less clear. It has been suggested that irradiated-riboflavin 
induced formation of reactive oxygen species and stable 
photoproducts that are able to induce cell death and autophagy in the 
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treated cells in vitro and in situ but, their chances of occurrence in 
vivo, is yet to be ventured although its phototoxic insults to cell matrix 
compounds in skin and eyes leading to lesions formation, cataract, 
inflammation, accelerated aging and even mutation and cancers are 
highly anticipated (Diaz et al., 1996). As for its positive side, it has 
been published recently that flavins have the capacity of inducing 
apoptosis and autophagy in human tumor cells cultured in vitro after 
visible light irradiation. Both cell death mechanisms in vivo have dual 
benefits: first, both are effective mechanisms for the killing of tumor 
cells and secondly, they do not cause any inflammation or damage to 
the surrounding healthy tissues otherwise that could lead to tumor 
prophylaxis (Muhoz et al., 2011). 
Riboflavin and cancer 
The literature relating riboflavin with cancer is quite complicated. 
Some studies plead that riboflavin deficiency enhances the risk of 
cancer at certain sites whereas others point to a possible attenuating 
effect of riboflavin in the presence of some carcinogens (Revlin, 1973). 
Some carcinogens are metabolized by flavin-dependent enzymes and 
riboflavin may enhance or alleviate the effects of such carcinogens 
(Webster et al., 1996). Scientific investigations on many animal 
species have displayed that riboflavin deficiency can lead to disruption 
of the integrity of the epithelium of the esophagus, similar to 
precancerous lesions in humans. Some epidemiologic studies have 
identified a relation between esophageal cancer and low intake of 
riboflavin (Foy and Kondi, 1984), although opposing studies to this 
relation have also been reported (Siassi et al., 2000). Combined daily 
supplements of riboflavin and niacin over 5 years were effective in 
reducing the occurrence of esophageal cancer in Linxian (China), an 
area with a high prevalence of this type of cancer (Blot et al., 1993). A 
decade ago, it was reported that riboflavin deficient rodents when 
exposed to hepato-carcinogens showed to have increased DNA strand 
Review of Literature 16 
breakage as well as enhanced induction of repair enzymes that might 
aid to the resistance to malignant transformations (Webster et al., 
1996). High-dose of riboflavin supplementation was observed to 
reverse both effects to near-normal values. Pangrekar et al. (1993) has 
reported a protective role of riboflavin in carcinogenesis demonstrating 
that carcinogen binding to DNA is decreased in riboflavin-sufficient 
rats. 
Richard S. Revlin (1973) has reported in his review that a 
prominent alteration occurs in riboflavin metabolism in the cancer 
patients showing considerably low excretion of riboflavin in urine 
(Kagan, 1960). Many studies have also indicated that riboflavin 
sufficiency showed protective effect against the development of tumors 
(except few types of cancer like lymphosarcoma and mammary cancer) 
as well as increased efficacy of anticancer drugs like methotrexate 
(Lichtenstein and Goldman, 1970). More recent studies confirm 
that riboflavin deficiency may favor tumor formation by increasing the 
activation of certain carcinogens, particularly nitrosamines. The flavin 
vitamin has been documented to provide protection against the 
damage to DNA caused by a number of carcinogens through its action 
as a coenzyme with a variety of cytochrome PASO enzymes. 
Hence, its concentration in the patients is very crucial during 
chemotherapy based treatment of cancer. In recent past, it has been 
reported that supplementation of riboflavin to breast cancer patients 
can decrease the levels of pro-angiogenic factors and increase the 
levels of anti-angiogenic factors that can attribute to reduction in 
tumor burden and may suggest good prognosis and efficacy of the 
treatment and might even offer protection from cancer metastases and 
recurrence (Premkumar et al., 2008). 
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Therapeutic perspectives of Riboflavin 
Although the damaging effects of riboflavin under photoillumination 
cannot be ignored but its substantial usage in photodynamic therapy 
(PDT) is yet to be explored for the treatment of different diseases. The 
interaction of riboflavin with various drugs or pharmaceuticals via free 
radicals is of paramount importance since it can either degrade them 
or decrease their therapeutic efficacy or even modify them into more 
toxic products. Nevertheless, possibility of occurrence of positive 
effect(s) from the interaction cannot be ruled out completely. The 
interaction can scavenge the free radicals generated by the drugs that 
can lessen the side effects or toxic insults of the drug involved 
(Massad et a l , 2004; Posadoz et al., 2000). The application of 
ribophototherapy for reduction of drug induced side effects is the need 
of the hour in the field of medicine. It is documented that 
photosensitizers generally induce apoptosis upon accumulation in 
mitochondria under photoillumination while necrosis occurs when the 
sensitizers build up in cytoplasm (O'Connor et al., 2009). These 
observations suggest the possible usage of the compounds with 
amazing photosensitizing property like riboflavin in the treatment of 
diseases involving radiation based therapy. It can be tested for cutting 
down toxic insults exerted by various drugs used in radiotherapy. This 
myriad of possibilities can be relative to many factors including 
properties of the drug and photosensitizer as individual entities, their 
concentration, type, reaction media, presence of possible inhibitors or 
stimulators and the radiation source (Tsao and Eto, 1994). 
Cancer, being one of the most dreadful diseases, is very little 
explored under photodynamic therapy especially with reference of 
riboflavin in particular. Many works entail a noticeable link between 
cancer and riboflavin. Due to the photodynamic properties of 
riboflavin, it has potential efficacy to be used as adjuncts in cancer 
treatment. Blue light has been reported to inhibit the proliferation of 
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B16 melanoma cells grown in culture as well as those transplanted to 
rodent models. It has shown both cytostatic and cytocidal properties 
in such studies (Ohara et al., 2003). Riboflavin is the only vitamin that 
has been observed to increase the degree of cell necrosis induced by 
blue light. The efficacy of riboflavin is concentration dependent and 
antagonized by catalase. Ohara et al. (2003) have postulated 
that riboflavin, by reacting with blue light to form active oxygen 
intermediate, may cause a greater degree of cell necrosis than blue 
light alone. As we are aware that cell requires a minimally requisite 
redox status to undergo apoptosis, hence, if riboflavin induced redox 
status is manipulated to such level then it can certainly open new 
vista to treat lethal diseases like cancer. 
Studies have been conducted to investigate the possibility of 
employing oxygen radicals (formed by the reaction of UVA with 
riboflavin) in the treatment of blue nevus (Sato et al., 2000) and 
erosive corneal processes (Schnitzler et al., 2000). The combination of 
blue light and photoreactive substances like riboflcLvin is also expected 
to be useful for the treatment of various conditions such as cancers, 
stains and blotches (Sparsa et a l , 2010; Ohara et al., 2003). These 
considerations imply that riboflavin directly or indirectly involved in 
carcinogenesis. Hence, riboflavin with light has bright prospectives in 
this context. 
Photosensitizers preferentially accumulate in the region of a 
tumor and provide the possibility of killing multidiiig resistant (MDR) 
cells or modulating the MDR phenotype (Capella and Capella, 2003; 
Pandey et a l , 1997) that can widen the therapeutic window of 
photodynamic therapy (PDT) as an alternative treatment for MDR 
tumors as well. This relatively new therapeutic modality for both 
neoplastic and nonneoplastic diseases involves a dye (photosensitizer) 
that has been selectively taken up by the target tissue, the presence of 
molecular oxygen, and light activation. This combined treatment leads 
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to the generation of reactive oxygen species (ROS), such as singlet 
molecular oxygen, hydroxyl radicals, and/or superoxide anions (Wang 
et a l , 2002). Riboflavin can efficiently perform all these actions. 
Edv^ard et al. (1999) reported that ROS and photoproducts of 
irradiated riboflavin can induce cell death in HL60 cells. Finally, De 
Souza Queiroz et al. (2007) and Santos De Souza et al. (2006) 
demonstrated anti-proliferative and anti-metastatic effect of irradiated 
riboflavin against cancer cells in situ by separately designed 
experiments. 
Another very striking aspect of riboflavin is that no toxic effect 
of this vitamin has been reported at very high dose in vivo till date. 
This fact allows this vitamin to be exploited for the betterment of 
current treatments or in designing novel treatment methods based on 
riboflavin for various diseases. The present work has been designed to 
address all these issues and explore all the possibilities. 
Cisplatin 
Cisplatin or, cis-diamminedichloroplatinum [cis-PtCl2(NH3)2] is an 
inorganic complex compound having platinum as its central atom that 
is coordinately bonded to two chlorine and two amino groups in cis-
configuration of a horizontal plane. It has been used as a first line of 
chemotherapy for the treatment of several cancers such as 
oropharyngeal, lymphoma, prostrate, osteosarcoma, melanoma, 
ovarian, testicular, cervical, small cell lung, head and neck cancer and 
neuroblastoma etc. alone or in combination with other drugs since its 
approval as an anticancer drug (Basu and Krishnamurthy, 2010; 
Weiss and Christian, 1993). It was firstly synthesized by Michel 
Peiyone in 1845 while Alfred Wegner was the first to describe its 
structure but it was Barnett Rosenberg (1969) who serendipitously 
discovered its cytotoxic effects (mitosis inhibition) in E. coli culture in 
1965. 
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Figure 7: Structure of cisplatin (cis-diamminedichloroplatinum) 
Lebwohl and Canetta (1998) were the first to confirm the anticancer 
activity of this drug in rodents while working at Michigan State 
University, USA. Finally, American Food and Drug Administration 
(FDA) approved its clinical usage in 1978 for the treatment of bladder, 
cervical, esophageal, head and neck, testicular and ovarian cancer etc. 
It is also used for chemotherapy of recurrent brain tumors and 
intracranial germ cell tumors (Spence et a l , 1992). During last three 
decades, its widespread clinical use has made it w^orld's third ranked 
anticancer drug against various cancers and solid tumors (Weiss and 
Christian, 1993). 
Transport of cisplatin 
Cisplatin is a neutral, hydrosoluble and square planar complex 
molecule consist of divalent platinum as the central atom coordinately 
bonded to two labile chloride groups and two relatively inert amine 
groups (Todd and Lippard, 2009). The drug enters the cells by both 
active and passive transport although active transport has been 
reported to be more prevalent. Several transporters like copper 
transporters (CTRl) Sodium-potassium ATPase and organic cationic 
transporters SLC22 (Solute carrier transporters) facilitate its active 
transport while copper transporters- CTR2, ATP7A , ATP7B and ATP-
dependent glutathione conjugated efflux pump have been implicated 
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to export cisplatin from the cells (Hall et al., 2008; Safaei and Howell, 
2005; Byfield and Calabro-Jones, 1981). Hence, ultimately it is the 
resultant effect of all these influx and efflux transporters that decides 
the final concentration of the drug inside the cells. Transport of the 
drug and their retention in the cancerous cells are few of the main 
contributing factors to get desired effect of the drug during therapy. 
Pharmacodynamics of cisplatin 
As soon as cisplatin gets into the cells, it is activated by aquation 
reaction involving the sequential thermal ligand exchange of two 
chloride groups by two water or hydroxyl ligands (Rosenberg, 1979). 
This reaction is facilitated by low chloride concentration (< 103mM) 
and highly hydrated environment of cytosol. It results in the formation 
of activated cisplatin (also called as bioactivated form) that can react 
with cytosolic and nuclear proteins and nucleic acids. According to 
pharmacokinetic studies, initial cisplatin-plasma half life is 25-49 
minutes while its secondary half life is of 58-73 hours. 90% of its total 
amount can bind to the various proteins within 2 hours of its 
administration. Major target organ of this drug is kidney which helps 
to excrete 27-45% of total platinum content of the drug within 5 days 
of its administration while the rest 43% can be retained in the body 
for < 50 days (Chirino et al., 2008). 
After activation, cisplatin acts as a potent nucleophile and 
attack on DNA to bind at N-7 of purine bases (preferentially guanine) 
leading to formation of 1, 2 or 1, 3-intrastrand cross-links (>90% of 
the total products) and a lower amount of interstrand cross-links 
(Furutaetal . , 2002). 
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Figure 8: Main adducts formed between cisplatin and nucleobases in 
DNA. (a) interstrand crosslink, (b) 1,2-intrastrand dApdG, (c) 1,3-
intrastrand, (d) monofunctional adduct [Gonzalez et al., Mol. 
Pharmacol. 59(4); 657-563: 2001] 
The trans-configuration of the drug is inactive as it is unable to 
be intercalated in between the DNA strands and hence, incapable to 
form such cross-links. Therefore, the fixed spatial arrangement of the 
groups with platinum in cis-configuration is essentially important to 
bind and/or intercalate in between the DNA strands. The cross-links 
are supposed to disrupt the stacking of purines that causes kinking of 
the double helix and bending it by 34° towards the major groove as 
well as unwinding of minor groove by 13° (Bellon et al., 1991). These 
conformational alterations in the helix introduced by these adducts 
and cross-links lesions cause the cellular replication and transcription 
machinery to derail if these anyhow evade from DNA repair machinery 
in the effected cells (Boulika and Vougiouka, 2003; Takahara et al., 
1995). 
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It is documented that DNA damage incurred by cisplatin 
transcends rapid activation of ataxia telangiectasia and Rad 3- related 
(ATR) that phosphorhylates a checkpoint kinase, Chk2. ATR/ Chk2 
signaling is largely responsible for p53 activation. The activated form 
of p53 further can bind to DNA that stimulate a cyclin dependent 
kinase (cdk), p21 inhibitor that subsequently interacts with cell 
division stimulating protein (cdk2). The complex of both does not let 
the cells to proceed to next stage of cell division (Pabla et al., 2008). 
Hence, the damage induced in the genomic DNA can activate delay 
cell cycle progression to provide time either for DNA repair or to 
eliminate the genetically unstable cells (like cancerous cells) by cell 
death induction. Hence, the DNA damage can engage intricate signal 
transduction pathways including Akt, PKC and MAPKs that regulate 
cisplatin induced apoptosis in the treated cells. During long term 
chemotherapy, the accumulation of cisplatin-DNA adducts mounts 
with time up to the extent that the cells undergo either apoptosis or 
necrosis depending upon the DNA or protein damage(s) induced by the 
drug. How the cells respond to cisplatin induced DNA damage plays 
deciding role whether they should live or die following cisplatin 
treatment. This is considered the most appropriate/accepted 
explanation for the anticancer activity of this drug (Santandreu et al., 
2010;Poolyetal. , 1984). 
Side effects of cisplatin 
Since alkylating agents like cisplatin are designed and intended to 
destroy cancerous cells (tumors or collection of abnormal human cells 
of a particular type) in human but inevitably non-cancerous (healthy) 
cells are also targeted after their clinical intake. The most common 
toxicities as a consequence of the alkylating agent administration 
under chemotherapy are related to the destruction of normal cells 
leading to pathogenesis of the target organs such as kidney, liver, 
brain, internal ear, intestinal mucosa etc (Kart et al., 2010; Cayir 
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et al., 2009; Aggarwal, 1993). Alkylating agents are known to cause a 
dose-dependent destruction of certain cells of the immune system as 
well. The central nervous system has also been found to be affected by 
alkylating agents as cisplatin is quite neurotoxic, leading to acute 
confusion, delirium, seizures, paralysis, and coma. Besides, alopecia 
(hair loss) and dysfunction of sex organs in male and female have also 
been recognized as other toxic insults. 
Hence, cisplatin toxicity is one of the major concerns in cisplatin 
based chemotherapy. These toxic insults exerted on the healthy cells 
collectively known as the side effects. These cytotoxic effects of the 
drug involve membrane peroxidation, dysfunction of mitochondria, 
inhibition of protein synthesis and genomic damage at cellular level 
(Kharbanda et al., 1995; Brady et al., 1990). Many literatures suggest 
that cisplatin generates reactive oxygen and nitrogen species leading 
to oxidative and nitrosative stress which result into such organ 
specific deleterious effects in vivo (Chirino and Pedraza-Chavarri, 
2009; Santos et a l , 2007; Ozyurt et a l , 2006). As the chemotherapy 
involving cisplatin prolongs, the accumulation of these toxic insults 
mounts in vivo resulting into nephrotoxicity, hepatotoxicity, 
neurotoxicity, ototoxicity, myelosuppression, excessive nausea and 
vomiting (Kart et al., 2010; Barabas et al., 2008). 
The enhancement of some oxidative and nitrosative markers 
and their depletion upon supplementation of antioxidants and free 
radicals scavengers strongly advocate involvement of the oxidative and 
nitrosative stress in cisplatin induced side effects both in vitro as well 
as in vivo models. In addition to it, no exact in vivo sequence of 
alterations post cisplatin treatment is vividly known till date. Some of 
the earliest events of its toxicity after its administration include DNA 
damage and activation of ATR/Chk2 proteins and poly (ADP-Ribose) 
polymerase (PAR?), glutathione (GSH) depletion and elevation of 
calcium level. Decrement in the activity of coEiplexes I-IV and 
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dropping of ATP level in mitochondria, mitochondrial Box 
translocation and release of cytochrome c from mitochondria could be 
set of secondary events. Mitochondrial dysfunction can leak out free 
radicals that can cause inflammation which can upregulate tumor 
necrosis factor-a (TNF- a), NADPH oxidase and inducible nitrogen oxide 
synthase (iNOS) under inflammatory response. These upregulations 
further may direct towards 02*" and NO* synthesis and peroxynitrite 
may be formed as a consequence. All these aggressive species bring 
modification in proteins, lipids and DNA and accumulation of their 
damage over the time can finally trigger apoptosis or necrosis in the 
cells under effect. 
So, intrinsic or acquired resistance, cytotoxicity to healthy cells, 
compromised antioxidant levels and abundant free radical generation 
constrict the organotropic profile of this drug. The severity of these 
effects is time and dose dependent of the drug. Hence, countering or 
controlling these side effects to enhance the drug dose and its efficacy 
for better management of cancer is one of the hot spots in the field of 
cancer research since its clinical application. 
Amelioration of cisplatin induced side effects 
Organisms are well equipped to withstand the toxic insults in the form 
of side effects exerted by the drugs like cisplatin. The drugs are 
undertaken by xenobiotic metabolism in the living system. As the 
studies proclaim that most of its side effects are induced by free 
radicals, they are controlled or defused in two ways: enzymatic way 
and non-enzymatic way. Superoxide dismutase (SOD), catalase (CAT), 
glutathione reductase (GR), glutathione peroxidase (GPx) are few of 
the most important antioxidant enzymes while glutathione-S-
transferase (GST) and thioredoxin reductase (TR) are essential 
detoxifying enzymes; both types of enzymes constitute enzymatic 
defense system against the side effects. Non-enzymatic way to counter 
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free radicals mediated cisplatin induced side effects is comprised of 
metabolic (endogenous) and nutrient antioxidants. Metabolic 
antioxidants are endogenously generated in our body such as uric 
acid, L-arginine, bilirubin, transferrin, lipoic acid etc. while nutrient 
antioxidants includes diet based on exogenous sources like vitamin-
A, C and E, medicinal herbs, melatonin, glutathione, flavinoids and 
various synthetic free radical scavengers (Pham-Huy et al., 2008). 
Several strategic trials have been published to tame the cisplatin 
elicited side effects since its clinical application in chemotherapy like 
intravenous hydration, stress busting activities and diuresis (Kart et 
a l , 2010; Ibrahim et al., 2009; Reedijik, 1999; Weiss and Christian, 
1993). These proposed methods either reduce or retard the side effect 
but most of them are merely temporarily effective. Among all these, 
antioxidants rich diet and stress free life style are considered the best 
regimes to contain or alleviate the side effects but no substantial 
breakthrough has been achieved in this field yet. The positive effect of 
antioxidants and free radical scavengers for decreasing the cisplatin 
induced toxicities in vivo confirms involvement of oxidative and 
nitrosative stress (Jia et al., 2011; Chirino et al., 2008, Ali and 
Moundhri, 2006). Hence, decreasing such stress by any non-toxic 
agent or molecule can be a very suitable solution to address this 
clinical aspect of the drug. 
Since the recent past, photo-oxidation sensitized by natural 
compounds is of great interest for investigation in relation to the 
substrates related to pharmacology and medicine. The interactions of 
drugs with molecules like vitamins are very important in the field of 
medicines as they can photodamage the drugs leading to their 
compromised therapeutic effects or even worse, the generation of toxic 
products. Nevertheless, a positive effect can also arise from such 
interactions with some photogenerated oxygen species that may 
contribute to fine-tune the therapeutic effect(s) or decrease the 
undesired effect(s) of such drugs (Massad et al., 2005; Pasodaz et al.. 
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2000). Combination therapy like radiotherapy or photodynamic 
therapy for the treatment of cancer involves anticancer drug or 
combination of the drugs along with another compound that can 
improve the treatment by either enhancing the anticancer activity or 
by decreasing the side effects of the drug (Ho, 2006). 
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Figure 9: Use of oxidative/nitrosative stress biomarkers in detection 
of disease initiation and/or progression as well as in assessing 
effective therapies. [Mass Spectrometry Reviews, 2005, 24, 55-99 
(Wiley Periodicals, Inc.) DOI 10.1002/mas.20006] 
Many scientific investigations indicate increased susceptibility 
to cancers and compromised immunity because of riboflavin 
deficiency in human and animal models broadening the therapeutic 
window of riboflavin in chemotherapy for cancer (Mufioz et al., 2011; 
O'Connor et a l , 2009; Bareford et al., 2008; Queiroz et a l , 2007; 
Santos De Souza et al., 2006; Ho, 2006). Its null toxicity in vivo record 
at very high dose, ubiquitous presence in all aerobes, excellent 
photosensitizing property and promising anticancer activity having 
encouraging in situ track record make it definitely a stronger trial 
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candidate in this regard in vivo. Besides, riboflavin has been 
recommended to help in preventing DNA damage, mutations and the 
occurrence of cancer as well as chemotherapy related adverse effects. 
Its adequate supplementation has been proposed to assist in 
preventing chemo/radiotherapy induced changes in intestinal mucosa 
by minimizing mucosal damage and restoration of normal intestinal 
function. A well functioning intestinal mucosa is requisite for eflicient 
absorption of diet and drug for better effect and health status of the 
patients undergoing chemo/radiotherapy. In this way, this flavin 
vitamin can show cooperative or synergistic effect with such therapies 
against cancer. 
The success of this drug is dependent on two major factors: the 
drug induced damage and subsequent DNA repair triggered by the 
damage. If DNA repair is predominant in the cancerous cells then 
efficacy of the drug is definitely compromised although this can help 
the neighboring healthy cells to avoid its toxicities. Hence, any 
treatment strategy that can elevate DNA damage in the cancerous 
cells concomitant with promoting efficient DNA repair in the healthy 
cells, is poised to be the most ideal treatment for cancer. The present 
work has been designed and planned keeping all these in mind as 
riboflavin can improve DNA repair and also can act as adjuvant in 
chemotherapy with antineoplastic agents like cisplatin by inducing 
apoptosis instead of necrosis which is safer way to kill the cancerous 
cells. 
For the last 20 years, our lab has been exploring the potentials 
of riboflavin and its interaction with various biomolecules in vitro 
(Nazarul et al., 2006; Jazzer and Naseem, 1994; Naseem et a l , 1993; 
Naseem et al., 1988). We have demonstrated that riboflavin under 
photoillumination generates reactive oxygen species that are capable 
to damage important biomolecules like DNA and protein (Husain et 
a l , 2006; Jazzer and Naseem, 1996). Later, we have also reported that 
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riboflavin upon photoactivation can decrease the efficacy and stability 
of drug like aminophylline together with increased toxicity in vitro 
(Hassan et al., 2006). Recently, we observed an extremely intriguing 
aspect of riboflavin when it blunted the cisplatin induced DNA damage 
in mouse skin cells under photoilluminated condition in situ in a dose 
dependent manner instead of enhancing the toxicity of the drug as we 
were expecting (Husain and Naseem, 2008). This in situ observation 
prompted us to investigate the effect of riboflavin and cisplatin 
combination in vivo to see whether it holds true in case of in vivo or 
not. The present study will provide the insight of the interaction 
between cisplatin and riboflavin that can guide to design novel 
photodynamic therapy for the treatment of cancer like diseases with 
more efficacy and ease. 
Materials 
and 
Methods 
Materials/Reagents used 
Agarose Qualigens Fine Chemicals, India. 
Beta- mercaptoethanol Sisco Research Lab (SRL), India. 
Bovine serum albumin (BSA) Sigma-Aldrich Chemical Company, USA. 
Cis-diamminedichloroplatinum (II) Sigma-Aldrich Chemical Company, USA. 
l-chloro-2,4-dinitrobenzene (CDNB) HiMedia Laboratories Pvt. Ltd., India. 
Dinitrophenylhydrazine (DNPH) Sigma-Aldrich Chemical Company, USA. 
Ethidium bromide (EtBr) 
Folin's Phenol Reagent 
Glycine 
Hank's balanced salt (HBSS) 
Histopaque-1077 
Hydrogen peroxide 
Low melting point agarose (LMPA) 
Nicotinamide adenine dinucleotide 
Nitro blue tetrazolium (NBT) 
Oxidized glutathione (GSSG) 
Sigma-Aldrich Chemical Company, USA. 
Sisco Research Lab (SRL), India. 
Qualigens Fine Chemicals, India. 
Sigma-Aldrich Chemical Company, USA. 
Sigma-Aldrich Chemical Company, USA. 
Qualigens Fine Chemicals, India. 
Sigma-Aldrich Chemicad Company, USA. 
Sigma-Aldrich Chemical Company, USA. 
Sigma-Aldrich Chemical Company, USA. 
Sigma-Aldrich Chemical Company, USA. 
Para-nitrophenyl phosphate (PNPP) HiMedia Laboratories l^t. Ltd., India. 
Phosphate buffered saline (PBS) 
Potassium phosphate 
Pyrogallol 
Reduced glutathione (GSH) 
Riboflavin (RF) 
RPMI 1640 media 
Sodium hydroxide (NaOH) 
Sodium phosphate 
Succinic acid 
Thiobarbituric acid (TBA) 
Trichloroacetic acid 
Triton X-100 
Sigma-Aldrich Chemical Company, USA. 
Qualigens Fine Chemicals, India. 
Qualigens Fine Chemicals, India. 
Sigma-Aldrich Chemical Company, USA. 
Sigma-Aldrich Chemical Company, USA. 
Sigma-Aldrich Chemical Company, USA. 
Sisco Research Lab (SRL), India. 
Sisco Research Lab (SRL), India. 
Qualigens Fine Chemiicals, India. 
HiMedia Laboratories Pvt. Ltd., India. 
HiMedia Laboratories Pvt. Ltd., India. 
Qualigens Fine Chemicals, India. 
All other chemicals used were of analytical grades. 
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In Vivo Studies 
Animal Husbandry 
60 adult Swiss albino mice of 45-50 g weight were purchased from 
Central Animal House of Jamia Hamdard University, New Delhi, in 
which half of them were female. 10 healthy females were kept 
separately for breeding with their male partners to generate the 
siblings for desired number of mice for treatment under the 
experimental conditions. All of them were kept in sufficiently large 
cages with uninterrupted supply of standard pellet mice diet 
(Ashirwad Industries, Chandigarh, India) and clean drinking water ad 
libitum. They were acclimatized and treated under humane and 
hygienic conditions with maintained 25 ± 2 °C and 12 hours day: 
night cycle according to 'University Guidelines for Experimentation on 
Animals'. 
The mice were randomly divided into various groups of 6 mice 
each according to demand of the study mentioned in the below. They 
were treated with riboflavin and cisplatin separately and also with 
their combinations. The test chemicals were freshly prepared in saline 
just prior to dosing to get the best effects. 
Photoillumination procedure 
The groups treated under photoillumination were housed in separate 
cages. They were exposed to full body irradiation under florescent light 
by Philips fluorescence lamp kept at -10 cm distance at fluence rate of 
38.6 w/m2 for 12 hours daily during daytime only. The 
photoillumination didn't cause any heating effect on the animals as 
the room was air conditioned with maintained temperature at 25 ± 2 
°C. The dorsal surface (head and back region) of all the mice treated 
under photoillumination was mildly shaved with the help of aseptic 
razor for maximum possible penetration of light through the skin. 
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Dosing and treatment strategy 
100 jal of all the test chemicals were given intraperitonially with 1ml 
capacity syringe in the respective groups. The mice were given a daily 
injection for 3 days followed by a gap of a week, then again a daily 
dose for 3 days with a week gap and finally 3 more daily injections. 
This treatment schedule was applied to mimic the current cancer 
treatment strategy for the patients. The treatment strategy, dose and 
the duration of treatment were chosen to study the chronic effect of 
the treatment at moderately toxic dose of the drug,, Their body weights 
were measured weekly. Group II was considered as the control to 
compare with all other groups for all calculations and evaluations 
purposes. All the mice were healthy during the treatment. The animals 
showing the signs of distress were removed from the treatment. The 
treatment was scheduled in such a way that all the animals were 
sacrificed on the same day. 
In vivo study conducted can be divided into 3 chapters as 
mentioned in the below: 
Chapter I: Dose and light dependent study 
Treatment on 10 groups (6 male mice in each group) was given 
according to Table no. 1 (given in the below) to study the effect of 
photoillumination on the outcome of the treatment with increasing 
dose of RF in vivo. Nine doses of the test chemicals were given 
according to our standardized dosing schedule as mentioned in 
'dosing and treatment strategy' of 'Methods' section. 
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Group 
I 
II 
III 
IV 
V 
VI 
VII 
VIII 
IX 
X 
Name 
Control normal 
Control* 
Riboflavin treated 
Riboflavin treated* 
Cisplatin treated 
Cisplatin treated* 
Combination I 
Combination I* 
Combination II 
Combination II* 
Treatment 
Saline 
Saline 
Riboflavin (2mg/kg) 
Riboflavin (2mg/kg) 
Cisplatin (2mg/kg) 
Cisplatin (2mg/kg) 
Cisplatin (2mg/kg) +Riboflavin (Img/kg) 
Cisplatin (2mg/kg) +Riboflavin (Img/kg) 
Cisplatin (2mg/kg) +'.Riboflavin (2mg/kg) 
Cisplatin (2mg/kg) +]Riboflavin (2mg/kg) 
(Note: * indicates that the treatment was given to the animals under 
photoillumination) 
Chapter 11: Sex dependent study 
Treatment of 5 female groups and 5 male groups under 
photoillumination was studied to investigate any existing differential 
effects of gender on the treatment. Dosing schedule and amount was 
' according to the following table (Table 2). 
Group 
I 
II 
III 
IV 
V 
Name 
Control 
Riboflavin treated 
Cisplatin treated 
Combination I 
Combination 11 
Treatment 
Saline 
Riboflavin (2mg/kg) 
Cisplatin (2mg/kg) 
Cisplatin (2mg/kg) +Riboflavin (Img/kg) 
Cisplatin (2mg/kg) +Riboflavin (2mg/kg) 
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Chapter IIJ: Age dependent study 
Treatment on 5 groups of young male mice (2-3 months), 5 groups of 
adult male mice (6-8 months) and 5 groups of old male mice (12-14 
months) to study the differential effect/response of age on the 
treatment. Dosing schedule and amount was according to the table 
given in the below (Table 3). 
Group 
I 
II 
III 
IV 
V 
Name 
Control 
Riboflavin treated 
Cisplatin treated 
Combination I 
Combination II 
Treatment 
Saline 
Riboflavin (2mg/kg) 
Cisplatin (2mg/kg) 
Cisplatin (2mg/kg) +Fdboflavin (Img/kg) 
Cisplatin (2mg/kg) +Pdboflavin (2mg/kg) 
Animal Sacrifice and sample collection 
The animals under treatment were sacrificed on the next day to the 
final dose (9^ dose) in each study. The animals were sacrificed by 
cervical dislocation method according to standards of animal 
handling. After the sacrifice, their blood was collected by heart 
puncture method in separate heparinised centrifuge tubes. Besides, 
their kidney, liver and brain were washed in chilled saline and their 
weights were noted. 
Sample preparation for biochemical estimations and assays 
First of all, heparinised blood of each mouse was centrifuged (Remi, 
India) at 2500 rpm (1500 g) to collect their serum in separate vials 
that are stored at -20 °C. 
After weighing, the organs were placed into ice cold potassium 
phosphate buffer (0.1 M, pH 7.36) separately on the basis of 10 % 
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(w/v). They were minced with sterile scissors in petridish in ice cold 
potassium phosphate buffer (0.1 M, pH 7.36) followed by 
centrifugation at 5000 rpm (SOOOg) by glass Teflon homogenizer for 10 
minutes. Their supernatants were kept in separate glass vials in -20 
°C till further analysis. 1 ml of pellet from each organ centrifugation 
was also stored for GSH and MDA level estimation. 
Biochemical Assays and Estimations 
1. Protein estimation 
The protein content in all the samples was estimated by the method of 
Lowry et al. (1951) in which BSA (30 mg %) was taken as standard for 
calculation. Aliquot of the samples were taken in separate tubes and 
the final volume was made up to 1ml. To this, 5 ml of alkaline copper 
reagent (98 ml of 2 % sodium carbonate in 0.1 M sodium hydroxide+ 1 
ml of 1 % copper sulphate + 1 mi of 2 % sodium potassium tartarate) 
was added. This solution was kept as such in room temperature for 10 
minutes followed by addition of Folin's Ciocalteau reagent. The test 
tubes were vortexed followed by incubation for 30 minutes at room 
temperature. The resulting blue color intensity was read at 660 nm 
using spectrophotometer. The concentration of protein was reported in 
mg protein per gram of the tissue (for liver, kidney and brain samples) 
and in mg protein per ml serum (for serum). 
2. Assay of antioxidant enzymes 
Superoxide dismutase (MnZn SOD) 
The assay of SOD (E.G. 1.15.1.1) was conducted according to the 
method of Marklund and Marklund (1974) on the basis of 
autoxidation of pyrogallol. In this procedure, 2.85 ml of tris-succinate 
buffer (0.05 M, pH 8.2) was added to 50 pi of sample followed by 
addition of 100 |il of pyrogallol (8 mM) under dark condition. The per 
minute change in absorbance was read at 412 nm on Centra-5 
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spectrophotometer for 3 minutes. References were also taken for every 
10 samples. The specific activity was reported in units per mg of 
protein. One enzyme unit is defined as the amount of enzyme 
required to cause 50 % inhibition to auto-oxidation of pyrogallol per 3 
ml of assay mixture. 
Catalase (CAT) 
The activity of CAT (E.G. 1.11.1.6) was measured by the protocol of 
Aebi (1984). To 1.95 ml of potassium phosphate buffer (50 mM, pH 7) 
was added, 50 )il of the sample to which 1 ml of hydrogen peroxide (30 
mM) was pipetted under dark condition. The change in absorbance 
per minute of the solution was immediately read at 240 nm for 3 
minutes on Centra-5 spectrophotometer. Catalase activity was 
calculated as nmoles of H2O2 consumed per mgof protein per minute. 
Glutathione reductase (GR) 
The assay of this enzyme was carried out by the method of Carlberg 
and Mannervik (1985) that is based on the NADPH dependent 
reduction of glutathione disulfide (GSSG) into glutathione (GSH). The 
reaction mixture in 2 ml contained 1.65 ml of sodium phosphate 
buffer (0.1 M, pH 7.4), 100 )J1 of EDTA (0.5 mM), 50 )al of GSSG and 
100 |Lil of the sample. The reaction was initiated by adding 100 |il of 
NADPH and change in absorbance per minute was recorded at 340 
nm for 3 minutes on UV-visible spectrophotometer. The specific 
activity was reported in nmoles of NADPH oxidized per mg of protein 
per minute. 
3. Estimation of cellular reductants 
Glutathione reduced (GSH) 
For the estimation of total GSH level in the samples, Jollow et al. 
(1974) method was implemented. According to this protocol, 0.5 ml of 
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sample homogenate was mixed with equal volume of 4% (w/v) 
sulphosalicylic acid and it was incubated at 4 °C for 1 hour followed 
by centrifugation at 1200g for 15 minutes. The supernatant (0.2 ml) 
was carefully taken out and was mixed with 1.1 ml of potassium 
phosphate (0.1 M, pH 7.4). The reaction was initiated by addition of 
0.2 ml of DTNB which was read at 412 nm within 30 seconds. The 
GSH level was reported in nmoles per gram of the tissue. 
Sulfhydryl groups (-SH) 
The estimation of -SH level was conducted by method of Sedalk and 
Lindsay (1968). For this, 100 |ul of the sample was added to 2.5 ml of 
Tris- HCl (0.1 M, pH 8), 0.3 ml of EDTA and 0.1 ml of DTNB. The 
reaction mixture was vortexed well followed by keeping at room 
temperature for 30 minutes which was later read at 412 nm. Its level 
was expressed in nmoles per gram of tissues. 
4. Estimation of renal function markers (RFT) in serum 
Urea 
The level of urea in the serum samples was estimated by commercially 
available kit (Span Diagnostics Limited, India.) and was reported in 
mg per 100 ml of the sample. 
Creatinine 
The level of creatinine in the serum samples was estimated by 
commercially available kit (Span Diagnostics Limited, India.) and was 
reported in mg per 100 ml of the sample. 
Blood urea nitrogen (BUN) 
The level of BUN in the serum samples was also estimated by 
commercially available kit (Span Diagnostics Limited, India.) and was 
reported in mg perl00 ml of the sample. 
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5. Estimation of liver function markers (LFT) in serum 
Glutamate pyruvate transaminase (GPT) or Alanine transaminase (ALT) 
GPT (E.G. 2.6.1.2) activity was assayed by commercial kit (Span 
Diagnostics Limited, India.) that was based on the protocol of Reitman 
and Frankel (1957). The enzyme catalyses the following reaction 
a- ketoglutarate +L- alanine —°^^ > L-glutamate + Pyruvate 
The method involves the reaction with pyruvate formed with DNPH to 
produce brown colored hydrazones which is read at 505 nm taking 
distilled water as blank. The activity was reported in units per ml of 
the sample by the standard plot provided with kit. 
Glutamate Oxaloacetate transaminase (GOT) or Aspartate transaminase 
(AST) 
The assay of GOT (E.G. 2.6.1.1) was also carried out by commercially 
available kit (Span Diagnostics Limited, India) based on Reitman and 
Frankel method (1957). The enzyme catalyses the reaction given in the 
below-
a- ketoglutarate +L- aspartate '^^^ ) L-glutamate + Oxaloacetate 
The product Oxaloacetate reacts with DNPH to give brownish 
hydrazones that are read at 505 nm. The activity was calculated with 
the help of the standard curve provided with kit and was expressed in 
units per ml. 
Alkaline phosphatase (ALP) 
The activity of this enzyme was measured by the protocol of Shah et 
al. (1979). The assay mixture in 1.65 ml contained 1.4 ml of assay 
buffer (50 mM glycine, 36 mM NaGl, 45 mM NaOH) and 0.1 ml of the 
sample. The reaction was initiated by addition of 0.015 ml of p-
nitrophenyl phosphate (0.6 M) and was incubated for 15 minutes at 
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37 °C. Later, 0.05 ml of 5 N NaOH was pipetted into the mixture and 
the yellow color was read at 405 nm against the blank. Its activity was 
denoted in jamols per mg of the protein. 
6. Estimation of melondialdehyde (MDA) level 
MDA estimation is one of the most reliable products to assess the 
extent of lipid peroxidation. Its level was determined by the procedure 
of Beuge and Aust (1978). The reaction mixture was made up to 0.5 
ml homogenate with equal volume of TBA (0.67 %) and TCA (30 %) in 
centrifuge tubes that were incubated at boiling water bath for 20 
minutes. The tubes were later centrifuged at 4000 rpm (5000 g) for 15 
minutes. The absorbance of the pink supernatant was taken at 530 
nm. The level was expressed in nmoles of MDA formed per mg of the 
protein by using molar extinction co-efficient of 1.56xl0"5M-i cm-i for 
MDA-TBA colored complex. 
7. Estimation of carbonyl content 
The measurement of protein oxidation was carried out by the 
estimation of total carbonyl content in the sample by the method of 
Levine et al. (1994). 1 ml of sample was mixed with 0.4 ml of ice cold 
40% TCA followed by centrifugation at 4 °C for 10 minutes at 12000 X 
g. The pellet was further dissolved in 0.2 ml of PBS (100 mM, pH 7.4) 
in which 0.4 ml of DNPH (20mM prepared in 4 N HCl) was added. This 
reaction mixture was incubated for 1 hour at 37 °C on shaking water 
bath followed by centrifugation at 12000g and thus the pellet further 
was mixed with 0.35 ml of 40% TCA and again centriJaiged at 12000g. 
Then, the pellet formed was washed thrice with 1 ml of mixture of 
ethanol and ethyl acetate (1:1; v/v). Finally, it was dissolved in 1ml of 
guanidine HCl (6M) and its absorbance was taken at 360 and 280 nm 
against guanidine HCl as blank. The carbonyl content was expressed 
in nmoles per mg of the protein using a formulae taking molar 
extinction co-efficient of DNPH as 1100 M'^cm-i. 
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8. Assessment of in vivo toxicity parameters 
Glutathione-S-transferase (GST) 
The assay of this detoxifying enzyme was conducted by the protocol of 
Habig et al. (1974). For this, 0.1 ml of the sample v/as mixed with 2.7 
ml of GSH (ImM) and 0.2 ml of CDNB (ImM) in the sequence. After 
mixing well, it was read at 340 nm in the time scan of 3 minutes 
against the blank containing all the reagents except the enzyme 
source (the sample). Its specific activity was calculated taking 
millimolar extinction co-efficient value of 9.6 mM-^  cm-i of CDNB and 
was expressed in nmoles of CDNB conjugates formed per mg of the 
protein per minute in the sample. 
Theoredoxin reductase (TR) 
This enzyme was assayed by Tamura and Stadtman method (1996). 
According to this protocol, 1.01 ml of potassium phosphate buffer (50 
mM, pH 7) was added to 0.055 ml of NADPH and 0.050 ml of the 
sample followed by incubation at room temperature for 5 minutes. 
Finally, 0.050 ml of DTNB (50 mM) was further added to the reaction 
mixture and it was read at 412 nm for 1 minute. Its specific activity 
was expressed in nmoles per ml of the sample. 
9. Estimation of nitric oxide (NO*) level 
It was carried out by commercially available kit (Quantichrom^M, 
DlNO-250) involving the Greiss reagent. The purple color formed by 
adding all the reagents and the sample was read at 540 nm. Its level 
was expressed in nmoles per mg of the protein in the sample using 
formulae given with the kit. 
Methods 41 
10. Assay of brain function markers (BFM) 
Glucose-6-phosphate dehydrogenase (G6PDH) 
This enzyme was assayed according to the protocol of Shonk and 
Boxer (1964). For this, 1.4 ml of tris-buffer (0.1 M, pH 7.4) was added 
to 0.1 ml of glucose-6-phosphate (0.05 M), 0.1 ml of MgCb (0.1 M) and 
0.1ml of NADP+. The reaction mixture was read at 340 nm after 
adding the sample (0.1 ml) at the end. Its activity was reported in 
lamoles per mg of the protein in the sample. 
Lactate dehydrogenase (LDH) 
Its activity was measured by Wrobleuiski and LaDue (1955) protocol. 
The cuvette (3 ml capacity) contained 2.7 ml of tris buffer (100 mM, 
pH 7.4), 0.1 ml of MgCb (10 mM), 0.1 ml of sodium pyruvate (0.5 M) 
and 0.1 ml of NADH(0.2 % w/v) to which 50 pi of the sample was 
added. After mixing, it's per minute change in absorbance was taken 
at 340 nm for 3 minutes against the blank. Its specific activity was 
expressed in units per mg of the protein. 
11. Preparation of samples for histopathological study 
For histopathology, liver, kidney and brain of the treated animals were 
kept in 10% formalin in separate glass vials for immersion fixation 
after washing with chilled saline. 10x5x3 mm sized tissue blocks of 
the organs were processed for paraffin embedding. Their sections of 10 
micrometer thickness were cut with rotary microtome and stained 
with Hematoxylin and Eosin stain. The sections were observed under 
trinocular light microscope (Olympus BX40, Japan) and their 
photomicrographs depicting important features were snapped at final 
magnification of 400 X. 
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12. Comet Assay (Single Cell Alkaline Gel Electrophoresis) 
Preparation cellular suspension for comet assay 
Freshly dissected organs (liver and kidney) were washed in PBS and 
kept in separate petridishes. All the organs in petridishes were 
submerged in chilled solution of HBSS and RPMI 1540 (1:1) and were 
minced with scissors or scalpel blade. Their suspensions were filtered 
with muslin cloth and their filtrates were kept in separate vials as cell 
suspension of each organ. 
Viability assessment of the cells for comet assay 
The viability of the cells in the suspensions was checked by standard 
trypan blue exclusion method (Pool-Zobel et al., 1993). For this, lOOfil 
of the cell suspension was mixed with same volume of 0.4 % trypan 
blue solution. The percentage of stained cells to the total number of 
the cells was calculated. The method is based on the principle that the 
non-viable cells have degenerated membrane and hence, they take-up 
the dye while viable cells do not show any staining. 
Comet assay procedure 
The assay was performed in alkaline condition in accordance with 
protocol of Singh et al. (1988) with few modifications. First of all, fully 
frosted slides precoated with 1 % NMA (normal melting agarose) as 
base layer at 60 °C were prepared on a day before sacrifice. About 
10,000 cells isolated from organ cell suspensions were mixed with 80 
|il 1 % of LMPA to form the working cell suspensions separately. Such 
suspension was pipetted over the base layer at 37 °C followed by 
covering with cover slips immediately. After solidification of second 
layer on ice packs, the cover slips were removed and a third layer of 
0.5 % LMPA (80 |il) was pipetted over followed by placing of cover slips 
on it. This layer was also kept on ice packs for solidification. Then, the 
cover slips were removed and the slides were immersed in cold lysing 
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solution (2.5 M NaCl + 100 mM EDTA + 10 mM tris-base + 1 % triton 
X-100 with pH 10). The lysis was allowed to proceed for 3 hours 
followed by unwinding for 30 minutes in alkaline electrophoretic 
running buffer (300 mM NaOH + 1 mM EDTA at pH 13) in 
electrophoretic tank. Then electrophoresis was performed for 35 
minutes at 4 °C with constant field strength of 0.74 volts/cm and 
variable current strength under the range of 295-310 mA. The slides 
were washed with cold saline and were subjected to neutralization by 
0.4 M tris-buffer of pH 7.5 followed by washing v/ith cold saline and 
this process was repeated twice. After that, they were stained with 75 
lal EtBr (20 (ig/ml) for 5 minutes. Finally, the slides were washed with 
chilled saline again and cover slips were placed on them and were 
kept in humidified slide box in refrigerator followed by analysis on the 
next day. The slides were scored with the help of CX41 fluorescent 
microscope (Olympus, Japan) coupled with an image analysis system 
(Komet 5.5, Kinetic imaging, Liverpool, U.K.) attached with integrated 
CC camera COHU 4910 (equipped with 510-560 nm excitation and 
590 nm barrier filters). The comets were scored at the magnification of 
lOOX and images from 50 cells (25 from each replicate slide) were 
scored. Comet tail-length (migration of DNA from its nucleus in jum) 
was chosen as the parameter to assess the cellular DNA damage that 
was automatically generated by Komet 5.5 image analyzing system. 
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In Vitro Study 
(1) FTIR of cisplatin, riboflavin and their combination in aqueous 
medium. 
To confirm the interaction between cisplatin and riboflavin in presence 
and absence of white light, FTIR was conducted. 2 sets each of 50 |uM 
RF, 50 )iM CP and their combination (50 |JM C P + 50 |uM RF) were 
prepared freshly in distilled water. One set was incubated for 1 hour 
under fluorescent light while other set was kept as their controls 
without any light exposure. The samples were loaded between two 
potassium bromide discs by hydraulic pressing and thus their 
infrared spectra were recorded by Shirnadzu-8300 FTIR 
spectrophotometer (Tokyo, Japan). Their scanning range was set at 
600 - 2000 cm-i with the resolution of 4 cm-^ 
(2) Estimation of superoxide radicals using riboflavin, cisplatin and 
their combinations in aqueous medium 
The generation of superoxide radical was estimated in the samples 50 
|JM, 100 |LiM and 150 iiM of riboflavin; 100 juM cisplatin and 
combinations of all three concentrations of riboflavin with 100 |iM 
cisplatin by Nitro blue tetrazolium (NBT) assay (Nakayama et a l , 
1983). A typical assay mixture was prepared by 50mM sodium 
phosphate buffer (pH 8), 33 (iM NBT, 100 |iM EDTA and 0.06% triton 
X-100 to make its final volume to 3 ml. The reaction was initiated by 
adding the test compounds. After'vortex, their absorbance was noted 
at 560 nm at different time intervals against the blank having all the 
reagents but without the test chemical. 
(3) Estimation of hydroxyl radicals using riboflavin, cisplatin and 
their combinations 
To confirm the generation of hydroxyl radicals, method of Quinlan and 
Gutteridge (1987) was employed. Calf thymus DNA (100 ng) was taken 
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as substrate and the MDA formed from deoxyribose radicals was 
assayed by reading the absorbance at 530 nm. All the samples 
prepared were same as in case of superoxide estimation. 
(4) Estimation of nitric oxide level using riboflairin, cisplatin and their 
combination in aqueous medium 
To check whether the test chemicals produce NO* in vitro, NO* 
estimation was conducted by commercially available kit 
(Quantichrom^M, DINO-250) involving the Greiss reagent. The color 
product formed by adding all the reagents and the sample was read at 
540 nm and its level was expressed in nmoles. 
Statistical Analysis 
All the data was statistically analyzed in accordance of Tice et al. 
(2000) procedure. To check the reproducibility, in vitro experiments 
were repeated thrice while in vivo experiments were repeated twice. 
Minor fluctuations but similar patterns of results were observed in 
both cases. All the data of in vivo studies have been expressed as 
mean + SEM. A student's t-test was conducted to examine their 
statistical significance. Their analysis of variance was performed by 
one way-ANOVA with the help of data analysis software 'Origin 61'. P-
value was calculated by software 'Sigma 10.0'. P value < 0.05 was 
selected as statistically significant throughout the course of study. 
Chapter I: 
Dose and Light Dependent 
Study 
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This chapter is dedicated to explain how the treatment affected the 
mice. For this, after the completion of the treatment and sacrifice, the 
biochemical estimations and enzymatic assays of all the parameters 
mentioned in 'Methods' were carried out in their kidney, liver, serum 
and brain samples. 
The post treatment analysis revealed that the treatment of 
cisplatin caused major alteration in virtually all the parameters in all 
the samples followed by riboflavin. Perturbation in antioxidant 
enzymes, cellular reductants, NO* levels and molecular oxidation 
products substantiates the involvement of oxidative and nitrosative 
stresses in the treated animals (Chirino and Pedraza-Chaverri, 2009). 
The effects on various parameters have been sequentially explained. 
The mice treated were divided into two sections and abbreviations for 
the groups given in the below will be used through-out the chapter: 
Under photoillumination Without photoUlumination 
Control (C) Control (C) 
Riboflavin treated (RF) Riboflavin treated (RF") 
Cisplatin treated (CP) Cisplatin treated (CP') 
Combination I treated (CB 1) Combination I treated (CB 11 
Combination II treated (CB II) Combination II treated (CB I11 
Dosage for respective groups: 
Control [CONT] treated with saline only. 
Riboflavin [RF] treated (2mg/kg body weight) 
Cisplatin [CP] treated (2mg/kg body weight) 
Combination I [CB I] of CP (2mg/kg) and RF (Img/kg) 
Combination II [CB II] of CP (2mg/kg) and RF (2mg/kg) 
1. Assay of Antioxidant enzymes 
It is well known that cisplatin exerts its toxicity via oxidative stress in 
vivo. RF is an excellent photosensitizer and generator of reactive 
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oxygen species in vitro. Hence, assessment of antioxidant enzymes 
post treatment was essential to see their effect. Superoxide dismutase 
(SOD), catalase (CAT) and glutathione reductase (GR) were chosen for 
this study to assess oxidative stress as they are considered the chief 
antioxidant enzymes in the living system (Kenneth, 2004). The specific 
activity of various enzymes was assayed in kidney, liver, brain and 
serum samples of all the treated animals. 
(a) Assay of Superoxide dismutase (SOD) 
The treatment significantly affected the specific activity status of SOD 
as evidenced by decrease/increase in the activity of all the groups in 
their samples. Following the treatment, CP as well as RF both caused 
decrease in the activity but the effect of CP was more pronounced. CP 
treatment showed the most compromised level of the activity about 
55% in kidney, 64.4% in liver, 47% in brain and 48.7% in serum as 
compared to the control. RF group also displayed decrease in specific 
activity by 10% in the both kidney and liver samples while the 
decrease was 23.5% in brain samples although the serum exhibited 
merely 7.7% decrement in the activity [Figure l(i)]. 
Among the combination treated groups, CB I showed decrease 
in the activity of about 24.8% in kidney, 33.3% in liver, 37.4% in brain 
and 28.2% in the serum samples while CB II demonstrated the 
decreased specific activity of 16.3%, 23%, 27.7% and 12.8% in kidney, 
liver, brain and serum samples with respect to the control. The similar 
but less pronounced effect was observed in the groups without 
photoillumination [Figure l(i)]. 
(b) Assay of Catalase (CAT) 
The treatment altered the specific activity of CAT in all the groups. 
Maximum decline was observed in CP treated group by 48.6%, 51%, 
36.4% and 48.6% in kidney, liver, brain and serum samples 
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respectively followed by RF treated group showing the decrease by 
19.2%, 27.4%, 12.6% and 13.9% in the organs mentioned above with 
respect to the control [Figure l(ii)]. 
CB I demonstrated the decrease in its specific activity by 32.3% 
in kidney, 37% in liver, 16.8% in brain and 27.5% in the serum 
samples while CB II exhibited the decrease by 21% in kidney, 31% in 
liver, 14.4% in brain and 15.4% in serum samples when compared to 
the control. Thus, the damage was progressively less with CB II 
depicting maximum positive effect of RF. Similar but less pronounced 
effect was observed in the treated groups without photoillumination 
[Figure l(ii)]. 
(c) Assay ofgluathione reductase (GR) 
The treatment with CP led to the rnarked decrease in the specific 
activity of GR in all the samples followed by RF treated group. CP 
treated group showed the maximum decline in the activity by 72% in 
liver, 64% in kidney, 47% in brain and 51% in serum followed by RF 
treated group displaying a decrease of 12%, 10.6%, 6% and 9.7% in 
kidney, liver, brain and serum samples respectively as compared to 
the control [Figure l(iii)]. 
Among the combination treated groups, CB I exhibited the 
decrease in the specific activity by 28.7%, 38.5%, 22.3% and 40% in 
kidney, liver, brain and serum samples. CB II showed more improved 
specific activity in which the decrease was found to be 20%, 30.7%, 
12% and 22.2% in the samples as compred to the control. This 
pattern was also followed by the groups without photoillumination but 
the effect was not strong [Figure l(iii)]. 
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Figure l(i): Showing bars of specific activity of Superoxide 
dismutase in Kidney, liver, brain and serum samples of various 
groups. 
C: Control (without photoilUumination) 
C : Control (treated with saline, under photoillumination) 
RF': Riboflavin ( 2mg/kg body weight, without photoillumination) 
RF: Riboflavin (2mg/kg body weight, under photoillumination) 
CP': Cisplatin (2mg/kg body weight, without photoillumination) 
CP: Cisplatin (2mg/kg body weight, under photoillumination) 
CB I': Cisplatin [2mg/kg body weight] + Riboflavin [Img/kg body 
weight] (without photoillumination) 
CB I: Cisplatin [2mg/kg body weight] + Riboflavin [Img/kg body 
weight] (under photoillumination) 
CB 11': Cisplatin [2mg/kg body weight] + Riboflavin [2mg/kg body 
weight] (without photoillumination) 
CB II: Cisplatin [2mg/kg body weight] + Riboflavin [2mg/kg body 
weight] (under photoillumination) 
All the data has been represented in mean± SEM of three 
independent experiments. 
* indicates statistically significant at p < 0.05 from the control. 
# indicates statistically significant at p < 0.01 from the control. 
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Treatment groups 
Under photoillumination Without photoillumination 
Figure l(ii): Showing bars of specific activity of Catalase in 
Kidney, liver, brain and serum samples of various groups. 
All the groups are the same as described in Figure l(i). 
All the data has been represented in mean± SEM of three 
independent experiments. 
* indicates statistically significant at p < 0.05 from the control. 
# indicates statistically significant at p < 0.01 from the control. 
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Figure l(iii): Showing bars of specific activity of Glutathione 
reductase in Kidney, liver, brain and serum samples of various 
groups. 
All the groups are the same as described in Figure l(i). 
All the data has been represented in mean± SEM of three 
independent experiments. 
* indicates statistically significant at p < 0.05 from the control. 
# indicates statistically significant at p < 0.01 from the control. 
3. Measurement of cellular reductants 
Cellular reductants like glutathione and sulfydryl groups are the 
naturally occurring reducing agents in the cells that help to maintain 
the redox status of the functional biomolecules and the cell (Martins 
et al., 2008). They can react with any oxidizing agent directly or can 
bring back the reduced form of the oxidatively damaged proteins or 
enzymes. Hence, their level was also assessed in the present study. 
(a) Level of reduced glutathione (GSH) 
The treatment resulted in the alteration of total GSH level in all the 
groups with respect to the control. CP treatment led to maximal 
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decrease in its level by 55.3% in kidney, 55.8% in liver, 49.3% in brain 
and 45% in serum samples. RF treated group also showed decrease in 
its level by 19%, 12%, 9% and 9.7% in the organs given in the same 
sequence as above [Figure l(iv)]. 
CB I treated group demonstrated decline in its level by 26.3%, 
30.9%, 25.4% and 24.4% in kidney, liver, brain and serum samples 
respectively while CB II treatment showed the decrement in its level by 
15%, 24.7%, 13.4% and 20.7% in the samples. Groups treated 
without light exposure also displayed similar pattern but the extent of 
damage was lesser than the groups treated under photoillumination 
[Figure l(iv)]. 
(b) Level of sulfhydryl (-SH) groups 
CP and RF treatment also affected level of -SH groups in all the 
groups as compared to the control. CP treatment caused the decrease 
in its level by 52.7% in kidney, 54.6% in liver, 39% in brain and 60% 
in serum while RF treated group displayed the lowering of 22%, 23%, 
8.2% and 15% in kidney, liver, brain and the serum samples 
respectively [Figure l(v)]. 
Among the combination of CP and RF, CB I treated group 
showed the decrease in its level in kidney, liver, brain and serum by 
32.7%, 40%, 23.5% and 37.5% respectively while CB II treated group 
showed the decrement in its level by 28.2%, 20.8%, 12.3% and 35% in 
the samples. The groups treated without photoillumination also 
demonstrated similar pattern but not as strong as shown by the 
groups treated with light exposure [Figure l(v)]. 
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Figure l(iv): Showing bars of levels of Glutathione in Kidney, 
liver, brain and serum samples of various groups. 
All the groups are the same as described in Figure l(i). 
All the data has been represented in mean± SEM of three 
independent experiments. 
* indicates statistically significant at p < 0.05 from the control. 
# indicates statistically significant at p < 0.01 from the control. 
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Figure l(v): Showing bars of levels of Sulfydryl groups in 
Kidney, liver, brain and serum samples of various groups. 
All the groups are the same as described in Figure l(i). 
All the data has been represented in mean± SEM of three 
independent experiments. 
* indicates statistically significant at p < 0.05 from the control. 
# indicates statistically significant at p < 0.01 from the control. 
4. Assessment of toxicity markers 
The organizms are naturally equipped with many detoxifying enzymes 
under xenobiotic metabolism to check the toxic insults exerted by 
xenobiotic substance including drugs like cisplatin. Glutathione-S-
transferase and theoredoxin reductase are two chief detoxifying 
enzymes under this system in our body. As long as these enzymes are 
normally active, the toxicity elicited by drugs like cisplatin are well 
tolerated by degrading them into less toxic forms or readily detoxified 
in the treated animals. But, when the extent of accumulation of such 
xenobiotics including the drug increases beyond the capacity of 
detoxifying system, the toxic insults are exerted in the living system. 
As both the enzymes play important role in the detoxification system. 
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hence, both are considered as good toxicity markers for in vivo 
studies. 
(a) Assay of glutathione-S-transferase (GST) 
Being one of the important detoxifying enzymes, the activity of GST 
was assayed in liver and kidney samples. CP and RF treatment 
triggered alteration in the functioning of target organs as observed in 
the levels of GST in treated animals groups under photoillumination 
as compared to the control. The specific activity of the en2yme in CP 
treated group was affected by 47% and 51% in kidney and liver 
followed by RF treated group exhibiting the decrease by 36.5 and 
48.6% in both the organs [Figure l(vi)]. 
CB 1 treated group showed decline in its specific activity by 
28.7% and 25.3% in kidney and liver samples while the CB II treated 
group demonstrated the decrease by 16.5% and 19.6% in both the 
samples. This pattern was also observed in the parallel groups 
receiving the same treatment without light exposure but the effect was 
not strong [Figure l(vi)]. 
(c) Assay of theoredoxin reductase (TR) 
TR is a cheif detoxifying enzyme in liver and kidney cells. Hence, 
assessment of its activity in both organs is a good index of toxicity 
burden on the living system. The treatment with CP caused a steep 
decline in its specific activity as compared to the control. CP treatment 
led to dip in its specific activity by 66.7% and 68.9% in kidney and 
liver whereas RF treated group showed the decrease in the activity by 
16.6% and 18.6% in both the organs [Figure l(vii)]. 
Among the combinations, CB I treated group demonstrated the 
decrease in the activity by 36% and 43.7% in kidney and liver which 
was further improved in CB II treated group depicting the decline in 
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the activity by 30.8% and 29.3% in both the organ samples 
respectively. The effect of the treatment in the groups without light 
exposure also depicted similar pattern but lesser than their 
counterparts with photoillumination [Figure l(vii)]. 
Treatment groups 
Under photoillumination Without photoillumination 
Figure l(vi): Showing bars of specific activity of Glutathione-S-
transferase in Kidney and liver samples of various groups. 
All the groups are the same as described in Figure l(i). 
All the data has been represented in mean± SEM of three 
independent experiments. 
* indicates statistically significant at p < 0.05 from the control. 
# indicates statistically significant at p < 0.01 from the control. 
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Figure l(vii): Showing bars of specific activity of Thioredoxin 
reductase in Kidney andliver samples of various groups. 
All the groups are the same as described in Figure l(i). 
All the data has been represented in mean± SEM of three 
independent experiments. 
* indicates statistically significant at p < 0.05 from the control. 
# indicates statistically significant at p < 0.01 from the control. 
5. Assessment of macromolecular oxidation 
After the assessment of antioxidant enzymes and proteins, it was 
desirable to estimate the extent of oxidatively damaged 
macromolecules like lipids(fats) and proteins for complete assessment 
of the oxidative stress incurred in the treated animals (Martins et al., 
2008). Hence, estimation of MDA levels (lipid peroxidation product) 
and carbonyl contents (protein oxidation product) was conducted for 
the purpose. 
(a) Measurement of melondialdehyde (MDA) level 
MDA level estimation is a very reliable procedure to assess the extent 
of lipid peroxidation for most of the in vivo studies. Its level was 
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checked in kidney, liver and brain to quantify the extent of oxidatively 
damaged lipids in the target organs post treatment. CP treatment 
caused very sharp increment in MDA level which was about 140%, 
172% and 164.3% in kidney, liver and brain respectively followed by 
RF treated group showing the increase in its levels by 25%, 19% and 
21.4% in kidney, liver and brain when compared to the control [Figure 
l(viii)]. 
CB I treated group showed the increase in its level by 76.9% in 
kidney, 35.5% in liver and 142.8% in brain while CB II exhibited the 
increase in its level by 53.8%, 20.6% and 85.7% in kidney, liver and 
brain samples. The groups without light exposure also showed similar 
pattern but the effect was not as significant as their counterparts 
under photoillumination [Figure l(viii)]. 
(b) Assessment of Carbonyl content 
All the groups showed enhancement in carbonyl content after 
treatment with CP as well as RF. CP treated group showed maximally 
elevated level of carbonyl groups by 160%, 190.2% and 146.2% in 
kidney, liver and brain while RF treated group demonstrated the rise 
in its level by 120%, 109.8% and 100% in the samples as compared to 
the control [Figure l(ix)]. 
Among the combination treated groups, CB I treated group 
showed increase in its level by 60.8%, 89.2% and 100% in liver, 
kidney and brain respectively whereas CB II treatment resulted into 
increase in its level by 26.6%, 21.6% and 33% in the samples. The 
groups treated without light exposure also demonstrated the similar 
pattern but the effect was less pronounced [Figure l(ix)]. 
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Treatment groups 
Under photoiUumination Without photoillumination 
Figure l(viii): Showing bars of levels of Melondialdehyde in 
Kidney, liver and brain samples of various groups. 
All the groups are the same as described in Figure l(i). 
All the data has been represented in mean ± SEM of three 
independent experiments. 
* indicates statistically significant at p < 0.05 from the control. 
# indicates statistically significant at p < 0.01 from the control. 
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Treatment groups 
Under photoillumination Without photoillumination 
Figure l(ix): Showing bars of levels of Carbonyl contents in 
Kidney, liver and brain samples of various groups. 
All the groups are the same as described in Figure l(i). 
All the data has been represented in mean ± SEM of three 
independent experiments. 
* indicates statistically significant at p < 0.05 from the control. 
# indicates statistically significant at p ^ 0.01 from the control. 
6. Estimation of nitric oxide (NO*) 
Normal level of NO* is essential for many physiological, immunological 
and neurological functions as it acts as a signalling molecule in many 
pathways if expressed in moderate level. However, when its level 
increases, it also acts as radical triggering a chain reaction leading to 
formation of many aggressive free radicals like peroxynitrite and other 
nitrogen derived radicals that can consequently damage important 
macromolecules and affect their functions (Nikolaev, 2006). 
Measurement of NO* level is therefore very relaible indicator to assess 
nitrosative stress in living systems. 
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After the treatment with CP, the mice showed the rise in NO* 
level by 166.7%, 183.3% and 146% in kidney, liver and brain while RF 
treated group showed an increase of 151.3%, 125% and 115.4% in the 
samples respectvely [Figure l(x)]. The combination treated group, CB I 
displayed the elevation in its level by 105.6%, 75% and 84.6% while 
the elevation was found to be 64%, 45.8% and 53.8% in the CB II 
samples when compared to the control. 
The groups treated without photoillumination also depicted the 
similar but less pronounced pattern of elevation [Figure l(x)]. 
RF CP CBI CBI 
• Kidney 
.;. Liver 
• Brain 
RF' CP' CBI' CBII' 
Treatment groups 
Under photoillumination Without photoillumination 
Figure l(x): Showing bars of levels of Nitric Oxide in Kidney, 
liver and brain samples of various groups. 
All the groups are the same as described in Figure l(i). 
All the data has been represented in mean ± SEM of three 
independent experiments. 
* indicates statistically significant at p < 0.05 from the control. 
# indicates statistically significant at p < 0.01 from the control. 
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7. Assay of liver function markers (LFMs) in serum 
Alkaline phosphatase, glutamate pyruvate transferase or alanine 
transaminase (GPT or ALT) and glutamate oxaloacetate transferase or 
aspartate transaminase (GOT or AST) are house- keeping enzymes of 
liver and their normal level in the serum indicate normal functioning 
of liver. If the organ anyhow is damaged, these enzymes are released 
into the blood stream leading to elevation of their level above the 
normal depending upon the extent of the damage incurred (Cayir et 
al., 2009). Their levels therefore, were assessed in the serum samples 
to check the effect of the treatment in the animals. 
(a) Assay of Alkaline phosphatase (ALP) 
CP treatment resulted into enhancement of its activitj^ in serum by 
115.2% while RF treatment caused an increase of 52%. The 
combination treated group, CB I showed its elevation by 58.2% which 
further decreased to 26.5% in the CB II treated group. The groups 
treated without photoillumination also showed similar effect but not 
as strong as observed in their counterparts with exposure to light 
[Figure l(xi)]. 
(b) Assay of Glutamate pyruvate transferase (GPT or ALT) 
CP treatment led to marked increment in the level of this enzyme by 
273% while RF treated group demonstrated its enhancement by 60% 
in serum. The combination CB I treated group showed rise of 97.3% in 
its level which was further found to be decreased by 66.5% in the CB 
11 treated group as compared to the control. The group treated without 
photoillumination showed the similar pattern but the effect was less 
pronounced [Figure l(xi)]. 
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(d) Assay ofGlutamate oxaloacetate transferase (GOT or AST) 
CP treated group showed an increase in its activity by 237% whereas 
RF treated group displayed the rise in its activity by 28% in serum 
when compared to the control. CB I treated group showed the 
elevation of its activity in the serum by 73% while CB II treated group 
demonstrated the increase by 56.2%. The groups treated without 
photoillumination also showed similar pattern with less strength 
[Figure l(xi)]. 
"T r 1" 
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Under photoillumination Without photoillumination 
Figure l(xi): Showing bars of levels of Liver function markers 
in the serum samples of various groups. 
All the groups are the same as described in Figure l(i). 
All the data has been represented in mean ± SEM of three 
independent experiments. 
* indicates statistically significant at p < 0.05 from the control. 
# indicates statistically significant at p < 0.01 from the control. 
8. Assessment of renal function markers (RFMs) in serum 
Three major RFMs- urea, creatinine and blood urea nitrogen (BUN) 
were chosen to quantify the extent of kidney damage induced by CP 
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and RF (Santos et al., 2007). They are the waste products of whole 
metabolism in a chordate organism which are essentially required to 
be excreted from the body after getting filtered in kidneys. If kidney 
function is affected because of any damage, their proper discharge 
from the body is also halted and consequently, their levels are 
elevated in the blood. 
(a) Estimation of urea level 
CP treated group caused prominent alteration in urea level in serum 
by 121.2% whereas RF treated group showed the rise in its level by 
16.4%. Among the combination treated groups, CB I treated group 
demonstrated the elevation in its level by 67.8% which further was 
found to be decreased by 33.3% in CB II. The groups treated without 
light exposure showed the similar effect [Figure l(xii)]. 
(b) Measurement of creatinine level 
CP treatment also led to obvious changes in serum creatinine level 
by 111. 11% while RF treated group showed the elevation in its level by 
74% as compared to the control. The combination treated CB I group 
demonstrated the rise in its level by 44.4% while CB II treated group 
showed the increase by 18.5%. The groups without photoillumination 
also showed similar but less pronounced effects [Figure l(xii)]. 
(c) Quantification of blood urea nitrogen (BUN) 
BUN level was found to be increased by 86.7% and 18.4% in CP and 
RF treated groups respectively while its level was increased by 35.7% 
and 26.7% in CB I and CB II treated groups. The groups without 
photoillumination also showed similar effect [Figure l(xii)]. 
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Figure l(xii): Showing bars of levels of renal markers in the 
serum samples of various groups. 
All the groups are the same as described in Figure l(i). 
All the data has been represented in mean ± SEM of three 
independent experiments. 
* indicates statistically significant at p < 0.05 from the control. 
# indicates statistically significant at p < 0.01 from the control. 
9. Assessment of brain function markers (BFMs) 
There are few house-keeping enzymes in braii> cells and their normal 
expression reflects the functional health status of brain (Ozyurt et al., 
2006). Glucose-6-phosphate dehydrogenase (Glu-6-PDH) and lactate 
dehydrogenase (LDH) are also come under this category and hence 
they were chosen for this purpose. 
(a) Assay of Glucose-6-phosphate dehydrogenase (Glu-6-PDH) 
CP treatment decreased the specific activity of Glu-6-PDH by 74% 
while RF treated group showed the decrease of 8.7% as compared to 
the control. The combination treated group CB I demonstrated the 
decline in its specific activity by 52.5% which further improved to 
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30.8% of decline in CB II treated group with respect to the control. 
The effect of the treatment was found similar in the groups without 
photoillumination [Figure l(xiii)]. 
(b) Assay of Lactate dehydrogenase (LDH) 
CP treatment caused dipping of LDH specific activity by 49.7% while it 
was decreased by 11.2% in RF treated group as compared to the 
control. The combination CB 1 treated group showed decline in the 
activity by 34% which further improved to 24% in CB II treated group. 
The groups treated without exposure to light also showed similar 
effect [Figure l(xiii)]. 
• Glu-6-PDH 
(nmol/mg) 
sLDH{units/mg) 
RF CP CBI CBII C RF' CP' C3I' CBir 
Treatment groups 
Under photoillumination Without photoillumination 
Figure l(xiii): Showing bars of specific activitsr of Brain 
Function Markers in brain samples of various groups. 
All the groups are the same as described in Figure l(i). 
All the data has been represented in mean ± SEM of three 
independent experiments. 
* indicates statistically significant at p < 0.05 from the control. 
# indicates statistically significant at p < 0.01 from the control. 
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10. Histopathological examination 
The sections of kidney, liver and brain of the treated animals were 
examined for histopathological changes if any. Histopathology is 
considered one of the most reliable and direct evaluation of effect of 
any treatment in vivo studies. The kidney section of RF treated group 
[Figure 1 (xiv-B)] v^as found very much comparable to the control 
group [Figure 1 (xiv-A)] showing no evident change in the anatomy of 
renal tubules and renal corpuscles while the histomicrograph of 
kidney of CP treated group showed structural features of acute 
tubular necrosis characterized by swelling. This could be due to loss 
of apical portion or separation of tubular epithelium from its 
basement membrane at various sites [Figure l(xiv-C)]. The 
combination CB II treated group histomicrograph depicted renal 
tubules as normal comparable to the control. However, the lumina of 
some of their tubules showed renal casts possibly arising from the 
sloughing of tubular epithelium. In addition, the lining of epithelial 
cells appeared flat as compared to the control [Figure l(xiv-D)]. These 
structural changes could arise as adaptational features to tolerate CP 
induced toxicity. 
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Figure 1 (xiv): Histomicrographs of kidney of [A] Control; [B] 
Riboflavin (2mg/kg) treated; [C] Cisplatin (2mg/kg) treated; [D] 
Combination of cisplatin (2mg/kg) and riboflavin(2mg/kg) 
The liver histomicrograph of RF treated group [Figure l(xv-B)] 
was appeared to be normal having the contour of hepatocytes intact 
while sinusoids remained patent without any sign of congestion except 
enlargement of the hepatocytes with respect to the control [Figure 
l(xv-A)[. The liver section of CP treated group showed prominent 
alteration in the hepatic microstructure including altered contour of 
hepatocytes, sparse presence of cell organelles, shrunken nuclei, 
collapsed sinusoids and poorly maintained hepatic cords [Figure l(xv-
C)]. These cellular features indicate that the cells were severely 
damaged and most of them were either undergoing apoptotic or 
necrotic pathway. CB II treated group revealed intact hepatic cords, 
hepatocyte contour and patent sinusoids in its liver histomicrograph 
[Figure 1 (xv-D)] which was closely comparable to the control group. 
LJTapreriij)^ 
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Figure 1 (xv): Histomicrographs of liver of [A] Control; [B] 
Riboflavin (2mg/kg) treated; [C] Cisplatin (2mg/kg) treated; [D] 
Combination of cisplatin (2mg/kg) and riboflavin(2mg/kg) 
Representative photomicrographs of the cerebral cortex of the 
mice have been depicted in Figure 1 (xvi-A to E). The superficial 
molecular layer and deeper granular layers in CP treated group 
showed decreased size of ganglion cells as well as increased sloughing 
of the cells [Figure l(xvi-C)] that indicates CP induced damage and 
necrosis in the cells. However, histopathological alterations of RF 
treated group was not significant like CP treated group [Figure l(xvi-
B)]. CB I and CB II treated groups displayed dose dependent recovery 
in the size of the cells as well as disappearance of the sloughing 
[Figure l(xvi-D and E)]. 
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Figure 1 (xvi): Histomicrographs of brain of [A] Control; [B] 
Riboflavin (2mg/kg) treated; [C] Cisplatin (2mg/kg) treated; [D] 
Combination of cisplatin (2mg/kg) and riboflavin(lmg/kg); [E] 
Combination of cisplatin (2mg/kg) and riboflavin(2mg/kg) 
Hence, histopathological examination of all the target organs 
clearly demonstrated the ameliorative effect of the combinations. 
However, groups without photoillumination did not show as 
significant effect as their counterparts under photoillumination 
[Figures not shown]. 
Based on the results, it is concluded that CP treatment causes 
alterations in all the parameters followed by RF while the combinations 
of cisplatin with riboflavin alleviate the alterations in a dose dependent 
manner and the effect is stronger under photoillumination. The 
histopathological examination has further confirmed it. 
H 
Chapter II: 
Gender (Sex) Dependent 
Study 
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The chapter is devoted to study the effect of gender on the 
ameliorative effect of riboflavin on cisplatin induced toxicities. It is 
documented that sex/gender is an important factor beside age, 
immunological status and medical history to finalize any treatment 
strategy to treat serious disease like cancer. After getting positive 
effect of cisplatin-riboflavin combination on various parameters tested, 
it was desirable to investigate whether and how differentially they are 
affected in mice of different gender. This part of the study examined 
the effect of the treatment on the gender in kidney, liver and brain of 
the treated mice under light. All treatment strate^^ and timing of 
sacrifice were the same as mentioned in 'Methods', Both male and 
female mice were divided into five groups (six in each group) as follows 
with their abbreviated forms and doses in the parentheses: 
Control [CONT] treated with saline only. 
Riboflavin [RF] treated (2mg/kg body weight) 
Cisplatin [CP] treated (2mg/kg body weight) 
Combination I [COMB I] of CP (2mg/kg) and RF (Img/kg) 
Combination II [COMB II] of CP (2mg/kg) and RF (2mg/kg) 
1. Effect on antioxidant enzymes 
(a) Superoxide dismutase (SOD) 
After the treatment, male RF treated group showed decrease in its 
specific activity by 17.4%, 18% and 18.7% in kidney, liver and brain 
while the female demonstrated decline in its specific activity by 14.6%, 
15% and 16% as compared to the control [Figure 2(i)]. CP treated male 
group displayed a decrease in its specific activity by 44.7%, 64.4% and 
39.2% whereas the female group showed decline in the activity by 
35.4%, 52.6% and 33% respectively. It has been observed that females 
are more tolerant to stress as compared to males of the similar age 
(Stakisaitis et al., 2010; Sobocanec et al., 2008). Literature also 
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suggests that females are better equipped to deal with oxidative stress 
than their male counterparts most probably because their female 
hormones which have strong antioxidant property (Tarn et al., 2003). 
These may be the reasons for the less decrement in the specific 
activity of SOD in all the target organs of females than males. 
The COMB 1 treated males displayed the decrease in its specific 
activity by 33.7%, 53% and 30.3% in kidney, liver and brain samples 
while the female of the same group showed decrease in its specific 
activity by 21%, 36.4% and 21.8% as compared to the control. The 
gain in activity was more improved in COMB II treated males 
demonstrating decrease in the specific activity by 23.3%, 42.7% and 
26% while the females showed the decrease in the specific activity by 
11.5%, 21.4% and 15.8% in the organs with respect to the control. 
Thus, females displayed better effect of the combination in countering 
the damage exerted on the organ by the drug. It is documented that 
females generally respond better to chemotherapy as compared to the 
males. This notion may be also applicable in the present study in 
which the combination of cisplatin and riboflavin showed better effect 
in females in improving the SOD activity with respect to the males 
[Figure 2(i)]. 
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Figure 2(i): Bars showing specific activity of Superoxide 
Dismutase in kidney, liver and brain samples of male and female 
of indicated groups. 
CONT: Control treated with saline only. 
RF: Riboflavin treated (2mg/kg body weight) 
CP: Cisplatin treated (2mg/kg body weight) 
COMB I: Combination I of CP (2mg/kg) and RF (Img/kg) 
COMB II: Combination II of CP (2mg/kg) and RF (2mg/kg) 
All the data has been represented in mean ± SEM of three 
independent experiments. 
RF and CP treated groups were statistically significant at p < 0.05 
from the control. 
The combination treated groups had p < 0.05. 
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(b) Catalase (CAT) 
RF treated males showed dip in its specific activity by 20.3%, 27.3% 
and 18.8% in kidney, liver and brain while this decrease was 16.4%, 
24% and 15% in females of the same group as compared to the 
control. Similarly, males of CP treated group demonstrated decline in 
its specific activity by 44%, 47.5% and 39.8% whereas the females 
showed its decrement by 32.8%, 44.6% and 32% in the organs with 
respect to the control [Figure 2(ii)]. Its activity was less affected in 
females by the treatment as compared to the males as the antioxidant 
system of females has better collaboration to withstand all kind of 
stresses including oxidative stress (Sobocanec et al., 2008). Besides, 
female sex hormones also play an additional protective role against 
such stress. 
Among the combination treated groups, male treated with 
COMB 1 showed decrease in the activity by 33.7%, 36.8% and 30.4% 
while the females depicted the activity-decline by 18.8%, 31% and 
19% in the organs as compared to the control. Furthermore, COMB II 
treated males demonstrated decrease in the activity by 27%, 32% and 
20.3% whereas females of the same group showed the decrease in the 
activity by 10.4%, 25.3% and 6.8% respectively. The better 
compensation of its specific activity in females post combination 
treatment may be because of their better response to chemotherapy 
coupled with coherent co-operation among antioxidant enzymes and 
supporting antioxidant property of estrogen (Sobocanec et al., 2008). 
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Figure 2(ii): Bars showing specific activity of Catalase in kidney, 
liver and brain samples of male and female of indicated groups. 
CO NT: Control treated with saline only. 
RF: Riboflavin treated (2mg/kg body weight) 
CP: Cisplatin treated (2mg/kg body weight) 
COMB I: Combination I of CP (2mg/kg) and RF (Img/kg) 
COMB II: Combination II of CP (2mg/kg) and RF (2mg/kg) 
All the data has been represented in mean ± SEM of three 
independent experiments. 
RF and CP treated groups were statistically significant at p < 0.05 
from the control. 
The combination treated groups had p < 0.05. 
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2. Toxicity assessment 
(a) Glutathione -S-transferase (GST) 
Male mice of RF treated group showed decrease in its specific activity 
by 15%, 17.8% and 13.5% while the female of the same group 
displayed the decline by 13.6%, 15.5% and 12% in kidney, liver and 
brain as compared to the control. CP treated males demonstrated 
decrease in the activity by 40%, 46% and 30% while it was 36.6%, 
48.8% and 24.8% in the females of the same group with respect to the 
control [Figure 2(iii)]. It is generally assumed that toxicity of any 
chemical/xenobiotic may vary in individuals depending upon many 
factors including gender, age, adaptation and health status (Wang and 
Huang, 2007). In our case, cisplatin was found be more toxic to 
females in kidney and liver but not in brain as compared to the males 
(Matsuki et al., 1997). Another study suggests that cisplatin reacts 
with GST-Pi to form stronger nephrotoxicant than cisplatin itself. As 
GST-Pi expression is higher in males than female in liver and kidney; 
hence its level in COMB 1 treated males displayed decrease in the 
specific activity by 17.9%, 27% and 21.5% while the females showed 
the decline by 23.8%, 26% and 16.6% in kidney, liver and brain. 
Furthermore, males of COMB II group showed the decrease in specific 
activity by 11.4%, 15% and 11.8% whereas the females demonstrated 
decline in the activity by 17.3%, 17.2% and 7% respectively. The 
discrepancy in the combination may be attributed to the higher 
expression of GST in males as compared to the females. Hitherto, 
when riboflavin was also given with cisplatin in the combination 
treated groups that showed normalizing the activity of GST in both the 
genders, it is very imperative that riboflavin might have interacted 
with cisplatin leading to less damage in the combination treated 
groups. 
I Males 
iiFauales 
Treatment groups Kidney 
i 
^ o o ^ 
•Males 
£'Females 
•^j 
Treatment groups 
Liver 
•Males 
i Females 
Treatment groups Brain 
Figure 2(iii): Bars showing specific activity of Glutathione-S-
Transferase in kidney, liver and brain samples of male and female 
of indicated groups. 
CONT: Control treated with saline only. 
RF: Riboflavin treated (2mg/kg body weight) 
CP: Cisplatin treated (2mg/kg body weight) 
COMB I: Combination I of CP (2mg/kg) and RF (Img/kg) 
COMB II: Combination II of CP (2mg/kg) and RF (2mg/kg) 
All the data has been represented in mean ± SEM of three 
independent experiments. 
RF and CP treated groups were statistically significant at p< 0.05 
from the control. 
The combination treated groups had p < 0.05. 
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(b) Theoredoxin reductase (TR) 
As this enzyme is not well expressed in brain; so it vi^ as only assessed 
in liver and kidney samples for comparison in this gender based 
study. RF treated group of male mice demonstrated decrease in 
specific activity of TR by 20% and 15.8% while females showed its 
decrement by 17.5% and 15.8% in kidney and liver as compared to 
the control. Similarly, CP treated males also showed the decrease in 
the activity by 41.7% and 60.7% whereas the females displayed the 
decline by 37.5% and 45% with respect to the control [Figure 2(iv)]. TR 
is considered sensitive to oxidative stress which generates reduced 
form of theoredoxin that up-regulates expression of antioxidant 
enzymes and detoxifying proteins. As both cisplatin and riboflavin 
generated ROS in the treated animals, they may oxidise theoredoxin 
directly or affect the activity of TR as evidenced by decrement in its 
activity post cisplatin as well as riboflavin treatment (Zhang et al., 
2011). 
The COMB I treated males displayed decrease in the activity by 
34.7% and 50.3% while the females showed its decline by 31.2% and 
38% in kidney and liver samples as compared to the control. Males of 
COMB 11 treated group showed the decrement in the activity by 23.5% 
and 42.8% while the female demonstrated the decline in the activity 
by 19.6% and 27%. It is speculated that the females may have better 
protection from cisplatin induced oxidative stress mediated toxicity, 
because of better antioxidant system and estrogen but at the same 
time, other modes of toxicity exerted by the drugs like cisplatin may 
be more effective in them as compared to the males. This may be the 
reason why both the detoxifying enzymes (GST and TR) are either 
equally effected in both the genders after the cisplatin treatment but 
female showed better tolerance to cisplatin as well as better response 
to the combination treatment. 
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Figure 2(iv): Bars showing specific activity of Thioredoxin 
Reductase in kidney and liver samples of male and female of 
indicated groups. 
CONT: Control treated with saline only. 
RF: Riboflavin treated (2mg/kg body weight) 
CP: Cisplatin treated (2mg/kg body weight) 
COMB I: Combination I of CP (2mg/kg) and RF (Img/kg) 
COMB II: Combination II of CP (2mg/kg) and RF (2mg/kg) 
All the data has been represented in mean ± SEM of three 
independent experiments. 
RF and CP treated groups were statistically significant at p < 0.05 
from the control. 
The combination treated groups had p < 0.05. 
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3. Status of macromolecular oxidation 
(a) MDA level 
Riboflavin, treatment caused increase in lipid peroxidation by 15.6%, 
20.8% and 16.7% in kidney, liver and brain samples of the male while 
in case of females; the enhancement was 12%, 14.8% and 12% as 
compared to the control. Cisplatin treated male mice depicted the 
increase in MDA levels by 132.8%, 166.7% and 155.8% in the organs 
whereas it was found to be 117%, 113% and 141.4% in the female 
mice [Figure 2(v)]. It is well known that females contain more fats than 
the males; but, in the present study, the extent of lipid peroxidation 
was found more in males than the females post cisplatin and 
riboflavin treatment. The better co-operative antioxidant system in 
females with additional antioxidant property of their sex hormones 
may provide this edge over the males (Sobocanec et al., 2008). 
COMB I treatment decreased elevation in its level; it was 75%, 
97% and 116.6% in male mice while 49.2%, 50% and 93% in the 
females of the same group in the respective organs. COMB II 
treatment displayed even better results as the increase in its level was 
43.7%, 58.3% and 91.6% in males while it was 22%, 16.2% and 
72.4% in the females. 
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Figure 2(v): Bars showing levels of Melondialdehyde in kidney, 
liver and brain samples of male and female of indicated groups. 
CONT: Control treated with saline only. 
RF: Riboflavin treated (2mg/kg body weight) 
CP: Cisplatin treated (2mg/kg body weight) 
COMB I: Combination I of CP (2mg/kg) and RF (Img/kg) 
COMB II: Combination II of CP (2mg/kg) and RF (2mg/kg) 
All the data has been represented in mean ± SEM of three 
independent experiments. 
RF and CP treated groups were statistically significant at p < 0.05 
from the control. 
The combination treated groups had p < 0.05. 
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(b) Level of carbonyl content 
The male mice treated with riboflavin showed the increment in 
carbonyl content by 60%, 43% and 26% while the female mice of the 
same group displayed the increase by 56.3%, 30.5%i and 23.7% in 
their kidney, liver and brain. Cisplatin treated male mice 
demonstrated enhancement in its level by 120%, 130.4% and 59.5% 
whereas the female mice exhibited increase in its levels by 97.5%, 
110.5% and 55.3% [Figure 2(vi)]. As females have generally stronger 
antioxidant potential including their hormones with antioxidant 
property which co-operates with all body functions to thrive with 
stress as compared to the males (Seeman, 1997); hence the results 
reflect this notion. 
COMB 1 treated males showed increase of 96.5%, 83.3% and 
47.6% while their female counterparts displayed 67.5%, 60% and 
39.5% of increase with respect to the control. COMB II treated males 
further showed increment of 74%, 64.7% and 33.3% while the female 
from the same group demonstrated the increase of 50%i, 42% and 
23.7% respectively as compare to the control. The imiproved effect of 
the combination in the female is in accordance of the previously 
mentioned notions implying that females do have better response to 
chemotherapy as compared to the males (Singh et al., 2005). 
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Figure 2(vi): Bars showing levels of carbonyl content in kidney, 
liver and brain samples of male and female of indicated groups. 
CONT: Control treated with saline only. 
RF: Riboflavin treated (2mg/kg body weight) 
CP: Cisplatin treated (2mg/kg body weight) 
COMB I: Combination I of CP (2mg/kg) and RF (Img/kg) 
COMB II: Combination II of CP (2mg/kg) and RF (2mg/kg) 
All the data has been represented in mean ± SEM of three 
independent experiments. 
RF and CP treated groups were statistically significant at p< 0.05 
from the control. 
The combination treated groups had p < 0.05. 
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4. Estimation of Glutathione (GSH) as a cellular reductant 
Riboflavin treated male group demonstrated decline in its level by 
23.8%, 34% and 19.4% while the female of the same group showed 
20.3%, 28.4% and 23.8% in kidney, liver and brain as compared to 
the control. Moreover, cisplatin treated male displayed the decrease in 
the level by 55%, 59.8% and 50.7% whereas the female showed a 
dipping of 47.6%, 52.6% and 44% in the organs [Fig;ure 2(vii)]. It is 
well known that cisplatin binds to GSH as soon as it enters the cell 
that leads to its depletion (Chirino and Pedraza-Chaverri, 2009). This 
is why GSH level was found markedly depleted in cisplatin treated 
group in the present study. In case of riboflavin, the cellular GSH 
might be consumed by them to maintain the redox status of the cells. 
With COMB 1 treatment a decrease of 37.8%, 49.8% and 43.6% 
in the GSH level in the male while 25.2%, 39.4% and 34.2% in the 
females was observed as compared to the control. Showing the better 
effect, COMB II treatment caused diminishing its level by 30%, 39% 
and 36.5% in the male and 13.6%, 25% and 21.7% in the females 
respectively. As the females have better coherent co-operation among 
their antioxidant enzymes as well as additional antioxidant potential 
of estrogen, the combination showed less damage to GSH level in 
females than the males. 
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Figure 2(vii): Bars showing levels of Glutathione in kidney, liver 
and brain samples of male and female of indicated groups. 
CONT: Control treated with sahne only. 
RF: Riboflavin treated (2mg/kg body weight) 
CP: Cisplatin treated (2mg/kg body weight) 
COMB 1: Combination I of CP (2mg/kg) and RF (Img/kg) 
COMB II: Combination II of CP (2mg/kg) and RF (2mg/kg) 
All the data has been represented in mean± SEM of three 
independent experiments. 
RF and CP treated groups were statistically significant at p< 0.05 
from the control. 
The combination treated groups had p < 0.05. 
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5. Level of Nitnc Oxide (NO) 
It is documented that there is differential expression in nitric oxide 
synthase (NOS) in both the genders following any stress. So, its level 
was also assessed to examine the effect of the treatment. RF treated 
male group showed increment in its level by 16.7%, 19% and 15.8% in 
kidney, liver and brain of male while its increase was found to be 11%, 
14.4% and 31.5% in the female mice of the same group as compared 
to the control. Similarly, CP treated group of males also demonstrated 
the enhancement in its level by 74.3, 92.8% and 69.5% whereas the 
females showed the rise in its level by 68.7%, 83.6% and 61.6% as 
compared to the control [Figure 2(viii)]. Nitric oxide generation is 
secondary effect of cisplatin in vivo, which occurs due to the 
inflammation induced by oxidative damage in the target organs. As 
oxidative stress is less severe in the female group post treatment, 
hence, consequently NO* level was also less in the females. 
COMB 1 treated males demonstrated increase in its level by 
52.4%, 64.3% and 51.4% whereas the female group showed its rise in 
level by 41.6%, 49.2% and 39.4%. COMB II treated males showed the 
elevation in its level by 21.4%, 25% and 22% while the females from 
the same group displayed a rise of 10.4%, 14.8% and 15% in the 
organs with respect to the control. The males have been rep)orted to be 
more sensitive towards nitrosative stress because of their low level of 
estrogen and relatively less efficient antioxidant system as compared 
to the females. 
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Figure 2(viii): Bars showing levels of Nitric Oxide lin kidney, liver 
and brain samples of male and female of indicated j^oups. 
CONT: Control treated with saline only. 
RF: Riboflavin treated (2mg/kg body weight) 
CP: Cisplatin treated (2mg/kg body weight) 
COMB I: Combination I of CP (2mg/kg) and RF (Img/kg) 
COMB II: Combination II of CP (2mg/kg) and RF (2mg/kg) 
All the data has been represented in mean ± SEM of three 
independent experiments. 
RF and CP treated groups were statistically significant at p < 0.05 
from the control. 
The combination treated groups had p < 0.05. 
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6. Estimation of Urea as renal function marker 
Urea is one of the important excretory products of renal function 
whose continuous discharge is indicative of the normal functioning of 
the kidneys. When renal function is disturbed anyhovi^, its level rises 
in the serum. Hence, its level was chosen as renal function marker in 
serum of the treated animals. The level of urea after F?F and CP 
treatment was found to shoot-up by 18% and 110.3% in males and 
12.5% and 82% in females respectively [Figure 2(be)]. Due to the 
stringent antioxidant system, the oxidative and nitrosative damage in 
the kidneys occurs less in the females as compared to the males. 
COMB 1 treatment elevated its level by 65.8% and 33% in males 
and females while COMB II treatment caused the rise by 37% and 
11.3% in males and females respectively as compared to the control. 
These estimations confirm that the combinations helped to recover 
organ damage in a dose dependent manner as compared to the control 
significantly. As the females responds strongly to the chemotherapy as 
compared to the males, the combination was hence raore effective in 
normalizing the urea level in serum of the females. 
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Figure 2(ix): Bars showing levels of urea in serum samples of male 
and female of indicated groups. 
CONT: Control treated with saline only. 
RF: Riboflavin treated (2mg/kg body weight) 
CP: Cisplatin treated (2mg/kg body weight) 
COMB I: Combination I of CP (2mg/kg) and RF (Img/kg) 
COMB II: Combination II of CP (2mg/kg) and RF {2mg/kg) 
All the data has been represented in mean ± SEM of three 
independent experiments. 
RF and CP treated groups were statistically significant at p < 0.05 
from the control. 
The combination treated groups had p < 0.05. 
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7. Estimation of ALP as liver function marker 
Alkaline phosphatase (ALP) was chosen to assess functional health of 
the liver in the treated animals by its estimation in serum samples. 
After treatment with RF and CP, marked decline was observed in its 
specific activity by 22% and 84% in male group while it was 15% and 
60.3% in female group respectively. As RF and CP damage many 
organs via eliciting free radicals, estrogen in females is assumed to 
have protective effect against such damage in the many organs 
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including liver (Yagi, 1997) and hence probably less damage observed 
in their liver. 
Post treatment vi^ ith COMB I, its specific activity was found to be 
decreased by 51.7% in males and 42% in the females. This extent of 
damage further decreased in COMB II treated group and it was 31% in 
males and 20.6% in the females [Figure 2(x)]. Females having better 
chemotherapy concomitant with stronger antioxidant system, showed 
better improvement in the specific activity of ALP. 
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Figure 2(x): Bars showing specific activity of Alkaline Phosphatase 
in serum samples of male and female of indicated groups. 
CONT: Control treated with saline only. 
RF: Riboflavin treated (2mg/kg body weight) 
CP: Cisplatin treated (2mg/kg body weight) 
COMB I: Combination I of CP (2mg/kg) and RF (Img/kg) 
COMB II: Combination II of CP (2mg/kg) and RF (2mg/kg) 
All the data has been represented in mean ± SEM of three 
independent experiments. 
RF and CP treated groups were statistically significant at p < 0.05 
from the control. 
The combination treated groups had p < 0.05. 
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8. Estimation of Glucose-6-phosphate (Glu-6-FDH) as brain 
function marker 
Glu-6-PDH is one of the key enzymes to assess normal brain 
functioning status. Hence, it was picked up as a brain function 
marker to investigate the differential effect of the treatment in both the 
genders. RF treated group showed the decrease in its specific activity 
by 30.8% and 24.2% in male and the female respectively while the CP 
treatment in males and females demonstrated decline in its specific 
activity by 45% and 33.2%. 
Males and females of COMB I demonstrated decrease in its 
specific activity by 36.6% and 20.8% which further improved to 31.2% 
and 12% in COMB II treated groups of male and female mice 
respectively [Figure 2(xi)]. 
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Figure 2(xi): Bars showing specific activity of Glucose-6-
Phosphate Dehydrogenase in brain samples of male and female of 
indicated groups. 
CONT: Control treated with saline only. 
RF: Riboflavin treated (2mg/kg body weight) 
CP: Cisplatin treated (2mg/kg body weight) 
COMB I: Combination I of CP (2mg/kg) and RF (Img/kg) 
COMB II: Combination II of CP (2mg/kg) and RF (2mg/kg) 
All the data has been represented in mean ± SEiM of three 
independent experiments. 
RF and CP treated groups were statistically significant at p < 0.05 
from the control. 
The combination treated groups had p < 0.05. 
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9. Comet Assay of kidney and liver 
Comet assay was conducted to investigate whether the treatment 
incurred any noticeable nuclear damage in kidney and liver cells of 
the treated animals from both the genders. Continuous dosing of CP 
in the treated mice causes accumulation of the drug in cell that can 
pass through the nuclear membrane and binds with DNA. It is 
considered the general anticancer mechanism of the drug. Besides, at 
higher doses, it can also effect the expression of portion of that DNA 
with which the drug is bound in the non-cancerous cells exerting 
genotoxic effects or side effects. That is why comet assay was 
employed to address all these possibilities post treatment in the 
present study. It is also very sensitive technique to assess the extent 
of DNA damage in vivo studies. 
RF treatment male group showed an increase in tail-length by 
113% and 89.4% in the kidney and liver cells of male group while the 
females showed the tail-length increment by 85.8% and 67.7% as 
compared to the control. CP treated male group demonstrated 
tremendous increase in the tail-length by 242.6% and 213.6% while 
its female counterparts showed the increase in tail-length by 211.5% 
and 192% in kidney and liver cells with respect to the control [Table 
1(a), Figure 2(xii); Table 1(b); Figure 2(xiii)]. The increase in tail-length 
in the tissues is clear indicator for genotoxic effect of CP followed by 
RF. It means that both the compounds were able to deteriorate the 
integrity of nuclear DNA in the tissues of treated animals as evidenced 
by comets in nuclear DNA of the treated animals. 
Combination I treatment displayed an increase in the tail-length 
by 129.6% and 116.7% their kidney and liver cells of male with 
respect to their controls while the female group showed increase in its 
tail-length by 88.5% and 88.7% in both the organs. Combination II led 
to increase in the tail-length by 88.8% and 62% in the kidney and 
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liver cells of the males while the females showed increment in the tail-
length by 53.8% and 33.8% in the organs as compared to the controls. 
Their counterparts without photoillumination showed the similar 
pattern of comet tail-lengths but the effect was not as significant as in 
case of the photoilluminated groups. These imply that the 
combinations were less genotoxic than their individual constituents. 
Groups 
I (CONT) 
II (RF) 
III (CP) 
IV (COMB I) 
IV'(COMB I) 
V (COMB II) 
V (COMB II) 
Tail-length (in nm) 
Male 
5.4± 1.5 
11.5'±1.2 
18.5'±2.4 
12.4''±1.2 
17.3±1.2 
10.2''±0.9 
16.5'±1.5 
Female 
5.2± 1.2 
9.7'± 1.4 
16.2'±2.5 
9.8* :^1.6 
14.9''±1.1 
S.O'i 0.6 
13.9'± 1 
Table 1(a): Average tail-length after comet assay of kidney cells of 
male and female of indicted groups. 
All the data has been represented in mean ± SEM of three 
independent experiments. 
* indicates statistically significant at p < 0.05 from the control. 
# indicates statistically significant at p < 0.01 from the control. 
Chapter II 95 
Treatment Male 
(Average comet picture) 
Female 
(Average comet picture) 
Control 
Riboflavin 
Cisplatin 
Combination I 
Combination 11 
Figure 2 (xii): Average comet picture of kidney cells of indicated 
groups under photoillumination. 
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Groups 
com 
RF 
CP 
COMB I 
COMB r 
COMB II 
COMB 11' 
Tail- length (in |Lim) 
Male 
6.6± 0.85 
12.5*± 1.05 
20.7''± 2.55 
H-S^i 1.20 
19.1±1.5 
10.7"^ : 0.85 
18.2'± 1 
Female 
6.2± 0.92 
10.4*±1.20 
18.1*±1.56 
11.7*±0.96 
16.5*±1.4 
8.3''± 0.92 
15.4'± 1.3 
Table 1(b): Showing average comet tail-length of liver cells of 
male and female of indicated groups. 
All the data has been represented in meant SEM of three 
independent experiments. 
* indicates statistically significant at p < 0.05 from the control. 
# indicates statistically significant at p < 0.01 from the control. 
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Treatment Male 
(Average comet picture) 
Female 
(Average comet picture) 
Control 
Riboflavin 
Cisplatin 
Combination I 
Combination II 
Figure 2 (xiii): Average comet picture of comet of liver cells of 
indicated groups under photoillumination. 
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In this section of the study, the females showed they were 
naturally better equipped to withstand the stress exerted by CP and RF. 
The combinations of RF and CP also displayed significantly less 
damage in the target organs as compared to the CP alone treatment in 
most of the parameters consistently in a dose dependent way under 
photoillumination. This protective effect ofRF in the combination treated 
animals was more pronounced in the females than the males and it 
appreciably increased underphotoilluminated condition. 
Sf 
Chapter III: 
Age Dependent Study 
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The chapter is aimed to investigate the effect of age on the efficacy of 
riboflavin in blunting the toxicity of cisplatin in kidney, liver and 
brain. Age is an important factor that is considered to prepare any 
treatment strategy for most of the cancer treatment. Hence, it was also 
desirable to evaluate the efficacy of the treatment in 3 major age 
groups. For this, male mice (Swiss albino) were divided into three age-
groups; each group was further distributed into five sub-groups (each 
containing 5 mice). The age of animals taken in three groups was 
young (2-3 months old), adult (6-8 months old) and old (12-14 months 
old). 
Group I: Control (Saline treated only) 
Group II: Riboflavin (RF) treated (2mg/kg) 
Group III: Cisplatin (CP) treated (2mg/kg) 
Group IV: Combination I treated [CP (2mg/kg) + RF (Img/kg)] 
Group V: Combination II treated [CP (2mg/kg) + RF (2mg/kg)] 
All the parameters tested were almost the same as in chapter I 
although the responses varied based on the age of the treated animals 
which have been summarized as follows. 
I. Antioxidant status 
1. Superoxide dismutase (SOD) 
(a) Effects on liver: 
RF decreased the SOD specific activity in young, adult and old mice by 
6.1%, 7.8% and 12.6% respectively. CP treated group showed % 
decline in its specific activity by 50%, 37.8% and 59,5% in the liver 
samples of young, adult and old mice. 
Treatment with combination I displayed improvement as 
decrease in the activity was found 43.8%, 29% and 55.7% in the three 
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age groups of mice treated which further improved post combination II 
treatment to 39.8%, 22.3% and 49.4% in the three age groups [Table 
3(a)]. 
(b) Effects on kidney: 
RF led to decline in SOD specific activity in kidney samples by 5.3% in 
young, 7.2% in adult and 17.4% in old group of mice whereas CP 
strongly affected the specific activity resulting into decrease in the 
activity by 44.2%, 36% and 60.8% in the three age-groups of mice 
respectively. 
With combination I treatment, the decrease in the activity was 
36.8%, 25.8% and 56.5% while combination II treatment caused 
decrease in the activity by 28.3%, 14.4% and 53.6% in young, adult 
and old mice groups respectively [Table 3(a)]. 
(c) Effects on brain: 
Treatment with RF decreased SOD activity by 18.2%, 12.3% and 
19.6% respectively while CP treatment led to decrement in the activity 
by 45.5%, 38.6% and 50% in three age groups. 
The decrease in activity was 38.2%, 29.8% and 43% after 
combination I treatment while it was 31%, 21% and 35.3% in 
combination II treated groups [Table 3(a)]. 
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Groups 
1 
II 
III 
IV 
V 
VI 
Young (2-3 months) 
Liver 
101±6 
98± 3 
92 ± 4 
49±3 
55 ±5 
59 ± 3 
Kidney 
97±3 
95±4 
90±3 
53±6 
60±5 
68±4 
Brain 
58±4 
55±3 
45±2 
30±3 
34±3 
38±4 
Adult(6-8 months) 
Liver 
105±6 
103±4 
95±4 
64±4 
73±3 
80±4 
Kidney 
102±4 
97±3 
90±3 
62±5 
72±3 
83±4 
Brain 
61±3 
57±3 
50±2 
35±4 
40±3 
45±4 
Old (12-14 months) 
Liver 
86±4 
79±3 
69±6 
32±3 
35± 3 
4()±4 
Kidney 
74±5 
69±3 
57±4 
27±4 
30±2 
32±2 
Brain 
54±3 
51±2 
41±2 
25±2 
29±2 
33±3 
Table 3 (a): Showing specific activity of SOD of kidney, liver and 
brain of young, adult and old mice of indicated groups. 
Group I: Control Normal without any treatment and photoillumination 
Group II: Control [CONT] treated with saline only 
Group III: Riboflavin [RF] treated (2mg/kg body weight) 
Group IV: Cisplatin [CP] treated (2mg/kg body weight) 
Group V: Combination I [COMB I] of CP (2mg/kg) and RF (Img/kg) 
Group VI: Combination II [COMB II] of CP (2mg/kg) and RF (2mg/kg) 
All the data has been represented in mean± SEM of three 
independent experiments. 
RF and CP treated groups were statistically significant at p < 0.05 
from the control. 
The combination treated groups had p < 0.05. 
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2. Catalase (CAT) 
(a) Effect on liver: 
RF treatment caused a decrease in CAT specific activit}^ by 23.3%, 
28.6% and 25% whereas CP treated groups demonstrated decline in 
the activity by 60%, 57% and 64.3% in the three age groups. 
Combination I treated groups of mice exhibited a decrease of 
50%, 45.7% and 57% while combination II caused a decrease of 
46.7%, 40% and 51.8% in the three age-groups respectively [Table 
3(b)]. 
(b) Effect on kidney: 
Treatment of RF caused a lowering in the specific activity of CAT by 
21%, 17.4% and 23% while CP affected the activity by 47.4%, 41% 
and 53% respectively. 
Combination 1 treatment showed decrement of 36.7%, 34.3% 
and 47% whereas combination II caused a dip by 26.3%, 21% and 
41.2% in young, adult and old age-groups of mice respectively further 
improving the situation [Table 3(b)]. 
(c) Effect on brain: 
The treatment with RF decreased CAT specific activity in the brain 
samples by 15.4%, 15.3% and 19.3%. Similarly, CP treated mice also 
showed decrement of 46.2%, 38.5% and 52.4% respectively. 
Treatment with combination I resulted into decrease of 34.6%, 
23% and 42.8% while combination II treated mice groups 
demonstrated 27.3%, 15.4% and 36.2% of decrement in young, adult 
and old groups of mice respectively [Table 3(b)]. 
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Groups 
I 
II 
III 
IV 
V 
VI 
Young (2-3 months) 
Liver 
32.5±3 
30±2.5 
23±3.2 
12±1.3 
15±3.3 
I6±2.2 
Kidney 
21±3.5 
19±2.2 
15±2.5 
10±2.6 
12±3.1 
14±2.5 
Brain 
14±2 
13±1 
l U l 
7±0.5 
8.5±0.6 
9.5±1 
Adult(6-8 months) 
Liver 
37±3 
35±2 
25±2 
15±3 
19±2 
2I±2 
Kidney 
25±2 
23±3 
19±2 
13.5±3 
15±2 
18.2±2 
Brain 
15±3 
13±2 
1U1.2 
8±0.8 
10±1.2 
11±1.3 
Old (12-14 months) 
Liver 
30±3 
28±2 
2I±3 
10:tL5 
12:tl.2 
13.5±2 
Kidney 
18±2 
17±1 
13±0.7 
8±0.5 
9±0.7 
10±2 
Brain 
12±1.2 
10.5±1.2 
8.5±0.8 
5±0.5 
6±0.6 
6.7±0.5 
Table 3 (b): Showing specific activity of CAT of kidney, liver and 
brain of young, adult and old mice of indicated groups. 
Group I: Control Normal without any treatment and photoillumination 
Group II: Control [CONT] treated with saline only 
Group III: Riboflavin [RF] treated (2mg/kg body weight) 
Group IV: Cisplatin [CP] treated (2mg/kg body weight) 
Group V: Combination I [COMB I] of CP (2mg/kg) and RF (Img/kg) 
Group VI: Combination II [COMB II] of CP (2mg/kg) and RF (2mg/kg) 
All the data has been represented in mean ± SEM of three 
independent experiments. 
RF and CP treated groups were statistically significant at p < 0.05 
from the control. 
The combination treated groups had p < 0.05. 
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3. Glutathione Reductase (GR) 
(a) Effect on liver: 
RF treatment caused decrement in specific activity^ of GR by 21%, 
19.4% and 28.3% while CP treatment led to its decrease by 56%, 
46.3% and 60% in young, adult and old age-groups of mice. 
Combination I treatment resulted into decline by 43.9%, 29.3% 
and 51.6% whereas combination II showed 39.2%, 23% and 47.5% of 
decrement in the activity of young, adult and old age-groups of mice 
respectively [Table 3(c)]. 
(b) Effect on kidney: 
After RF treatment, young, adult and old groups of mice showed 
decline in the activity by 29%, 21.7% and 32% in their kidney samples 
while CP treatment decreased the activity by 57.3%, 51.7% and 61%. 
Combination I treatment caused 47.3%, 39.2% and 55% of 
decrement whereas combination II treated group displayed decline in 
the activity by 41.8%, 32.4% and 52% in young, adult and adult age-
groups respectively [Table 3(c)]. 
(c) Effect on brain: 
RF treatment led to dip in the specific activity of GR in brain samples 
of young, adult and old age-groups of mice by 16.3%, 14.4% and 20% 
while it was found to be lowered by 35%, 28.8%, 40% post CP 
treatment. 
Combination I demonstrated decline of 27.5%, 20% and 35% 
whereas combination II showed 21.2%, 11% and 28.2% in the activity 
in young, adult and old groups of mice in the sequence [Table 3(c)]. 
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II. Level of cellular reductants 
1. Sulfydryl level 
(a) Effect On liver: 
RF treatment decreased the level of -SH groups in liver samples of 
young, adult and old mice by 13.7%, 10% and 14.6% while CP 
treatment resulted into the lowering of 52.6%, 50% and 61% in the 
three age-groups. 
Combination I treated group showed depression of 43.2%, 
33.3% and 53.7% whereas combination II treatment shov/ed decrease 
of 29.5%, 25% and 48.8% in young, adult and old age-groups of the 
mice [Table 3(d)]. 
(b) Effect on kidney: 
Treatment with RF caused dip in its level by 6.2%, 5.4% and 17% 
while CP treatment led to the decrease of 50.6%, 47.8% and 56% in 
young, adult and old groups of mice respectively. 
Combination I treated group demonstrated decrease in its level 
by 40.7%, 34.8% and 49.2% whereas combination II resulted into 
32%, 20.6% and 44% of decline in young, adult and old age-groups of 
mice [Table 3(d)]. 
(b) Effect on brain: 
RF treated young, adult and old aged mice-groups showed decline in 
its level by 9.6%, 8% and 16.6% whereas CP treatment decreased its 
level by 44.2%, 35% and 50% in the three age-groups. 
Combination I treated group showed decrease of 32.7%, 20.6% 
and 40.5% while combination II showed improvement as the decline 
was 25%, 11% and 35.7% in young, adult and old age-groups of mice 
respectively [Table 3(d)]. 
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2. Glutathione (GSH) level 
(a) Effect on liver: 
RF treatment led to marked decline in GSH level by 19%, 17.8% and 
22.2% in the liver samples of young, adult and old mice while CP 
treatment caused depletion in its level by 54.8%, 52% and 58.3% in 
the three age-groups of mice respectively. 
Combination I treated groups exhibited the decline of 47.6%, 
43.3% and 53.3% whereas combination II treatment caused the 
decrease of 39%, 33.3% and 44.4% in the groups in sequence [Table 
3(e)]. 
(b) Effect on kidney: 
RF treated groups of young, adult and old mice showed depletion in 
its level by 24.2%, 15.2% and 20% in kidney samples while CP 
treatment led to decrease in its level by 51.6%, 45.5% and 52.8%. 
Treatment of mice with combination I demonstrated the 
decrease in its level by 45.2%, 36.4% and 58.8% which got better 
post combination II treatment showing the decline of 32.3%, 21.2% 
and 36% in young, adult and old groups of mice respectively [Table 
3(e)]. 
(c) Effect on brain: 
Treatment of RF resulted into decrease in the GSH level in the brain 
samples of young, adult and old groups of mice by 21.3%, 18.4% and 
26.6% whereas CP treatment caused dipping of 55%, 36.8% and 
62.5% in the groups in sequence. 
Combination I treated groups of mice showed decrement by 
47.5%, 42% and 57.5% while combination II treatment exhibited 
39.4%, 31.6% and 50% of decline in young, adult and old age-groups 
of mice [Table 3(e)]. 
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III. Status of liver function markers in serum 
SGPT and SGOT were assessed as liver function markers in the serum 
samples. RF treatment enhanced the level of SGPT by 53.7%, 36.5% 
and 59% while SGOT activity was elevated by 68.4%, 42.8% and 
69.2% in young, adult and old groups of mice respectively. CP 
treatment enhanced SGPT level by 156%, 129.4% and 191% whereas 
SGOT level was raised by 173.7%, 166.7% and 192.3% in young, 
adult and old aged groups of mice. 
Combination I treated groups of mice demonstrated increase in 
SGPT activity by 119.5%, 100% and 159% while SGOT activity was 
found to be increased by 105%, 90% and 123% in the three groups of 
mice respectively. Moreover, combination II treatment caused 
increment in SGPT activity by 82.9%, 41.2% and 123.6% while SGOT 
activity was found to be increased by 78.9%, 42% and 100% in young, 
adult and old groups of mice [Figure 3(i), Figure 3(ii)]. 
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Figure 3(i) Showing bars of activity of SGPT in serum of young, 
adult and old mice of indicated groups. 
Group I: Control Normal without any treatment and photoillumination 
Group II: Control [CONT] treated with saline only 
Group III: Riboflavin [RF] treated (2mg/kg body weight) 
Group IV: Cisplatin [CP] treated (2mg/kg body weight) 
Group V: Combination I [COMB I] of CP (2mg/kg) and RF (Img/kg) 
Group VI: Combination II [COMB II] of CP (2mg/kg) and RF (2mg/kg) 
All the data has been represented in mean ± SEM of three 
independent experiments. 
RF and CP treated groups were statistically significant at p < 0.05 
from the control. 
The combination treated groups had p < 0.05. 
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Figure 3(ii) Showing bars of activity of SGOT in serum of young, 
adult and old mice of indicated groups. 
Group I: Control Normal without any treatment and photoillumination 
Group II: Control [CONT] treated with saline only 
Group III; Riboflavin [RF] treated (2mg/kg body weight) 
Group IV: Cisplatin [CP] treated (2mg/kg body weight) 
Group V: Combination I [COMB I] of CP (2mg/kg) and RF (Img/kg) 
Group VI: Combination II [COMB II] of CP (2mg/kg) and RF (2mg/kg) 
All the data has been represented in mean ± SEM of three 
independent experiments. 
RF and CP treated groups were statistically significant at p < 0.05 
from the control. 
The combination treated groups had p < 0.05. 
IV. Assessment of kidney function markers in serum 
The serum level of urea and creatinine was measured to examine the 
functional status of kidneys post treatment. RF treatment caused 
increment in urea level by 33%, 23.8% and 28.3% whereas the 
creatinine level was raised by 22.2%, 17.2%) and 30.6% in young, 
adult and old groups of mice respectively. The treatment with CP 
further enhanced the urea level by 89.2%, 69.5%) and 108.7%) while 
creatinine level was raised by 107.4%, 103.4% and 113.8% in the 
three groups as compared to the control. 
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Combination I treated groups showed increase in the level of 
urea by 62.2%, 52.3% and 78.3% while creatinine level was found to 
be increased by 81.5%, 75.8% and 91.6% in young, adult and old 
groups of mice respectively. Combination II treated groups 
demonstrated increase in urea level by 29.7%, 19% and 52.2% while 
creatinine level was observed to be 51.8%, 38% and 62% in the three 
age groups of mice [Figure 3(iii), Figure 3(iv)]. 
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Figure 3(iii) Showing bars of levels of urea in serum of young, 
adult and old mice of indicated groups. 
Group 1: Control Normal without any treatment and photo illumination 
Group II: Control [CONT] treated with saline only 
Group 111: Riboflavin [RF] treated (2mg/kg body weight) 
Group IV: Cisplatin [CP] treated (2mg/kg body weight) 
Group V: Combination I [COMB I] of CP (2mg/kg) and RF (l;mg/kg) 
Group VI: Combination II [COMB II] of CP (2mg/kg) and RF (2mg/kg) 
All the data has been represented in mean ± SEM of three 
independent experiments. 
RF and CP treated groups were statistically significant at p < 0.05 
from the control. 
The combination treated groups had p < 0.05. 
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Figure 3(iv) Showing bars of levels of creatinine in serum of 
young, adult and old mice of indicated groups. 
Group I: Control Normal without any treatment and photoillumination 
Group II: Control [CONT] treated with saline only 
Group III: Riboflavin [RF] treated (2mg/kg body weight) 
Group IV: Cisplatin [CP] treated (2mg/kg body weight) 
Group V: Combination I [COMB I] of CP (2mg/kg) and RF (Img/kg) 
Group VI: Combination II [COMB II] of CP (2mg/kg) and RF (2mg/kg) 
All the data has been represented in mean ± SEM of three 
independent experiments. 
RF and CP treated groups were statistically significant at p < 0.05 
from the control. 
The combination treated groups had p < 0.05. 
V. Measurement of MDA level 
(a) Effect on liver: 
RF treatment elevated the MDA levels in the liver of young, adult and 
old groups of mice by 19.4%, 15.3% and 28.2% while CP treatment 
raised its level by 173%, 168% and 198.8% in groups. 
Combination I treated group showed increase in its level by 
129.8%, 101.4% and 164.7% whereas combination II treated group 
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showed elevation of 56.7%, 27.7% and 129.4% [Table 3(f]]. Hence, a 
moderate recovery of 42.6%, 52.3%, 23.2% was observed in 
combination II treated groups followed by combination I as compared 
to CP treated group. 
(b) Effect on kidney: 
RF treated groups of young, adult and old age showed increase in 
MDA level by 22%, 14.5% and 24% while CP treatment enhanced its 
level by 145.7%, 116% and 151.8% in the mentioned groups. 
Combination I treated group showed the increase of 66%, 42% 
and 108.8% in young, adult and old aged groups of mice while 
combination II caused elevation in its level by 40.7%, 29% and 83.5% 
in the mentioned groups [Table 3(i)]. 
(c) Effect on brain: 
RF treated groups of young, adult and old age showed elevation in 
MDA levels by 28.6%, 13.5% and 34.8% whereas CP treated group 
demonstrated increase in its level by 139.3%, 129.7% and 156.5% in 
the respective groups. 
Combination I treatment increased its level by 107%, 94.6% and 
128.3% while combination II treatment caused enhancement in its 
level by 50%, 40.5% and 95.7% in young, adult and old groups of 
mice respectively [Table 3(f)]. Thus, the improvement post combination 
treatment was constantly least in the old group of mice. 
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VI. Estimation of NO* level 
(a) Effect on liver: 
RF treatment caused increase in NO* level in liver samples of young, 
adult and old groups of mice by 23%, 16% and 27.6%. Moreover, CP 
treated groups showed high upsurge of 187.5%, 170% and 200% in 
them. 
In combination I treated group, the elevation was 141.6%, 96% 
and 169% while with combination II treatment its level was increased 
by 87.5%, 40% and 106.8% in young, adult and old groups of mice 
respectively [Table 3(g)]. 
(b) Effect on kidney: 
RF treated groups showed the upsurge in NO* level by 25%, 18.8% 
and 27.3% in kidney samples of young, adult and old mice while CP 
treatment increased its level by 160%, 142.6% and 227.3% 
respectively. 
Combination I enhanced its level by 120%, 78.2% and 181.8% 
while combination II increased its level by 55%, 38.6% and 131.8% in 
the groups [Table 3(g)]. 
(C) Effect on brain: 
The treatment with RF resulted into elevation in NO* level by 18.3%, 
8.5% and 30.7% in young, adult and old groups of mice respectively. 
Furthermore, groups treated with CP also demonstrated marked 
increment of 101.8%, 93.8% and 123% in the mentioned groups. 
Combination I treatment increased its level by 66%, 55% and 
77% while combination II treated groups exhibited enhancement in its 
level by 28.4%, 16.3% and 53.8% in the three groups [Table 3(g)]. 
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Thus, the enhancement in NO* level was enormous in CP 
treated three age-groups in all the organs tested indicative of an 
inflammatory response. The most affected organ was kidney of the old 
group followed by liver of the old and young groups although brain of 
adult group was the least affected organ possibly due to blood brain 
barrier. 
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VII. Estimation of carbonyl content 
(a) Effect on liver: 
RF treatment led to enhancement in carbonyl content by 29%, 27.3% 
and 29.8% while groups treated with CP demonstrated elevation in its 
content by 190.7%, 184.6% and 207.7% in young, adult and old 
groups of mice respectively. 
Combination I caused increment in its content by 51.2%, 29.3% 
and 86.5% whereas combination II showed enhancement in its 
content by 39.5%, 20.2% and 60.6% in the groups of mice in the 
sequence [Table 3(h)]. 
(b) Effect on kidney: 
Following RF treatment, the mice exhibited the increase in carbonyl 
content by 52%, 50.3% and 54.6% in young, adult and old groups of 
mice. Hitherto, CP treatment raised its content by 158.4%, 156.8% 
and 179.6% in young, adult and old groups of mice respectively. 
Combination I increased its content by 46%, 43.5% and 89.2% 
while combination II enhanced its content by 29.2%, 20.3% and 
56.9% effecting moderately in young, adult and old groups of mice in 
the sequence [Table 3(h)]. 
(c) Effect on brain: 
RF treated groups demonstrated enhancement in its level by 39%, 
36.4% and 41.7% in brain samples of young, adult and old groups of 
mice while CP treated groups displayed increment by 75%, 72.7% and 
87.5% in the groups. 
Combination I increased the carbonyl content by 50.5%, 45.5% 
and 64.6% in young, adult and old groups while combination II 
showed the decline by 33.5%, 27.3% and 50.8% in the groups [Table 
3(h)]. Thus, a significant decrease of 23.7%, 26.3% and 19.5% was 
observed in three age groups after combination II treatment. 
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VIII. Comet Assay 
(a) Kidney 
RF treatment caused increase in comet tail length by 146.8%, 54.7% 
and 166.3% in the kidney cells of young, adult and old mice. CP 
treated group showed increment in the tail-length by 309.4%, 257.8% 
and 344.6% in the mentioned groups in the sequence. Combination I 
treated showed increase in the tail-length by 215.6%., 156.5% and 
260% in young, adult and old groups of mice under photoilluminated 
condition. Combination II under photoilluminated condition displayed 
further improvement showing an increase in the tail-length by 
170.3%, 43.4% and 231.5% in young, adult and old whereas the 
counterpart of combination I without light exposure demonstrated the 
increase by 278%, 223.6% and 317.4% and the counterpart of 
combination II without illumination showed increase in their tail-
length by 254.6%, 200% and 306.5% in the three age groups [Figure 
3(v); Table 3 (i)]. 
Group 
I 
II 
III 
IV 
IV' 
V 
v 
Treatment 
Saline 
RF (2mg) 
CP (2mg) 
CP (2mg) + RF (Img) 
CP(2mg) + RF(Img) 
CP (2mg) + RF (2mg) 
CP (2mg) + RF (2mg) 
Young 
6.40 ± 0.8 
15.8 ±1.5 
26.2±1.4 
20.2 ±1.6 
24.2 ± 0.9 
17.3 ±1.4 
22.7 ±1.8 
Adult 
7.6 ± 0.65 
16.8=1 
27.2 ±2.3 
19.5 ±1.2 
24.6± 0.8 
10.9 ±0.9 
22.8 ±0.4 
Old 
9.2±1.5 
24.5±1.6 
40.9± 2.5 
33.1±2 
38.4± 1.5 
30.5± 2 
37.4±1.8 
Table 3 (i): Showing average comet length in kidney cells of 
different age-groups of indicated groups. 
All the data has been represented in mean ± SEM of three 
independent experiments. 
RF and CP treated groups were statistically significant at p < 0.05 
from the control. 
The combination treated groups had p < 0.05. 
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Groups Average Comet Picture 
Young Adult Old 
Control 
Riboflavin 
Cisplatin 
Combination I 
Combination II 
Figure 3 (v): Average comet picture of kidney cells of indicated 
groups under photoillumination. 
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(b) Liver 
RF treated groups demonstrated increment in tail-length of liver cells 
from young, adult and old mice by 128.6%, 103% and 140% while CP 
treated groups exhibited greater damage as the increase in their comet 
tails was found to be 267.8%, 228.4% and 305.8% in the respective 
groups. Combination I showed increase in tail-length by 175%, 
126.8% and 221.2% which further improved in combination II treated 
groups displaying the increase in the tail-length by 123.2%, 52.2% 
and 191.7% in the age-groups under photoillumination. The 
counterparts of the combination groups without photoillumination 
showed moderate recovery in the tail-lengths that was not as 
prominent as in case of the combination treated groups under 
photoillumination [Figure 3 (vi); Table 3(j)]. 
Group 
I 
11 
111 
IV 
IV' 
V 
v 
Treatment 
Saline 
RF(2mg) 
CP (2mg) 
CP(2mg) + RF(lmg) 
CP(2mg) + RF(lmg) 
CP (2mg) + RF (2mg) 
CP (2mg) + RF (2mg) 
Young 
5.6 ±1.2 
12.8±1.6 
20.6 ±2.5 
15.4±1.9 
18.7±1.5 
12.5 ±2.5 
17.2 ±1.2 
Adult 
6.7 ±1.7 
13.6±1.5 
22 ±1.9 
15.2 ±1.5 
19.6 ±2 
10.2±1.5 
17.6±2 
Old 
8.5±1.5 
20.4± 2 
34.5± 1.5 
27.3± 1.6 
32.4±1.2 
24.8± 2 
31±1.4 
Table 3 (j): Showing average comet length in liver cells of 
different age-groups of indicated groups. 
All the data has been represented in mean ± SEM of three 
independent experiments. 
RF and CP treated groups were statistically significant at p < 0.05 
from the control. 
The combination treated groups had p < 0.05. 
TH' 
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Groups 
Control 
Riboflavin 
CispJatin 
Combination I 
Average Comet Picture 
Young Adult Old 
DD 
Combination II 
Figure 3 (vi): Average comet picture of kidney cells of indicated 
groups under photoillumination. 
From Chapter III, it is evident that age is an important factor 
influencing the fate of chemotherapy. It is established that the efficacy 
of antioxidant system (including antioxidant enzymes and cellular 
reductants) and DNA-repair machinery in all organisms increases up to 
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adulthood then again declines with age (Olinski et al, 2007; Vails et al, 
2005). Thus, all the major parameters including MDA levels, NO* levels, 
serum markers and carhonyl content were least altered in the adult 
mice (Lopez-Diazguerrero et al, 2005; Kart et al, 2010; Cayir et al, 
2009; Kasapoglu and Ozhen, 2001). Furthermore, comet assay of the 
liver and kidney cells derived from the treated animals also showed 
agreement with the pattern of results observed in the mentioned 
parameters (Olinski et al, 2007). The antioxidant system of young mice 
is also very effective yet they could not show better recovery than the 
adults in most of the parameters because their system is naive devoid 
of the robustness like the adults. The old mice demonstrated maximum 
alteration in all the parameters for which many theories have been put-
forward to explain their poor resistance to any stress. It is considered 
that a number of mutations accumulate in the nuclear DMA with 
increasing age that not only affect the expression of various antioxidant 
enzymes but also the level of cellular reductants which consequently 
increase their vulnerability to various stresses. Besides, low clearance 
of xenobiotic wastes from the body, compromised efficiency of DNA 
repair machinery and decreased membrane fluidity are other 
contributing factors in the old mice (Ali et al, 2008; Vails et al, 2005; 
Rebrin et al, 2003; Devi et al, 1996; Remade et al, 1992). Our findings 
are also in accordance with many age dependent studies (Lopez-
Diazguerrero et al, 2005; Navarro and Boveris, 2004; Bohr et al, 2002; 
Kasapoglu and Ozben, 2001; Rao et al, 1990). Moreover, generation of 
NO* is considered as one of the inflammatory response in the target 
organs post treatment (Chirino and Pedraza-Chavarri, 2009; Santos et 
al, 2007). Hence, the pattern of its rise in the groups was similar to 
MDA and carbonyl content. 
Hence, the vulnerability to any stress or disease increases with 
age after certain age (adulthood) in any multicellular species including 
mice and humans according to well established Harrnan's theory of 
aging (Harman, 1956). 
Chapter IV: 
in vitro Studies 
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As cisplatin has been extensively documented to exert its toxic insults 
via generation of free radicals including superoxide, hydroxyl and 
nitric oxide in vivo, the present section is devoted to investigate the 
generation of these radicals by the drug and riboflavin as well as 
whether riboflavin can show its ameliorating effect in vitro. This study 
will help us to comprehend the insight after the treatment in vivo. 
1. Estimation of superoxide generation in vitro 
The superoxide estimation based on NBT assay revealed that RF 
generated the radicals in a dose dependent manner (50^M, 100 )LIM, 
150 juM). CP (100 |uM) also showed upsurge in the generation of 
superoxide anion radicals. Their generation was maximum at 300 min 
for both RF and CP. The generation of radicals was found to be 
quenched in CP-RF combinations in a dose dependent manner of RF. 
The quenching was 4.6% in combination I, 9.2% in combination II and 
17.5% in combination III (Graph I). 
2. Estimation of hydroxyl radicals in vitro 
Estimation of hydroxyl radicals was conducted by method of Quinlan 
and Gutteridge (1987). The experiment demonstrated the generation of 
hydroxyl radicals by RF as well as CP. The combinations of the two 
revealed that there is a prominent quenching by RF on CP induced 
radicals in a dose depended manner. 50 JLIM, 100 |JM and 150 |aM of 
RF were able to decrease hydroxyl radicals in 100 |uM of CP by 5.9%, 
17.6% and 29.4% respectively [Figure 4(i)]. 
3. Estimation of nitric oxide in vitro 
To observe the effect of RF on NO* generated by CP, NO* estimation 
was conducted in vitro. For this study, various concentrations of RF 
(50 ^M, 100 |iM and 150 ixM) were allowed to react with constant 
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concentration (100 |iM) of CP under photoillumination. Very small 
level of NO* was detected in all these solutions as compared to 
superoxide and hydroxy! radicals. RF was able to quench the NO* 
levels generated in CP in a dose dependent way as evidenced by the 
combinations of CP and RF [Graph II]. 
1.8 
l.G 
14 
i l , 2 
o 
m 
c 1 
0/ 
c 0.8 
O 
5 0.6 
0.4 
0.2 
• R F l 
vimmsmtQp 
COMBni 
** a^tfl 
> ' ^ g j t t ^ ^ ' " ^ 
'••&»RF2 
COMB I 
•RF3 
COMB II 
0' S' 10 15' 20' 25' 50' 45' 60' 90' 120'150'ISO'210'240'270'300'530'360' 
incubation time under light (in min) 
Graph I: Showing time-dependent superoxide generation by NBT 
assay under photoillumination. 
RFl: Riboflavin solution (50|uM) 
RF2: Riboflavin solution (100|iM) 
RF3: Riboflavin solution (150|dM) 
CP: Cisplatin solution (100 luM) 
COMB I: Riboflavin solution (SO^JM) + Cisplatin solution (100 |JM) 
COMB II: Riboflavin solution (100^M) + Cisplatin solution (100 |iM) 
COMB III: Riboflavin solution (ISOJLIM) + Cisplatin solution (100 |iM) 
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Figure 4 (i): Showing hydroxyl radical generation by Quinlan and 
Gutteridge (1987) method under photoillumination. 
RFl: Riboflavin solution (50|iM) 
RF2: Riboflavin solution (100|uM) 
RF3: Riboflavin solution (150|uM) 
CP: Cisplatin solution (100 \iM) 
COMBl: Riboflavin solution (50|iM) + Cisplatin solution (100 nU) 
C0MB2: Riboflavin solution (100|LIM) + Cisplatin solution (100 |LIM) 
C0MB3: Riboflavin solution (ISO i^M) + Cisplatin solution (100 |iM) 
All the data has been represented in meant SEM of three 
independent experiments. 
Chapter IV 130 
0.02S - ^ ' R f l <s>t#»RF2 < li RF3 .•.«.»CP COMB v> COMB II COMB I 
0.02 
E 
c 
o 
^ O.OIS 
i 0.01 
o.oos 
n' ' ' ' ' ' I 
<k£ ^ tw? 
0^ " W 30' 45' 60' 00' 120' ISO' 180' 
Incubation time under light (in min) 
Graph II: Showing time dependent generation of NO* by the test 
chemicals. 
RFl: Riboflavin solution (50juM) 
RF2: Riboflavin solution (lOOpM) 
RF3: Riboflavin solution (150|uM) 
CP: Cisplatin solution (100 MM) 
COMB I: Riboflavin solution (50|iM) + Cisplatin solution (100 |JM) 
COMB 11: Riboflavin solution (100|JM) + Cisplatin solution (100 ^M) 
COMB III: Riboflavin solution (150|LIM) + Cisplatin solution (100 pM) 
4. FTIR results and analysis confirm the interaction of riboflavin 
and cisplatin at the molecular level. 
The UV-visible fluorescence spectral studies conducted previously in 
our lab observed a prominent change probably due to interaction 
between riboflavin and cisplatin. Therefore, FTIR was carried out to 
confirm the interaction involved between RF and CF'. For this, FTIR 
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was conducted with the compounds individually as well as with their 
combination. 
RF (50|uM) without photoillumination showed characteristic 
peaks at 1648.49 and 1630.41 cm-i for C=0 group and 1240.02 cm-i 
for -NH group of its alloxazine ring. After 1 hour incubation under 
light, RF of the same concentration showed stretching of its C=0 bond 
generating new peaks at 1614.62, 1641.06 and 1669.19 cm-i. -NH 
group of the ring also demonstrated shifting of peak from 1240.02 cm-
1 (in native state) to 1232.07 cm-i (in photoexcited state) [Figure 4(i) 
and 4(ii)]. On the other hand, CP (50|uM) without exposure of light 
displayed its characteristic peaks at 1245.85, 1234.96, 1539.24 and 
1558.93 cm"i for its two -NH2 groups while its -CI groups showed 
peaks at 676.81 and 720.12 cm-i [Dobrosz- Teperek et a l , 1998; 
Pathmamanoharan et al., 1996]. Photoillumination caused shifting of 
the peaks of both the groups slightly [Figure 4(iii) and 4(iv)]. 
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%T 6 -
Wave number (cm") 
Figure 4(ii) FTIR of RF without incubation under light. 
Wave number (cm'^ ) 
Figure 4(iii) FTIR of RF after 1 hour incubation under light. 
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Figure 4(iv) FFIR of CP without incubation. 
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Figure 4(v) FTIR of CP after 1 hour incubation under light. 
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Figure 4(vii) FTIR of CP-RF after 1 hour incubation under light. 
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In case of the combination I without photoillumination, the 
interaction was poor between RF and CP as the characteristic peaks of 
all the active groups (-NH, C=0) were almost similar to the native form 
of the compounds. Hitherto, the combination after 1 hour incubation 
under light demonstrated generation of a series of new peaks 
from 1698.71 to 1540.03 cmi for -NH groups and 1212.63 
and 1188.52 cm-i for C=0 groups [Dobrosz-Teperek et al., 1998; 
Pathmamanoharan et al., 1996]. These peaks indicate that the 
interaction between RF and CP increases under photoillumination as 
compared to their combination without light exposure [Figure 4(v) and 
4(vi)]. 
Hence, the study revealed that both the molecules have some 
active functional groups (two amino groups in cisplatin and ketone 
groups of the alloxazine ring in riboflavin) which interact with each 
other that generated new peaks. Although this interaction was 
observed even in absence of light but the interaction certainly 
strengthens under photoilluminated condition. 
The results presented in this chapter suggest that both CP and RF 
individually are able to generate ROS but not NO* in vitro under 
photoillumination. When both are combined, their individual free radical 
generating potential is quenched. The mutual interaction is attributed to 
this phenomenon. Besides, generation of NO* in vivo but not in vitro 
indicates that its generation is a secondary effect of CP that occurs 
when inflammatory response is triggered in the target organs after ROS 
mediated damage as the primary effect. 
i 
Discussion 
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Cancer is one of the deadliest diseases in the world that probably 
claims 7.6 million human lives annually around the world according 
to a report issued by World Health Organization (WHO) on 5th June, 
2010. Several treatment strategies including chemotherapy, 
radiotherapy, photodynamic therapy (PDT) and recently developed 
catalytic therapy (CT) hfive been employed to increase the survival rate 
of cancer patients. Among these, chemotherapy, radiotherapy or 
combination of the botli called as chemoradiotherap}'- are considered 
the most effective kinds of cancer treatment. Nevertheless, all the 
chemotherapeutic drugs used in the treatment regime exert many 
toxic insults in vivo that are collectively called as side effects. These 
effects not only increase the suffering of the cancer patients but also 
considerably decrease their life span. Among all the chemopreventive 
drugs against cancer, cisplatin is one of the most widely used 
anticancer drugs for over four decades against various kinds of solid 
tumors and cancers including neuroblastoma, lymphoma, 
osteosarcoma, melanoma, ovarian, testicular, cervical, prostrate, 
small cell lung, head and neck, mammary, oropharyngeal and colon 
cancer (Weiss and Christian, 1993; Basu and Krishnamurthy, 2010). 
It has been used as the first line of therapy alone or in combination 
with other drugs. Like all other anticancer drugs, cisplatin elicits 
many serious side effects like nephrotoxicity, hepatotoxicity, 
neurotoxicity, nausea, myelosuppression and ototoxicity in vivo (Kang 
et al., 2011; Kart et al., 2010; Cayir et al., 2009; McDonald et al., 
2005; Yang and Sung, 1966). Various strategies like smtioxidant 
supplementation, saline diuresis, diuretics, vitamins-rich diet etc. 
have been advised to ameliorate these side effects since its clinical 
usage but an effective way to minimize these side effects is yet to be 
acknowledged (Barabas et al., 2008). 
The most classical yet very valid reason behind all these toxic 
effects is the generation of various types of free radicals by cisplatin in 
vivo (Kang et al., 2011) These radicals and anions of o:<ygeri, nitrogen 
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and combination of the both induce oxidative and nitrosative stress 
that ultimately results into the side effects (Chirino and Pedraza-
Chaverri, 2009, Martins et al., 2008; Santos et a l , 2007). It is also 
established that cancer cells are under persistent oxidative and 
nitrosative stress due to the altered antioxidant system. (Lu et al., 
2006; Schumacker, 2006). In case of cisplatin also, it has been 
reported that it binds to the protein like GSH in the target cells 
(kidney, liver etc.) exhsiusting its level low enough to push the cells 
under oxidative stress, if the supporting antioxidant systems fails in 
this whole event; the continuous bombardment of the oxygen free 
radicals and anions to the target tissues leads to organ damage that 
consequently attracts the inflammatory response. Such response 
involves nitric oxide (NO*) as a secondary messenger and also 
produces lethal radical like peroxynitrite (Reuter et al., 2010; Tang 
and Grimm, 2004). All these radicals and anions together generate 
oxidative and nitrosative stress capable enough to damage protein, 
lipid, carbohydrate and DNA in vivo (Wiseman and Halliwell, 1996). 
Chronic inflammation has been documented to be linked with 
the processes of carcinogenesis including cellular transformation, 
promotion, survival, proliferation, invasion, angiogenesis and 
metastasis (Reuter et al., 2010; Montovani, 2005). Contemporary 
studies indicate that free radicals play important role in all three 
major stages of cancer that are initiation, promotion and progression. 
ROS may introduce DNA mutation and structural alteration in 
initiation stage. In promotion stage, ROS induce abnormal gene 
expression, break cell to cell communication and also modify 
secondary messenger system that may consequently evade apoptosis 
and enhance cell proliferation. They also participate in progression 
stage by accumulating further DNA alterations in the alretidy altered 
initiated cells (Reuter et a l , 2010; Circu and Aw, 2010). It is generally 
accepted that excessive oxidative and nitrosative stresses induce 
apoptosis but it is less explored that moderate oxidative stress imparts 
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a survival advantage to tumor cells by promoting proliferation, 
metastasis through suppression of the immune response as well 
(Reuter et al., 2010). Whether the radicals promote tumor survival or 
act as antitumor agents; it depends upon the cells involved, the 
location of ROS production and their concentration. Induction of 
redox sensitive pathways like MAPK/AP-1 and N F - K B during tumor 
promotion is essential as excessive cancerous cell division and 
heightened energy demand to fuel metabolism generate plenty of free 
radicals. They have to be buffered or quenched to avoid oxidative 
damage to the tumors by such pathways (Pennington et al., 2005). A 
better understanding of the mechanisms that regulate the generation 
and metabolism of reactive oxygen nitrogen species (RONS) provides a 
rationale for developing novel therapeutics for the treatment of cancer. 
For example, selective pharmacologic suppression of reactive oxygen 
nitrogen species (RONS) in cancer patients has been shown to provide 
a meaningful clinical benefit. Hence, it is very strongly speculated that 
management of these free radicals and anion generation not only 
decreases the related side effects of the drug but also enhances the 
drug efficacy and median life span of the patients (Circu and Aw, 
2010, Fang et a l , 2009; Nikolaev, 2006; Kenneth, 2004; Hanigan et 
al., 2001). Thus, it opens a novel promising avenue for the treatment 
of cancer. 
Photodynamic therapy (PDT) is one of the least explored 
treatment modes that have potential to manage vast nmge of diseases 
including cancer (Mitsunaga et a l , 2011). The treatment uses special 
drugs along with suitable photosensitizing agents and utilises light to 
kill cancer cells. It only works after the drug(s) used is activated or 
"turned on" by light. Depending on the part of the body being treated, 
the drug with proper photosensitizing agent is either put into the 
bloodstream through a vein or put on the skin. Over a certain amount 
of time, the drug is absorbed by cancer cells, then the eirea under 
effect is photo-irradiated for specified time. The time period between 
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administration of the drug and the light exposure is called the "drug-
to-light interuar. It can be anywhere from a couple of hours to a couple 
of days depending on the drug used. During this, light causes the 
drug to form certain chemical species potent enough to kill cancer 
cells. Alternatively, photodynamic therapy (PDT) may also work by 
inhibiting angiogenesis to starve the cancer cells or by triggering the 
immune system to attack the cancer. Because of excellent efficacy of 
this treatment for diseases of skin and peripheral tissues, 
photodynamic therapy is under extensive research to employ it for 
internal organs like prostrate, liver, kidney, brain, breast, throat, 
lungs etc. However, most of the photoproducts are more photo toxic 
than the parent drugs depending on their longer excited-state 
deactivation lifetimes and higher solubility in hydrophobic 
environments. Hence, drugs generating more photoproducts are 
expected to be more phototoxic (Cosa, 2004). Through proper 
handling and manipulation, they can be tamed for clinical purposes in 
the photodynamic therapies for better treatment. 
Vitamin Ba or riboflavin has great prospective to be employed in 
photodynamic therapy for the treatment by itself or for improving the 
present mode of treatment of various diseases. This v/ell proved 
photosensitizer having complex photochemistry is known to exert 
toxic effects to the ubiquitously present biomolecules in the cells 
(Edward and Silva, 2001; Alvi et al., 1984). It has been postulated as 
viable sensitizer for in vivo photo-oxidative degradation of numerous 
naturally relevant or externally added substrates in diverse organisms 
(Heelis, 1982). The photodynamic action of riboflavin is generally 
explained with the involvement of oxygen free radicals (Fontana et al., 
2011; Ha et a l , 2009; Mi et a l , 2005; Ali et al., 2000). Riboflavin 
generates several reactive oxygen species upon light exposure; 
riboflavin radicals through type I mechanism while singlet oxygen, 
superoxide, peroxide and hydroxyl radicals through type II 
mechanism. Among these, hydroxyl radical is most lethal vidth longer 
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half life and relatively larger diffusion radii that assist its penetration 
through cell membranes freely (Edwards and Silva, 2001). For any 
aerobic organism, exposure of cells to oxygen radiceds and its 
consequent damage is inseparably associated with the life processes. 
If anyhow, the antioxidant system goes too astray to maintain 
minimally required redox status, the cells undergoes tremendous 
oxidative stress (Tabatabie and Floyd, 1994). 
The photochemicaJ degradation of pharmaceutical compounds 
especially under daylight irradiation has drawn strong attention since 
the last decade (Castillo et al., 2007). Although most of the drugs with 
pharmaceutical potential are transparent to daylight, the presence of 
any compound having light absorbing property can affect the stability 
and efficacy of the drug inside the system. During tlieir elaboration, 
storage or after administration in vivo, they are affected adversely due 
to the presence of such photosensitive compound(s). Study on the 
photosentized reactions of medicinally relevant compounds is 
important because such reactions can give rise to products with 
different, null or undesirable bioactivity. It is also possible that 
interaction of such reactive species with pharmaceutically relevant 
compounds may either decrease their original therapeutic potential or 
even worse, modifying their specific effects eventually generating toxic 
products. Together with these, there is also possibility of positive effect 
that can arise from such interactions (Massad et al., 2005). Hitherto, 
certain biologically relcA^ant endogenous or externally administered 
compounds can inhibit or promote photodamage in living siystems. In 
this context, an important category of biologically active and 
commercially valuable compounds that can potentially interact with 
riboflavin in human could be the externally administered drugs. 
Aminophylline in combination with riboflavin has demonstrated to 
augment degradative capacity of RF which is oxidized in the process 
(Hassan et al., 2006; Ali and Naseem, 2002; Jazzer and Naseem, 
1996; Jazzer and Naseera, 1994). Contemporary studies suggest that 
Discussion 141 
many anticancer drugs like 5-Fluorouracil are photochemically 
activated under microenvironment of tumors, means it does have 
cancer preventive action (Ito et al., 2008). It is also reported that 
riboflavin deficiency makes human vulnerable to cancers and its 
sufficiency helps to fight tumors as it has some antitumor activity 
(Zhu et al., 2006; Webster et al., 1996). All these positive aspects of 
riboflavin in photodynamic therapy prompted our lab to explore its 
effect on animal model. We observed that riboflaivin under 
photoillumination blunted the toxicity of cisplatin on mice 
keratinocytes instead of enhancing its toxicity (Husain and Naseem, 
2008). This intriguing observation led us to investigate the effect of 
cisplatin- riboflavin combination in vivo. The present thesis entitled "in 
vivo studies on riboflavin- cisplatin interactions" is devoted to confine 
all of it. 
It is well known that cisplatin and riboflavin elicit toxic insults 
via generation of free radicals like superoxide ions and hydroxyl 
radicals. Hence their estimation was carried out using both the 
compounds and their combination(s) in vitro. It was observed that 
riboflavin produced more superoxide ions and hydroxyl radicals as 
compared to cisplatin in vitro and riboflavin was able to quench free 
radical generation potential of cisplatin in a dose dependent manner. 
Besides, negligible amount of nitric oxide was detected in both 
compounds and their combination. It is assumed that both the 
compounds generate reactive oxygen species in vivo in the target 
organs and their continuous bombardment on the tissues caused 
tissue damage that invited inflammatory response via elevating the 
level of nitric oxide (NO*). Thus, its level was not found in vitro but was 
much enhanced in vivo more in case of cisplatin than riboflavin. As 
riboflavin is mildly water soluble, it could be excreted while cisplatin 
remains accumulated in the target organs by binding witli proteins 
and DNA with limited ouster by excretion. Hence, cisplatin exerts 
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more toxic insults than, riboflavin although riboflavin generates more 
free radicals than cisplatin. 
It is well established that cisplatin binds to the cellular protein 
and DNA and elicits reactive oxygen species (ROS) generating oxidative 
stress (Cepeda et al., 2007). To counter it, activity of antioxidant 
enzymes is upregulated and expression of cellular reductants are also 
over expressed. If the antioxidant defence system of the body is unable 
to contain it, the excessively generated free radicals can damage the 
target tissues. These damages cause toxicity that activate xenobiotic 
metabolism in which externally administered chemicals like drugs are 
detoxified or converted into less toxic forms by detoxifying enzymes 
like glutathione-S-transferase and theoredoxin reductase. If all these 
systems fail to contain the organ damage, inflammatory response sets 
in and nitric oxide (NO*) is synthesized by inducible nitric oxide 
synthases of mitochondrial and endothelial origin. NO* acts as 
secondary messenger to heal up the damaged tissues but forms 
peroxynitrite radicals to destroy the damaged tissues if they are 
beyond the repairing capacity (Kang et al., 2011; Zhang et al., 2011; 
Chirino and Pedraza- Chaverri, 2009), they die either by apoptosis or 
necrosis depending upon the severity of the damage (Cepeda et al., 
2007; Vcitkovic, 1998). Many theories have been postulated to 
explain the two different modes of death. Most assumed theory in this 
regard is that if functionality of the cells under effect is subnormal 
and have moderate level of ATP, they undergo apoptotic dea1±i whereas 
if the cells are extensively damaged and ATP is too lov/ to carry 
apoptosis, then they choose necrotic pathway of cell death. It is 
believed that if the cells fail during apoptosis, they can also die by 
necrosis. Hence, many reports plead that cisplatin induced cell death 
involves apoptosis as well as necrosis (Montero et al., 2002). Hence, 
sub-populations of both kinds cell death have been observed in many 
cell line studies (Vcitkovic, 1998). It has also been observed that poly 
ADP- ribose polymerase -1 (PARP-1) overactivation leads to cisplatin 
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induced necrotic pathway of cell death while its inhibition causes 
apoptotic cell death (Herceg and Wang, 1999). Third type of cell death 
post cisplatin treatment has been reported is ubiquitin- proteasome 
pathway based that can selectively degrade cellular regulatory 
proteins pushing the cells towards cell death (Nguewa et al., 2005). 
Furthermore, effect of gender and age on the treatment was 
anticipated after getting the positive correlation between dose and its 
effect in the first part of this work. The investigation showed that 
females were more stress resistant as their level of antioxidant 
enzymes and cellular reductants were less effected concomitant with 
moderate rise in NO* level, MDA level and carbcnyl content as 
compared to the male mice post cisplatin and riboflavin treatment. 
Moreover, female mice responded better to the combination treatment 
as evidenced by better improvement in the level of lantioxidant 
enzymes, cellular reductants along with decreased level of lipid and 
protein oxidation as compared to their male counterparts. It is also 
notable that even if females showed better effect of the treatment yet 
quantitatively their enzymatic activities and level of MDA, NO* and 
carbonyl content were less as compared to the males which could be 
because of their smaller organ size, less volume of blood and low basal 
metabolic rate as compared to the males (Vina et al,, 2003). Males 
have high basal metabolic rate as energy demand in their body is 
higher than the females; thereby generating more free radicals during 
their metabolism. However, they are unable to decrease ROS levels as 
a consequence; the derogatory effects are also high even when nature 
has provided them more robust physiological system. It is speculated 
that females are more resistant to stress also because of their 
hormones (estrogen and progesterone) which have antioxidant, anti-
aging and even anticancer properties (Abplanalp and Ravi Subbiah, 
2001; Yaffe et a l , 1998). A bulk of literature indicates th:at female 
hormones including estrogen protect heart, brain, liver, macrophages, 
skeletal muscles from oxidative injuries whereas few studies entail its 
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carcinogenic effect in Titerus, breast and prostrate (Abplanalp and 
Ravi Subbiah, 2001; Gomez-Zubeldia et al., 2001). It is documented 
that if the gonads are removed from the female mice, their stress 
tolerance and anti-aging characteristics are markedty decreased and 
become equally vulnerable for stress and aging like males. It is also 
reported that if gonads are removed from male mice <axid female 
hormones are sufficiently injected, they also show similar' resistance 
to stress and aging like the females (Yagi, 1997). Seeman (1997) 
further added that female hormones improve co-ordination among 
various body functions to enhance the tolerance level to toxic agents. 
Besides, the level of glutathione and expression of 16s rRNA are 
considered two major age markers which were found to be many folds 
higher in females compared to the males. According to contemporary 
studies, females behave as if they were younger than the males of 
same chronological age (Brovm et al., 2007; Vina et al., 2003). In case 
of humans, it has been observed that women are less prone to 
infections and stress than males of same age until their female 
hormones levels were normal or menopause; after that they are 
equally vulnerable to the stress and infections like men. Similarly, 
female mice do have estrous cycle that helps them to maintain female 
hormones which supports them to withstand the treatment induced 
stress and toxicity. Recendy, it has been reported that females do 
have more coherent co-operation among antioxidants enzrjmies than 
the males that helps them to cope with stress and toxicity better than 
the males (Sobocanec et a l , 2008; Bohr et al., 1998). It is noteworthy 
that females do have better level of GSH than their male counterpart 
that is considered the strongest biological stress-buster to counter 
drug induced stress as well as toxicity. This is the reason for the 
comet results indicating less DNA damage as well as better 
antioxidant defense status in female post cisplatin treatment than the 
male. As the drug induces oxidative and nitrosative stresses, it is 
better coped up by females; hence they showed improved response to 
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the combination treatment as compared to the males. It is also 
documented that female (XX) neurons can sustain toxic insults as well 
as stress better than the male (XY) neurons with the help of their 
elevated level of GSH (Du et al., 2004). Recently, it has been reported 
that GST which imparts in detoxification of drugs or xenobiotics, is 
also important determinant for toxicity and stress induction in vivo. 
Besides, male mice express more GST which generates major 
nephrotoxic product (cisplatin-glutathione-S-conjugates) following 
cisplatin dosage; thus, they are also more prone to the drug induced 
toxicities than the females. This vulnerability of males was not 
observed in GSTP (glutathione-S-transferase Pi) knocked out mice 
(Townsend et al., 2009; Wongtawatchai et al., 2009). Several studies 
indicate female heart, ileum, liver, brain tissues have diminished 
function of the Na, K-ATPase pump as compared to males (Eraser and 
Samacki, 1989). Moreover, it has been observed that female sex 
hormones can inhibit Na, K-ATPase enzyme activity in many tissues, 
whereas the male sex hormone may stimulate its activity that appears 
to be responsible for increased acute symptomatic hyponatremia and 
increased urinary Na excretion. As Na,K-ATPase-dependent active 
transport of CP across the cell membrane is important intracellular 
accumulation source, it must be one of the reasons for differential 
gender-related CP toxicity making males more sensitive to renal injury 
in response (Stakisaitis et al., 2010; Yadav et a l , 2010; Attia et al., 
2003). Singh et al. (2005) has contradictorily reported that women 
cancer patients are more susceptible to the chemotherapy mediated 
toxicity but surprisingly responded to the treatment better as increase 
in median life span post chemotherapy in them was more than the 
male patients. They conjectured that differential response to the drug 
by both sexes is multifactorial such as pharmacokineti:cs of the drug, 
pharmacogenomic profile of the patient, pharmacological history of the 
patient, race, dosing, age, overall health and immunological status of 
the patient before chemotherapy (Wang and Huang, 2007; Singh et 
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al., 2005). Earlier studies convey that pharmacokinetic processes of 
any administered drug involve four major steps in the living system: 
absorption, distribution, metabolism and excretion (ADME) and all 
these may have sex-related variability (Undevia et al., 2005; Tam et 
al., 2003). The genes and the proteins involved in the 
pharmacokinetics of drugs, like the drug-metabolizing enzymes, drug-
transport systems, drug targets, downstream signaling events and 
drug-drug interactions, may contribute in the treatme;nt related 
differential toxicity and response between female and male. Obviously, 
many genes forming complex functional network, collectively 
contribute to the sex-selective toxicity to anticancer drugs. 
Henceforth, there exist intricate interplay among sex factors, gene 
networks and drug response phenotypes. A better understanding of 
these with respect to chemotherapy induced toxic insults will be of 
paramount importance for recognizing factors that predispose the 
patients to chemotherapeutic toxicity. The prediction of sex related 
effects for any anticancer drug that can ultimately help to design 
personalized cancer therapy is also possible. The present study 
depicts that female mice are stronger in tolerating the toxic effects 
exerted by cisplatin and riboflavin and also exhibits better response to 
the combination treatment as compared to the male mice. This sexual 
discrepancy in treatment induced toxicity and its response may be 
attributed to multiple factors; in which level of GSH, activiity of GST 
and hormonal level may be major players. 
Currently, studies of oxidative stress-related modifications in 
cellular components with age are most popular among researchers 
because they provide testable cellular and molecular mechanisms 
(Olinski et al., 2007; Turnheim, 2003; Ruberin et al., 2003; Shacter, 
2000; Rao et a l , 1990). Although it is generally accepted ttiat ageing 
results from inborn, acquired and environmental factors. Most of the 
theories on ageing share the concept that age-£LSSociated 
malfunctioning is a consequence of physiological accumulation of 
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irreparable damage to biomolecules (Navarro and Boveris, 2004; Devi 
et al., 1996). This is an unavoidable side effect of normal metabolism 
that underlines the importance of defense and repair mechanisms in 
the system (Yin and Chen, 2005). The most widely recognized 
biological reaction leading to ageing is the modification of different 
kinds of biomolecules caused by oxidative and nitrosative stress. 
According to tenets of the Oxidative stress theory of aging, imbalances 
and dysregulation in cellular redox process are responsible for 
oxidatively damaged homeostasis in the aging organisms (Harman, 
1956). The study of effect of the treatment on three major age groups 
where 2-3 months old mice was considered as young, 6-8 months old 
as adult and 12-14 months old as old revealed that adult mice were 
found to be most tolersint to the cisplatin and riboflavin treatment 
followed by the young and old groups of mice in the sequence. The 
adult group also responded in the best manner to the cisplatin-
riboflavin combinations followed by the young group whereas the old 
group showed relatively poor recovery. It is documented t;hat young 
organisms in general are more sensitive to xenobiotics-induced 
toxicities than the old most probably because of underdeveloped 
detoxification capabilities but for heavy metals or all^ylating agents 
like cisplatin, the reverse is true (Ali et al., 2008; Yamano et a l , 1998). 
In the present study, it is also noticeable that the activity of most of 
the antioxidant enzymes and cellular reductants were found to be the 
highest in the adult group. The response to the combination of 
cisplatin and riboflavin was overall the best in the adult group 
although significantly decreased level of MDA, NO* and carbonyl 
content was also observed in the young group among all the groups. It 
illustrates that adults showed enhanced level of MDA, NO* and 
carbonyl content compared to the young group because of higher 
metabolic rate to compensate the energy demand. Despite high BMR 
and energy demand in both young and the adults; the adults were 
better in coping up with stress than the young most probably because 
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their antioxidant system is mature and at the optimum. The stress 
induced by the cisplatin as well as riboflavin was the highest in aged 
group of mice because of decreased levels of antioxidant enzymes and 
cellular reductants. Moreover, it is also believed that aging causes 
accumulation of free radicals with time that decreases the efficacy of 
their physiological robustness. Consequently, it makes the aged ones 
more vulnerable to the stress and infections that incorporate marked 
alteration in the proper functioning of the system leading. This thus 
can increase the adverse drug effects and related toxicity (Stephenson, 
2005; Turnheim, 2003; Zhang et a l , 2003; Kasapoglu and Ozben, 
2001). Recently, it has been reported that sensitivity to cisplatin 
increases with age whereas the tolerance level towards the drug 
induced stress and toxicity decreases with the age (Espandiari et a l , 
2010). A great deal of literature implies that tolerance level peaks up 
around adulthood (4 months) in rodents including mice and remains 
stable till 7-8 months followed by decline with age (Espandiari et a l , 
2010; Kasapoglu and Ozben, 2001). One of the major speculated 
reasons for age related differences is cisplatin pharmacodynamics. 
The treatment effects differently in the three age groups like 
glomerular filtration rate (GFR). Hence, accumulation of platinum 
would be less in young aiid adult groups compared to the old group of 
mice; hence the damage caused by cisplatin is also less in adult and 
young group (Fleck et al., 2001; Fleck, 1999). It has also been 
observed that adult and young have better regeneration and repairing 
powers against any damage incurred during toxicity or injury that 
decreases with age (Tachibana et al., 2010; Fleck et ill., 2001; 
Appenroth et a l , 1988). Many papers have reported that young mice 
have some 'silent cells' in their target organs that are activated or 
switched on upon sensing any damage that compensates the function 
of the effected target organs (Ali et a l , 2008; Appenroth et al., 1988). 
But adult mice showed better effect than the young ones because of 
their heightened robustness and best physiological status fetching 
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better response to the combination based treatments among all the 
groups. Old group of mice was lacking this robustness; hence, they 
exhibited highest sensitivity to cisplatin and riboflavin induced toxicity 
along with relatively poor response to the combination therapy. Comet 
assay has also shown that adult mice were more enduring towards 
stress exerted by cisplatin and riboflavin treatment and also 
demonstrated better improvement after the combination based 
treatment. The comet results are in accordance with simflar studies 
conducted earlier (Higami et al., 1994). Hashimoto et al. (2007) have 
reported that DNA repair activity and metabolic activation decline with 
age that causes accumulation of DNA and protein, damage. This 
consequently leads to compromised metabolic and xenobiotic activities 
in the aged organisms. Thus, the antioxidant enzymes a:nd cellular 
reductants were highly compromised with prominently enhianced level 
of MDA, carbonyl, nitric oxide together with increased comet tail-
length in the aged group. Adult group of mice have most robust DNA 
repair capacity which efficiently removes any mutation or DNA 
damage in the cells. On the other hand, young group has relatively 
low rate of invasion by damaging free radicals due to lesser extent of 
exposure (Lopez-Diazguerrero et al., 2005; Kenneth, 2004). Hence, 
antioxidant status of the adults was found to be healthy along viith 
shorter comet tail-lenglihs followed by the young ones. As the 
robustness of DNA repair system declines and accumulation of 
mutation or DNA damage increases with age, hence the old group of 
mice showed longest comet tails indicative of more DNA damage as 
compared to other groups. 
Our lab has shown that absorption spectrum of riboflavin was 
neatly enhanced by cisplatin in the aqueous medium suggesting 
existence of interaction between the two compounds. Furthermore, 
fluorescence study demonstrated quenching of the characteristic 
fluorescence of riboflavin in presence of cisplatin under dark 
strengthening the view that a weak interaction does occur between the 
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pigment (riboflavin) and medicament (cisplatin) in dark. However, the 
peak was found to ascend with cisplatin under photoillumination and 
the complex formation between the compounds increased in a 
concentration dependent trend. In the present investigation, FTIR of 
the compounds individually as well in combination in dark and under 
illumination revealed the newer peaks which were formed in the 
combination suggestive of intermolecular interaction via active groups 
in both the compounds. Mechanistic aspects of their mutual 
interaction entails that riboflavin attains active enol-form v/hose active 
groups interacts with amino groups of activated cisplatin yielding the 
new peaks in the spectra of the combination. It also indicates that cis-
diamminoplatinum oxide is formed during cisplatin activation which 
is further converted into cis-diamminoplatinum containing Pt"^  that 
attacks on the lone pairs of electrons of each nitrogen atom of 
alloxazirie ring of riboflavin possibly leading to the formation of four 
complexes between the two compounds as depicted in the following 
reaction mechanism: 
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Hence, there are possibly four types of complexes that are possibly 
formed via mutual interaction between riboflavin and cisplatin in case 
of combination. Apart from them, there is a possibility of formation of 
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an additional complex in which cisplatin molecule can be sandwiched 
between two riboflavin molecules by co-ordinate bonding between lone 
pair of electrons of nitrogen of alloxazine ring and cis-
diamminoplatinum in cis- configuration. 
It is reasonable to assume that reduction in toxicity and 
macromolecular damage observed in the combination treated groups 
of mice demonstrated by improvement in various parameters 
undertaken was because of the interaction of the two compounds 
leading to complex formation. Our results are analogous to the 
findings of Massad et aJL (2005) wherein phenylephrine was shown to 
have inhibitory action towards photogenerated oxygen active species 
originated by riboflavin. The term 'photocisplatin reagents' was coined 
for rhodhium and related metal complexes that are thennally inert; 
hence, need activation by light for induction of the thermal chemistry 
between cisplatin and the target molecule (Lognathan and Morrison, 
2005). The activity profile of cisplatin upon photoillumination differed 
in intensity from the pharmacological characteristics displayed in the 
native condition. Corde et al. (2003) has also submitted a report 
entailing that increment in DNA strand breakage occurred by cisplatin 
under light. 
The study clearly demonstrates that cisplatin treatment caused 
prominent decrease in body and brain weight as its continual dosing 
accelerates catabolic activities and reduces appetite in the treated 
animals. Cisplatin treated animals exhibited compromised level of 
antioxidant enzymes (superoxide dismutase, catalase and glutathione 
reductase) and cellular reductants (glutathione and sulfhydiyl groups) 
concomitant with markedly elevated levels of melondialdehyde and 
carbonyl content in the target organs: kidney, liver and brain. Renal 
function markers (urea, creatinine and blood urea nitrogen) and liver 
function markers (alkaline phosphates, serum glutamate pyruvate 
transaminase and serum glutamate oxaloacetate transaminase) were 
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also found to be highly elevated while brain function markers 
(glucose-6-phosphate dehydrogenase and lactate dehydrogenase) were 
abnormally low post cisplatin treatment in the mice. This pattern was 
also followed by riboflavin treated group of mice as well but the effect 
of treatment was not as strong as cisplatin. The treatment with 
combination of cisplatin and riboflavin displayed tendency of all 
parameters going towards normal in a dose dependent manner; that is 
the extent of negative effects on the parameters was decreasing with 
increasing dose of riboflavin. As we know that enzymes and proteins 
are expressions of cellular DNA, so integrity of their DNA was assessed 
by comet assay to check if there was any correlation bet^veen DNA 
damage vidth the level of enzymes and proteins. The assay depicted 
that tail-length in cisplatin treated group was the longest followed by 
riboflavin treated group of animals while the combination treated 
groups showed dose depended decrease in their tail- length. To 
confirm further, histopathological examination of the tissue section of 
the target organs (kidney, liver and brain) was performed which 
revealed that cisplatin caused extensive tissue damage and 
disintegrated tissue microstructure (features of apoptosis and 
necrosis) followed by riboflavin treatment. The combination treated 
groups showed significant improvement in dose dependent way. One 
of the most important aspects of this treatment was that the effect 
was stronger under photoillumination as compared to the ambient 
light or in absence of photoillumination for all the parameters. Hence, 
the rest of the experiments were conducted only under light. 
Thus, all the data collected post treatment confirmed that the 
treatment caused noticeaible alterations in all the parameters in the 
mice. In addition, kidney samples showed the highest alteration post 
cisplatin treatment followed by liver and brain in sequence that proves 
that kidney is the main target organ of the drug. As the investigations 
demonstrated that cisplatin-riboflavin combinations were able to 
normalize most of the parameters; hence, it pertains that cisplatin and 
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riboflavin interacted with each other as the combinations of both the 
compounds showed quite different effect than expected. Hence, 
Fourier transform infra red (FTIR) of RF and CP was conducted 
separately as well as in the combination to figure out how exactly the 
interaction between the two compounds occurred. Finally, it 
elucidated that cisplatin and riboflavin interact strongly to form 
possibly four types of complex. 
As the actual mechanism of action of cisplatin is not clear, it is 
speculated to involve complex array of mechanisms (Liu et al., 2010; 
Shukla et al., 2008; Martins et a l , 2008; Santos et al., 2007). CP-DNA 
adducts formation is considered the most basic mechanism for CP 
toxicity. These adduct may possibly impair the normal gene 
expression leading to compromised levels of antioxidant enzymes and 
stress-shooting proteins. Besides, free radical mediated oxidative and 
nitrosative stresses are also much applauded mechanism that is 
operative in our case as evidenced by perturbation in the redox status 
of the treated animals. Apart from DNA, CP is also supposed to bind 
with cellular reductants leading to compromised physiological redox 
state that may also be operative in our case. These may be the reason 
for lowering activity of major antioxidant enzymes and cellular 
reducing powers. CP is also capable of binding with various relevant 
proteins and carbohydrate moieties of the cell that can either hyper-
activate or deactivate the concerned enzymes leading to increased 
toxicity in the target organs. Together with ROS generation by CP, 
these mechanisms can also perturb the membrane of ttie cells leading 
to leakage of the enzymes or the metabolites in the vicinity of the 
organs. These might have caused in elevation of organ functions 
markers in the serum samples. The inflammatory response to counter 
the extensive damage ma}'- elevate the NO* level as well. 
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In case of RF-CP combinations, RF may combine with CP to form 
complexes too large to be intercalated between the DNA strands that 
can consequently avoid or lessen the adduct formation. The formation of 
complex may lead to the reduction in their ability to generate ROS as 
the active component of both the compounds involved in excitation and 
generation of ROS, are possibly interacting due to higher affinity for 
each other. Hence, there is down-regulation in free radical generation 
leading to lowering of oxidative stress in general under combination in 
vivo. This could be responsible for decreased inflammation and hence 
decreased RNS generation in vivo. The complex formation may also 
evade CP to bind with other proteins, enzymes and carbohydrate 
moieties of the cells. RF may counter majorly ROS generating potential 
of CP as well as minimize the adduct formation with DNA and 
interaction of CP with other macromolecular content of the cells. This is 
how RF was able to help the mice recovering from CP induced insults in 
the combination treated groups. Nevertheless, the possibility of other 
unexplored mechanism operating in CP- induced toxicity in vivo cannot 
be ruled out in our case also. 
H 
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A B S T R A C T 
Cisplatin is a widely used anticancer drug. It is documented that it elicits major side effects like nephro-
toxicity and hepatotoxicity due to oxidative stress forcing the patients to limit its clinical use in long term 
treatment. Riboflavin (vitamin B2) is a strong photosensitizer because it generates reactive oxygen spe-
cies (ROS) upon photoillumination. We have tried to trap its photosensitizing property to ameliorate 
the cisplatin induced nephrotoxicity and hepatotoxicity in mice. They were treated with riboflavin and 
cisplatin separately as well as with their combination under photollluminated condition. The status of 
major antioxidant enzymes, antioxidant proteins, functional markers, lipid peroxidation and protein oxi-
dation was studied in liver, kidneys and serum samples of all the groups. Cisplatin treated group showed 
significantly compromised level of antioxidant enzymes and the proteins with higher extent of lipid and 
protein oxidation. Similar but less pronounced pattern was observed in the riboflavin treated group. The 
groups treated with the combination of cisplatin and riboflavin showed all the parameters tended 
towards normal levels in a dose dependent manner. Hence, it can be hypothesized that riboflavin shows 
ameliorative effect on the cisplatin induced nephrotoxicity and hepatotoxicity under the mentioned 
treatment conditions. 
© 2010 Elsevier Ltd. All rights reserveji 
1. Introduction 
Cisplatin (cis-diamminedichloroplatinum II, CIS) is platinum 
coordinated complex based anticancer drug used against many hu-
man cancers including oral, lung, head and neck cancer, metastatic 
tumors of testis and ovaries, advanced bladder cancer and many 
other solid tumors (Gottfried et al., 2008; Turk et at., 2008). In spite 
of its effective anticancer behavior, it exerts many unwanted side 
effects including nephrotoxicity, hepatotoxicity, ototoxicity, 
emetogenesis myelosuppression and spermiotoxicity (Tarladacali-
sir et al.. 2008; Liao et al., 2008; Atessahin et al., 2006; Mc Keage, 
1995). Hence, these major side effects limit the clinical use of the 
drug. 
The anticancer property of QS comes from its ability to bind to 
N-7 of purine bases of cellular DNA leading to formation of mono-
adducts which are later transformed into inter- and intra-strand 
cross links by reaction of second reactive site of the drug with 
the second nucleobase (Hah et al., 2006; Fichtinger-Schepman 
et al., 1985). This is inhibitory to fundamental cellular processes 
/4i)6revian'ons: BUN. blood urea nitrogen; QS. cis-diamminedichloroplatinum 11; 
ROS. reactive oxygen species; RF. riboflavin; -SH, sulfhydtyl groups. 
• Corresponding author. Tel; +91 571 2700741; fax; +91 571 2706002. 
E-mail addresses: iftekharhassan2002@gmaii.com (I. Hassan), sandeshchibber® 
gmail.com (S. Chibber). imrananaseem2009@igmail.com (I. Naseem). 
including replication, transcription, transjlation and DNA-repair in 
many cell types (Suo et al., 1999). Beside these, CIS generates oxii-
dative and nitrosative stresses (Srivastava et al., 1996; Xiao et al., 
2003) because of depletion or inhibition of antioxidant enzynns 
and proteins which results into nephrotoxicity and hepatotoxidl^ 
as major side effects of the drug (Iseri et al., 2007; Nazirogiu et al., 
2004). 
Riboflavin (RF) or vitamin B2 is chemically 6,7-dimethyl-9-D-l-
ribityl isoalloxazine. It is a natural constituent of all forms of life, 
exists in the two co-enzymatic forms - flavinadenine dinucleotide 
(FAD) and flavinadenine mononucleotide (FMN) that are used in 
metabolic redox reaction by different enzyme-systems. It also acts 
as photosensitizer via radical species or via the generation of sin-
glet oxygen. It reacts via its singlet and triplet excited states with 
molecular oxygen leading to generation of superoxide anion, ribo-
flavin radical (Kumari et al., 1996) and generates hydroxy! radical 
in presence of transition metal ions (Yoshida et al., 2003). These 
species exert a collective damaging effect on several biologically 
important molecules (Jazzer and Naseem, 1994,1996) and can also 
affect the drugs as well as the medicines (Cosa, 2004). Apart from 
being an essential vitamin, its photosensitizing property makes it 
an effective agent for photodynamic therapy in killing tumors 
(Edwards et al., 1994), inactivation of neurotoxin A (Eubanks 
et al., 2005), treatment of neonatal hyp(;rbilirubinemia, blue nevi, 
pigmented skin lesions (Sato et ai., 2000) and sterilization of blood 
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products (Cui et al., 2008). The present study was designed to en-
large the therapeutic window of RF to regulate the nephrotoxic and 
hepatotoxic effects of CIS in mice as animal model system. It is a 
preliminary attempt to suggest alternative regime for the cancer 
patients undergoing CIS based chemotherapy based on our earlier 
in vitro observation. 
2.6. Estimation of /ipid peroxidation and frotein oxidation 
The extent of lipid peroxidation was estimated by the method of Beuge and 
Aust (1978) involving the measurement of total melondialdehyde (MDA) which Is 
the major product of lipid peroxidation. IProtein oxidation was measured by estima-
tion of total carbonyl content (Levine et al.. 1994) Chat is Che final product of the 
oxidation. 
2. Materials and methods 
2.1. Chemicais 
Riboflavin, cisplatin, reduced and oxidized glutathione, nicotinamide adenine 
dinucleotide phosphate reduced (NADPH). nicotinamide adenine dinucleotide re-
duced (NADH) were bought from Sigma-Aldrich Chemical Company, USA. Succinic 
acid, potassium dihydrogen and monohydrogen phosphate, glycine, pyrogallol, 
hydrogen peroxide, trichloroacetic acid (TCA) and ethylenediaminetetra-acetic acid 
(EDTA) were purchased from Qualigens Fine Chemicals, Mumbai, India. Folin's phe-
nol reagent, bovine serum albumin (BSA), (l-mercaptoethanol, sulphosalicylic acid 
were bought from Sisco Research Laboratory. Mumbai, India. p-Nitrophenyl phos-
phate (pNPP), l-chloro-2.4-dinitrobenzene (CDNB) and thiobarbituric acid (TBA) 
were purchased from HiMedia Laboratories Pvt. Ltd.. Mumbai, India. Rest all other 
chemicals used were of analytical grade. 
22. Animal treatment strategy 
Thirty-sb( adult Swiss albino male and adult mice (48-50 g, 6 months old) were 
bought from the central animal house, Jamia Hamdard University, New Delhi, India. 
They were kept and treated under humane and hygienic conditions (25 ± 5 °C with 
12 h day:night cycle) in accordance with the institutional guidelines. They were al-
lowed to acclimatize for 10 days prior to the treatment on standard pellet mice diet 
(Ashirwad Industries, Chandigarh, India) and fresh drinking water ad libitum. All 
the animals were randomly divided into six groups - control normal was named 
as group I, control as group II. riboflavin (RF, 2 mg/kg body weight) treated as group 
III, cisplatin (CIS, 2 mg/kg body weight) treated as group IV and combination of cis-
platin and riboflavin in ratio of 1:0.5 and 1:1 as group V (OS + RF1) and group VI 
(CIS + RF2). Each group had five to six mice. Among them, groups II, HI, IV, V and 
VI were exposed to visible light (Philips tube light, 40 W, 5 cm distance) during 
day-time for 12 h except group I. A/I the doses were injeaed intraperitoneally with 
40 units (1 ml) insulin syringe and. saline was used as vehicle of RF and CIS. In the 
combinational groups V and VI, RF was injected prior to CIS at the interval of 
30 min. The control, group 11 was given only saline of equal volume to that in the 
treated groups, whereas control normal, group I was kept as such. 
The treatment was continued for 1 month at the rate of 2 doses/week. The dor-
sal surface of all the mice (except group i) was mildly shaved for maximum possible 
penetration of light through the skin. The strategy, dose and the duration of treat-
ment were chosen to study the chronic effect of the treatment at moderately toxic 
dose of the drug. The treatment was scheduled in such a way that all the animals 
were sacrificed on the same day under light chloroform anesthesia. Their kidneys, 
livers and blood (vrith anticoagulant) were collected. The otgans were washed with 
saline (with EDTA) and then kept in cold saline buffer in deep freeze. 
2.3. Preparation of samples 
The blood was centrifuged at 2500 rpm (1500g) for 10 min to collect their ser-
um which was later stored in cold. Their kidneys and livers were also homogenized 
separately at 5000 rpm (3000g) in potassium-phosphate buffer (pH 7.36,0.1 M) and 
their supematants were taken-out for biochemical assays and estimations. Prior to 
it, 1 ml of homogenate of each mouse is saved for reduced glutathione (GSH) esti-
mation. All the samples were labeled properly and kept in -20 °C for further 
analysis. 
2.4. Effect of the treatment on body weight of the mice 
The body weight of all mice was noted before and after the treatment to see ef-
fect of the treatment on the animals. 
2.5. Assoy o/antioxidant enzymes 
The activity of different antioxidant enzymes were assayed with standard pro-
tocols. Cu Zn superoxide dismutase (CuZnSOD) was assayed by autoxidation of 
pyrogallol (Marklund and Marklund. 1974) while that of catalase (CAT) was done 
by decomposition of hydrogen peroxide (Aebi, 1984).The activity of glutathione-
s-transferase (GST) was measured by Habig et al. method (1974). Glutathione 
reductase (GR) activity was carried-out by the method involving oxidation of 
NADPH into NADP+ in presence of oxidized glutathione (Carlberg and Mannervik, 
1985). Assay of alkaline phosphatase (ALP) was done by Shah et al, method (1979). 
2.7. Estimation of GSH level and -SH groups 
The level of reduced glutathione (GSH) was estimated by method of Jollow e r al. 
(1974) while that of total sulfhydryl groups (-SH) was measured by Sedalk and 
Lindsay method (1968). 
2.S. Estimation of urea as kidney /iinction marker 
The level of urea was estimated in the serum by the commercially available 
diagnostic kits (Span Diagnostics Limited, India). 
2.9. Estimation of GOT and GPTas liver function markers 
The activity of glutamate pyruvate transaminase (CPT) and glutamate aunUiv-
etate transaminase (COT) in the serum was assayed by commercially available esti-
mation kits (Span Diagnostics Limited, India). 
2.10. Statistical onalysis 
All the data have been expressed as in mean ± standard error of mean (SEM) for 
5-6 different preparations in duplicate. Their statistical significance was evaluated 
by one-way ANOVA software. The probabiliti/ of occurrence was selected at 
p 5 0.05. The treatment and the experiments were repeated twice to checitrepro-
dudbility of the results. 
3. Results 
The animals were given 8 intraperitoneal doses of the treat-
ment. They were sacrificed all together on the same day. Major tar-
get organs of the treatment - kidney and liver and the blood of all 
mice were collected. Their organs were homogenized and blood 
was centrifuged to get the supematants and the serums, respec-
tively, at - 4 °C and was stored at -20 °C after that. Their biochem-
ical study and analysis were camed-otit to see whether the guuijs 
fifth and sixth showed any recovery or healing from the CIS-in-
duced nephrotoxicity and hepatotoxicity. Minor fluctuations in 
readings were observed on repetition of the assays and the estima-
tions. All parameters have been expressed in mean ± SEM wkA' S/ 
change (in parentheses marked by *) from the control (group 11) 
in the all the tables for groups III and IV and % recovery (in paren-
theses marked by'') for groups V and \^ as compared to the fourth 
group. 
3. J. Efled of the treatment on body wey^ht 
Before starting of the treatment, weight of all the mice was in 
the range of 49-50 g/mouse but after the treatment, there was 
noticeable decline in all the groups except group 1. The average 
body weight of groups III and IV decreased by 4.05% and 14.65%. 
Table 1 
Effect of the treatment on body weight (in g) of the mice (6 mice per group). 
Croups 
1 
11 
in 
IV 
v VI 
Before treatment 
49.8 ±0.50 
50.2 ±0.50 
49.4 ±0.30 
49.5 ±0.80 
49.6 ±0.70 
50.0 ±0.30 
Alter treatment 
50.25 ± 0.32 
49.50 ±0.50 
47.40 ±OJ25 
42.251032 
4'1.12±0.23 
46.25 ±0.32 
XChag^ 
+<U0 
-139 
-4flS'' 
- 1 « S » 
-11.05"^' 
-7.50^' 
' % Change from control. 
"• % Change from CIS. 
"^  Significantly different at p < 0.05. 
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respectively, compared to the weight before the treatment. The 
hair quality of the fourth group was also not as smooth and lus-
trous as that in the groups II and III of mice. These could be the 
obvious side effects of chemotherapy (Table 1). 
3.2. Effect of the treatment onto the antioxidant status 
Four major antioxidant enzymes - CuZnSOD, CAT, ALP and GR, 
were assayed in all organ samples. It was observed that group I 
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Fig. 1. Effect of the treatment on specific activity of antioxidant enzymes in target organs, (a) CuZn SOD; (b) CAT; (c) ALP; (d) GR. CuZn SOD, copper zinc superoxide 
dismutase; CAT, catalase; ALP, all<aline phosphatase; GR, glutathione reductase; mg. milligram of protein in the sample. Result;: have been expressed in mean ± SEM of 
different samples. 'Significantly different at p < 0.05. 
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which was neither under any treatment nor under photoillumina-
tion, showed maximum activity of all the enzymes in both kidney 
and liver samples, followed by the second group which was kept 
under photoillumination but was given no treatment. The specific 
activity of all the enzymes decreased most significantly in the CIS-
treated group, whereas the RF treated group also showed a mild 
dip in all the enzymes with respect to the control group II. The 
combinational groups V and VI, showed a recovery in all the enzy-
matic activities in a dose dependent manner. All the enzymes 
showed better recovery of activity in kidneys in case of the combi-
national groups except ALP which showed better recovery in their 
liver samples. The most effected enzyme among all after CIS treat-
ment was GR which showed inhibition by 62% and 55% in kidney 
and liver, respectively, followed by 61% decline of SOD and CAT 
both in kidney. Group III also showed the decline in the enzymes 
but it was not as pronounced as in group IV. As far as recovery is 
concerned, SOD, GR and CAT showed highest % recovery in kidney 
of group VI by 121%, 121% and 116%, respectively (Fig. la-d). 
3.3. Effect on activity of GST 
GST is considered as the main detoxifying enzyme for drugs and 
xenobiotic compounds along with other supporting enzymes in li-
ver and kidney. Hence its activity level was taken as toxicity mar-
ker in the target organs. The RF treated group III showed drop in 
activity by 13% in kidney and 8% in liver, whereas CIS-treated 
group IV exhibited 38% decrement in kidney and 51% in liver. 
The % recovery was 28 and 47 in group V and; 40 and 71 in group 
VI in kidney and liver, respectively (Table 2). 
3.4. Effect on the lipid peroxidation and the protein oxidation 
MDA levels and carbonyl contents are considered as final prod-
ucts for estimation of lipid and protein oxidation, respectively. 
Group III showed the lipid peroxidation enhancement by 24% in 
kidney and 19% in liver while group IV showed tremendous incre-
ment of the same by 131% and 191% in kidney and liver, respec-
tively. In groups V and VI, its level decreased significantly 
showing the recovery of 44-48% in kidneys and 54-59% in liver 
with increasing dose of RF (Table 3). 
a s and RF treatment also caused protein oxidation in thenKffi. 
The carbonyl content was enhanced in group 111 by 50% in kidhey 
and 27% in liver while it shot up to 154% and 191% in kidney and 
liver, respectively, in the fourth group. But, there was also appre-
ciable recovery in the groups V and VI. The % recovery in the fifth 
group was 44 in kidney and 56 in liver while it was 53 and 62 in 
kidney and liver, respectively, in the sixth group (Table 3). 
Table 2 
Effect of the treatment on the major detoxifying enzyme. GST. 
GST (units/mg) IV VI 
Kidney 
Uver 
85.00 ± 6.29 
119.41 ±5.03 
87.76 ±7.39 
121.45 ±5.65 
76.46 +5.23 ( - l a r 
111.60 + 4.87 ( - s r 
54.75 ± 4.03 ( - 3 8 r 
59.65 ±6,25 (-51 r 
70.13 ± 2.86 (+28r 
87.50±6.22 (+47)"'^  
76.60 ±3.89 {+40)"' 
102.09 ±7.04 (+71)"'^  
GST, glutathione-S-transferase; mg, milligram of protein in the sample. 
Results have been expressed in mean ± SEM of different samples. 
' Values In parenthesis indicate % change from control. 
'' Values in parenthesis indicate % change from CIS. 
' Significantly different at p < 0.05. 
Table 3 
Effect of the treatment on extent of oxidation of the macromolecules. 
End-products I II IV VI 
Ijpjd peroxidarion/totol MDA level (nmol/mg) 
Kidney 0.50 + 0.02 0.51±0.07 0.63 ±0.03 (+24^-' 1.18±0.06 (+131)" 0.66±0.06 (-44)"' 
Liver 0.64±0.03 0.67±0.05 0.80±0.07 (+19)*' I.95±0.15 (+191)'' 0.90±0.02 (-54)"' 
Protein oxidation/total carbonyl content (nmol/mg) 
Kidney 5.88±0.04 5.94±0.09 8.90 + 0.13 (+50)'-' 15.11 ±0.2 (+154)" 8.50±0.24 (~4<0"-' 
Uver 9.87±0.24 9.99±0.38 12.69±0.3 (+27)" 29.05±0.3 (+191)" 12.83±0.6 (-56)"' 
0.61 ±0.09 (-48)"' 
0.81+0.04 (-59)"' 
7.11 ±0.30 (-53)"' 
11.05 ±0.41 (-62)"' 
MDA, melondialdehyde; nmol/mg, nanomoles per milligram of protein in the samples. 
Results have been expressed in mean + SEM of different samples. 
' Values in parenthesis indicate % change from control. 
" Values in parenthesis indicate % change from OS. 
' Significantly different atp< 0.05. 
Table 4 
Effect of the treatment on antioxidant proteins. 
Antioxidants I IV VI 
Level of GSH (nmol/mg) 
Kidney 37.61 ± 1.04 37.55 ± 1.49 
Uver 59.71 ±0.93 57.34 ±0.58 
Total -SH groups content (tm^ol/mg) 
Kidney 0.50 ±0.02 0.47 ±0.01 
Uver 0.72 + 0.02 0.68 ± 0.02 
30.24+ 0,63 (-20)*' 
52.19±1.37(-9)'' 
0.39 ±0.01 (-17)*' 
0.60 ±0.01 (-12)*' 
17.65 ± 0 7 (-53)^-' 
29.65 ± 1.92 (-48)'' 
023 ±0.02 (-55^' 
0.42+ 0.02 (-43)" 
28.61 + 136 (+62)"' 
48.57 ±0.35 (+64)"-' 
OJ6±0.01 (+57)"' 
0.56 + 0.01 (+33)"' 
3131 ±1.49 (+77)"-
51.50 ±0.37 (+74)"-
0.42 ±0,01 (+83)"' 
0.63 ±0,02 (+50)"' 
GSH, reduced glutathione: -SH, sulfhydryl groups; nmol/mg, nanomoles per milligram of protein in the samples. 
Results have been expressed in mean ± SEM of different samples, 
' Values in parenthesis indicate % change from control, 
" Values in parenthesis indicate % change from CIS, 
' Significantly different at p < 0,05, 
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3.5. Effect of the treatment on -SH groups and GSH level 
Both, -SH and GSH are indicative parameters of redox status of 
any living system that help to counter oxidative stress along with 
the antioxidant enzymes. GSH level was affected by the treatment 
as group HI showed decrement by 20% and 9% in kidney and liver, 
respectively. Hitherto, group IV showed much lower level of the 
same by 53% in kidney and 48% in liver. The recovery shown by 
the group fifth and sixth was 62% and 77% in kidney; 64% and 
74% in liver, respectively (Table 4). 
The -SH level, in group III was also observed to deaease by 17% 
in kidney and 12% in liver, whereas group IV showed decline by 
55% and 43% in kidney and liver, respectively, of the same As % 
recovery is concerned, it was 57% in kidney and 33% in liver of 
group fifth although the sixth group showed better recovery, i.e., 
by 83% in kidney and 50% in liver (Table 4). 
3.6. Effect of the treatment on kidney function markers in serum 
Urea was chosen as kidney function marker in serum samples. 
Its level was found to be 34% higher in the third group's serum 
while group IV showed 98% inaement in the serum as compared 
to the control (Fig. 2). The graph also shows the recovery of the 
marker towards the normal levels after the combinational treat-
ment as shown by groups V and VI. The group fifth exhibited the 
level of urea recovered up to 28% from CIS induced damage in ser-
um while it showed better improvement in sixth group by 37% in 
the serum (Fig. 2). 
40 
if ' 
1 
.1 -1 II 
1 I 
II m 
Treatment grotips 
Fig. 2. Effect of treatment on urea, a serum kidney function marker. mg/lOOml. 
milligram per 100 milliliters of the samples. Results tiave been expressed in 
mean ± 5EM of different samples. 'Significantly different at p < 0.05. 
3? 
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Fig, 3. Effect of treatment on liver function markers in serum. lU/U international 
units per liter of the sample; GPT, glutamate pyruvate transaminase; GOT. 
glutamate oxaloacetate transaminase. Results have been expressed in mean ± SEM 
of different samples. 'Significantly different at p < 0.05. 
The levels of creatinine and BUN were also affected following 
similar pattern as urea (data not shown). 
3.7. Effect of the treatment on liver function markers in serum 
The level of glutamate pyruvate transaminase (GPT) and gluta-
mate oxaloacetate transaminase (GOT) was estimated in serum 
samples as the liver function markers. 
The treatment had markedly affected the liver specific enzymes. 
There was increase in the level of GPT by 252% in serum of gnxq) 
IV. Group III also showed the increiised level of GPT by 36% in their 
serum samples. In case of GOT, the third group serum samples 
showed minor raised level by 39% while the fourth group exhibited 
significant increment up to 228% in serum (Fig. 3). 
This graph also suggests that liver function markers are ele-
vated in the serum due to release of the enzymes from damaged" 
liver. This was not so in the QS-RF combinational treatment as 
shown by groups V and VI. Group VI showed better recovery 
dependent on the dose of RF (Fig. 3). 
4. Discussion 
Cisplatin (CIS) is one of the most widely used anticancer drug 
for the treatment of various cancers and solid tumors (Sweetman, 
2002). However, its major side effects - nephrotoxicity and hepa-
totoxicity are the main limiting factors of its clinical use for long 
term treatment (Antunes et al., 2000; Zicca et al.. 2002). Various 
treatment-strategies and curing agents have been tried and used 
to monitor or control its side effects since its discovery. Eariier 
studies from our lab have shown that photoilluminated riboflavin 
(RF) can ameliorate the toxic effects of CIS via interaction at molec-
ular level in situ in keratinocytes (Husain and Naseem, 2008). The 
present part of our work is an attempt to see whether our in situ 
observation holds true in vivo or not 
Administration of CIS to mice resulted in decrease in the body 
weight of the animals. This weight loss observed in the CIS-trea-
ted group may be because of reduced appetite and enhanced cat-
abolic rate which are considered as the obvious side effects of 
chemotherapy. It could be also due to CIS-induced dysfunction 
of the gastrointestinal system. The treatment affects the target or-
gans - kidneys and liver as evidenced by their elevated functional 
markers in the serum of the CIS-treated group. This is a clear indi-
cation of nephrotoxicity and hepatotoxicity caused by CIS as the 
markers are released by the damaged organs in the circulatory 
system. A marked recovery was observed in the markers post-
combination treatment by CIS with RF. Several possible mecha-
nisms have been proposed to explain the pathological status of 
kidney and liver post-CIS treatment (Martin et al., 2008; Tikoo 
et a!., 2007). 
In eariier studies, it is documented that CIS is accumulated in 
its target organs by covalentiy binding with their proteins (Perra 
et al., 1992). This can affect their antioxidant enzymes which are 
the first line of defense against iiny oxidative insult to the cells. 
This may be the primary factor behind the alteration in the 
parameters observed in group IV. It is obvious from our results 
that CIS caused nephrotoxicity and hepatotoxicity evidenced by 
marked decline in activity of the antioxidant enzymes (SOD, 
CAT, ALP and GR). RF being photosensitive gets activated under 
photoillumination and generates free radicals. Hence, the effect 
of RF on all the parameters observed in the RF treated group 
HI was similar to group IV but not as pronounced as seen in 
the later indicating that RF is toxic under light but not as much 
as CIS. 
GST is considered as the main detoxifying enzyme for drugs and 
xenobiotic compounds along with other supporting enzymes in 
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liver and kidney. Hence its activity level was taken as toxicity 
marker in the target organs. Its level in group IV also showed sig-
nificant decrement in activity (Hanigan et a!., 2001). The multiple 
doses of a s given may have exerted abundant toxic burden on 
the enzyme so much that it was either insufficient to counter the 
toxicity or it may have been inhibited or its expression may have 
been affected. 
Reduced glutathione (GSH) is considered as a sensitive oxida-
tive stress marker because it helps to maintain the integrity of 
mitochondria and cell membrane. Its compromised level in the 
cells may deteriorate the membrane permeability and risks the cel-
lular defense against ROS resulting in oxidative injuries (Younes 
and Siegers, 1981). Many glutathione based antioxidant enzymes 
and proteins (GST, GR, GSH and -SH) are important to maintain re-
dox status of the cells. All these enzymes utilize glutathione (GSH) 
in the reactions they catalyze which may lead to depletion of GSH 
and -SH groups in the living system in the condition of oxidative 
stress. This may be the possible reason for decreased level of 
GSH and -SH level in target organs in OS treated mice (Cayir 
et al., 2009). On the other hand, GSH may also cause metal reduc-
tion as thiol-part of it is highly reactive to the alkylating agents like 
CIS. There are also evidences that CIS can bind to GSH and gets 
metabolized via y-glutamyl transpeptidase pathway which may 
also contribute to nephrotoxicity and hepatotoxicity in mice due 
to the depletion of GSH in the target organs (Hanigan et al., 
2001). From literature, it is clear that CIS induces lipid peroxidation 
by excessive free radical generation (Younes and Siegers, 1981) 
that can lead to oxidation of cell membrane lipids and the lipid 
of membrane surrounding organelles in the target organs deterio-
rating the membrane functions. Hence, it is possible that CIS gets 
access to the nuclear and the organelle DNA (Corde et al., 2003) 
and proteins directly or indirectly (Perra et al., 1992) which may 
either inactivate or degrade or hamper their activity and hence it 
can effect their biological functions as well. This could be the ulti-
mate possible reason for decline in the activity of antioxidant en-
zymes and depletion in the levels of protective groups (GSH and 
-SH) in group IV. 
Groups V and VI showed significant recovery in all the parame-
ters taken in the experiments in a dose dependent manner. The 
antioxidant enzymes and proteins tended to rise towards normal 
levels along with recovery in the extent of lipid peroxidation, pro-
tein oxidation and the level of target organ function markers 
(including BUN and creatinine in serum samples) to appreciable 
levels in a dose dependent way. This observation in both the 
groups V and VI could be explained on the basis of previous studies 
demonstrating the ameliorative effect of RF on cisplatin induced 
damage to the system in vitro as well as in situ (de Souza et al., 
2006; Husain and Naseem, 2008). We have previously shown 
recovery from oxidative damage in the presence of CIS-RF combi-
nation compared to RF alone or CIS alone through UV-vis and fluo-
rescence spectra (Husain and Naseem, 2008). We have also 
demonstrated the recovery to protein damage when exposed to 
this combination supporting our in vivo results. Previously, it has 
been demonstrated that the photoproducts of RF can act as adju-
vants with chemotherapy leading to the activation of Fas ligand 
- Fas mediated apoptosis in human prostrate cancer cell line 
(PC3) as well in leukemia (de Souza et al., 2006; de Souza Queiroz 
et al., 2007). 
In our case, when CIS is used in combination with RF, the toxic-
ity of the drug is possibly minimized via interaction of CIS with the 
excitable electrons of the alloxazine ring of RF when exposed to 
light, there by inhibiting the ROS generation. At the same time, 
RF may be helpful in inducing apoptosis in cancer cells via induc-
tion of Fas-Fas ligand mediated caspase pathway, possibly making 
CIS-RF together, a more effective chemotherapeutic combination 
against solid tumors. 
5. Conclusion 
It may be hypothesized that the excitable electrons in allox-
azine ring of RF may interact with the active groups of CIS at the 
molecular level which may possibly lead to decreased producaon 
of ROS by CIS thereby reducing the oxidative stress as well as sup-
pressing the riboflavin prooxidant potential leading to decreased 
ROS generation in the target organs and correspondingly improved 
status of the organs effected by CIS toxicity. Hence, our work opens 
a novel window to manage CIS-induced nephrotoxicity and hepa-
totoxicity in the cancer patients undergoing chemotherapy with 
CIS that can lessen their suffering and may prolong their survival. 
Our findings can also help to design better and safer platinum 
based anticancer drugs but more in vivo studies and clinical trials 
in the cancerous mice strains or patients are required to be done in 
future to establish this hypothesis. 
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